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Scientific research in the last decades has revolutionized our insight in how 
microorganisms colonizing the human body correlate with and even impact our health. 
Microbiological research has come a long way from the 1680s when Antonie van 
Leeuwenhoek compared oral and fecal microbiota and found specific differences according 
to sample origin and even health status. From there, the field of microbiology developed 
slowly, until the late 1800s when Louis Pasteur and Robert Koch postulated and proved that 
microorganisms are the cause of infectious diseases. Further research was mainly focused 
on these pathogenic microorganisms and the treatment of infected people, which lead to the 
discovery of antibiotics. This discovery and the development of vaccines in the mid-1900s, 
strongly reduced the incidence of diseases like pneumonia, tuberculosis, meningitis, polio 
and so on. Parallel to the study of the pathogenic microorganisms in the late 1800s, the use 
of beneficial bacteria to improve health was introduced. Henry Tissier reported that acute 
gastroenteritis could be cured by intake of bifidobacteria and together with Elie Metchkinov 
they introduced the idea that the intake of probiotics is beneficial for human health (Ozen and 
Dinleyici, 2015). But it was only at the end of the twentieth century that research focus shifted 
from pathogens to the large amounts of commensal microorganisms living in and on the 
human body, without causing (direct) harm. These viral, archaeal, fungal and mainly bacterial 
communities are referred to as the human microbiota, and their collective genomes are 
called the microbiome.  
These commensal bacteria are most densely populated in the human gastrointestinal 
tract, mainly in the colon. Research has shown how intricate the microbe-microbe and the 
host-microbe interactions are and how subtle imbalances in our microbial populations can 
cause disease. Previous studies show a correlation between gut microbiota composition and 
obesity (Ley et al., 2006), inflammatory bowel diseases (Walker et al., 2011), diabetes 
(Karlsson et al., 2013),… The prevalence of these diseases has strongly increased over the 
past decades, initially solely observed in Western countries but more recently also in 
developing countries, and it is still increasing (Mosca et al., 2016). In 2016, 650 million adults 
were obese (13%), and an estimated 422 million adults were suffering from diabetes (WHO, 
2017). Inflammatory bowel disease (IBD), which comprises Crohn’s disease and ulcerative 
colitis, affects more than 3.6 million people (Loftus, 2004). The possibility to remedy these 
conditions or mitigate their symptoms by interventions on the gut microbiota has inspired 
many researchers to investigate, unravel, and understand the complex microbial community 
and its interaction with the human host. Large scale human studies, such as the Human 




Microbiome Project, MetaHIT, the Flemish Gut Flora Project… were set up to understand the 
links between gut bacteria, health and lifestyle.  
Interestingly, scientific research has shown a negative correlation between the 
prevalence of above-mentioned diseases and the abundance of Akkermansia muciniphila, an 
important mucin degrading microbe in the human gut. While no causal relationship between 
Akkermansia and human health status has been established yet, several animal models for 
disease have demonstrated Akkermansia’s (or Akkermansia derived products) potential to 
improve health markers. There are several knowledge gaps on the ecological integration of 
Akkermansia in the human gut. In light of these recent developments, this PhD research will 
focus on studying Akkermansia muciniphila and the mucin degradation niche in complex 
microbial ecosystems. This chapter will introduce the complexity of this microbial ecosystem, 
discussing both the host, the microbiota and their interaction, by giving a general informative 
overview and gradually zooming in on the PhD topic of Akkermansia muciniphila and mucin 
degradation. 
 
1. Gut microbiome and health 
The fact that we have a human microbiota, isn’t surprising when we consider that 
bacteria have thrived on this planet for 3.5 billion years, animals for half a billion years and 
humans for just 200.000 years. So our entire evolution, from our oldest ancestor until now, 
has happened in the presence of bacteria. Many of the genes that were responsible for the 
evolutionary inventions that led to humans and certainly those involving signaling and 
immune regulation were in part driven by the interaction with the microbiome (Domazet-Loso 
and Tautz, 2008; McFall-Ngai et al., 2012). Moreover, not only have we evolved with these 
bacteria, they have co-evolved with us. Studies have shown that free-living bacterial 
communities from very different environments, even extremes like acidic hot springs, are 
more similar to each other than the mammalian gut microbiota. This indicates a co-evolution 
over millions of years between vertebrates and their microbiota that has resulted in a 
community that thrives in the gut environment (Ley et al., 2008; Pace, 1997). 
The human microbiota is not confined to just the gut environment; also other outer and 
inner surfaces of the human body are colonized with bacteria (Figure 1.1). The skin hosts a 
maximal concentration of 1011 bacteria per m2, saliva contains 109 bacteria per mL, dental 




Figure 1. 1: Microbial community composition (relative abundances of the six dominant bacterial phyla) at 
different body sites in healthy people. Figure derived from (Spor et al., 2011). 
The most densely populated area of the human body is the large intestine (colon) with 
1014 bacteria. Each body site (gut, skin, oral nasal, urogenital) is home to a unique 
community and also within body sites there are vast differences, for example different areas 
on the skin (armpits versus bellybutton), in the mouth (tongue versus buccal) and in the gut 
(stomach versus colon) (Costello et al., 2009).  
The total amount of bacterial cells equals that of the human cells, meaning that our 
body is 50% human and 50% bacterial (Sender et al., 2016) and the microbiome contains 
around 3 million microbial genes, which is 100 times more than the 23.000 human genes in 
our own genome. The human genome, inherited from our parents, was generally thought to 
be stable during life compared to the dynamic microbiome that is influenced by 
environmental and host factors. However over the years, research has shown that our 
genome as well can be affected by environmental, so-called epigenetic factors, changing the 
epigenome (Simmons, 2008). The metabolic capacity of the microbiome is enormous, as well 
as its influence on the human host and is sometimes called ‘our forgotten organ’. The 
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microbiome has the capacity to carry out more biochemical conversions than the liver, it 
protects against opportunistic pathogens, it manages the immune system, produces health 
beneficial compounds (vitamins, short chain fatty acids, ..) and breaks down indigestible food 
compounds (Thursby and Juge, 2017). SCFA, such as acetate, propionate and butyrate, are 
produced by bacterial fermentation activity. Propionate plays a role in gluconeogenesis in the 
liver, acetate is used in lipogenesis and butyrate has anti-carcinogenic effects and is the 
major energy source for colonocytes (Louis and Flint, 2017; Pryde et al., 2002; Scott et al., 
2008). 
It is important to remember that besides bacteria, the human microbiome also includes 
Archaea, viruses, and eukaryotes: Methanobrevibacter smithii is a member of the Archaea 
and involved in cross-feeding with bacteria (section 3.4); the virome is expected to be unique 
for each individual and an integral part of the healthy human ecosystem; eukaryotic members 
of the microbiome include fungi such as Candida and Saccharomyces. Insight in the 
functionality of these organisms within the microbiome is very limited since molecular-
profiling techniques are mainly developed for bacteria (Lloyd-Price et al., 2016). Knowledge 
about the taxonomy of the bacterial microorganisms and their abundance in different parts of 
the human body is increasing. However, knowledge is still lacking about how they function as 
a system: their interactions, which of these fulfill key functions, and how sensitive their 
community is (Jordan et al., 2015). In a healthy, normal situation our microbiome provides us 
with health benefits, but when homeostasis is disturbed, it can have short- and long-term 
consequences for human health with several areas of host health that are compromised. The 
gut microbiota is for instance responsible for the production of essential vitamins such as 
folic acid, biotin and vitamin K, provides colonization resistance, it plays a role in host energy 
metabolism possibly contributing to overweight problems and it is considered an important 
modulator of our immune system (Thursby and Juge, 2017; Turnbaugh et al., 2006). 
1.1 Key health functions 
Mucosal surfaces, like the colon, constitute the largest and most important interaction 
between the body and the outside environment and the mucosal epithelial cells are 
continuously exposed to pathogens. They are protected by both innate, such as the epithelial 
barrier, and adaptive immune systems, such as the mucosal immune system. 
1.1.1 Epithelial barrier 
The intestinal barrier is a multi-layered defense mechanism that protects our internal 
milieu against the harsh external environment in the gut lumen, preventing intrusion of 
antigens, while also allowing absorption of nutrients (Figure 1.2). In the lumen, commensal 
bacteria produce antimicrobial substances to inhibit colonization of pathogens. The mucus 
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layer between the lumen and the epithelial cells is a viscous gel matrix made up of mucin 
glycoproteins, trefoil peptides and surfactant lipids. It protects the epithelium from mechanical 
damage from food particles and due to its high concentration of sIgA and antimicrobial 
peptides (AMPs) it protects against bacterial invasion (Atuma et al., 2001; Meyer-Hoffert et 
al., 2008). Below the mucus layer lays the epithelium, consisting of epithelial cells separated 
by junction regions. These epithelial cells constitute the epithelial barrier, which is selective 
and facilitates transcellular transport of soluble or particulate matter through active transport 
proteins, diffusional processes or endocytosis and paracellular translocation across the 
junction regions (Bischoff et al., 2014; Keita and Soderholm, 2012; Shen et al., 2011). The 
junctions are regulated by the junctional complexes that consist of tight junctions, adherens 
junctions, gap junctions and desmosomes. Tight junctions form a seal between adjacent 
epithelial cells near the apical surface, thereby preventing paracellular diffusion of antigens 
or microorganisms across the epithelial barrier while allowing flow of water ions and small 
molecules (Farquhar and Palade, 1963; Zihni et al., 2016). The adherens junctions are 
situated below the tight junctions and are involved in cell-cell adhesion, together with de 
desmosomes, and in and intracellular signaling, together with the gap junctions (Garrod and 
Chidgey, 2008; Perez-Moreno and Fuchs, 2006; Sosinsky and Nicholson, 2005). The tight 
junctions are complex structures containing over 50 proteins, including transmembrane 
proteins claudins and occludin, which interact with the actin cytoskeleton within the cell 
(Chiba et al., 2008). Claudin-1,-3,-4,-5, and -8 tighten the tight junction whereas claudin-2 
forms selective paracellular pores (Bucker et al., 2010).The tight junctions are dynamic 
structures and are regulated by internal signaling and external stimuli from commensal 




Figure 1. 2: The intestinal barrier: components of the multilayered defense system. Figure adapted from 
(Mowat and Agace, 2014). The epithelial cell layer is made up of intestinal epithelial cells (IECs, beige), 
goblet cells (orange), stem cells (green), intestinal endocrine cells (blue) and M-cells (red). IgA: 
Immunoglobulin A; DC: Dendritic cell; AMP: antimicrobial peptide. 
 
A compromised intestinal barrier is characteristic for multiple diseases where the 
inflammation might be triggered by the translocation of luminal components into the host, 
such as IBD (Suenaert et al., 2002), celiac disease (Vogelsang et al., 1998) and obesity (Ley 
et al., 2006). Intestinal barrier integrity also decreases with age and due to stress (Liu et al., 
2005; Saunders et al., 1994). In vitro and in vivo experiments have shown that commensal 
bacteria and probiotics can increase intestinal barrier integrity. Patients suffering from 
Crohn’s disease were treated with Lactobacillus helveticus and L. rhamnosus, and this 
treatment reduced intestinal permeability. Another study showed that L. plantarum could 
regulate tight junction proteins and provide protection against disruption of the epithelial 
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barrier  (Ulluwishewa et al., 2011). Several in vivo mice studies showed improvement of 
epithelial barrier function by A. muciniphila (Everard et al., 2013; Li et al., 2016; Shin et al., 
2014), including a study with obese mice where genes encoding tight junction proteins were 
affected by treatment with A. muciniphila, possibly through TLR2 activation (Plovier et al., 
2017). The commensal bacteria can regulate epithelial barrier function directly, by releasing 
metabolites such as acetate and butyrate or indirectly, by inducing the release of cytokines 
which can reduce (TNFα, IFNγ) and enhance (IL-10) barrier function (Arrieta et al., 2006; 
Fukuda et al., 2011; Hamer et al., 2008).  
1.1.2 Mucosal immune system 
The gut-associated lymphoid tissue, representing the gut part of the total mucosal 
immune system, includes more than 70% of the total amount of immune cells in the human 
body, indicating the important role of intestinal immunity (Gaskins, 1997) (Figure 1.2). 
The mucosal immune system can be partitioned into inductive and effector site. At the 
inductive site, antigens are taken up to initiate a proper immune response. In the epithelium 
at these inductive sites, Microfold cells or M cells are present and unlike their neighboring 
epithelial cells, they are specialized in antigen uptake from the lumen via transcytosis (Mowat 
and Agace, 2014). The antigen is released to cells of the immune system beneath the 
epithelium and presented by antigen presenting cells, to naïve T-cells. This causes and 
induction of activated antigen-specific T- and B-cells that (Hooper et al., 2012) travel through 
the lymph vessels to the effector site, where the immune response is expressed. 
Immunoglobulin A (IgA) is the predominant antibody in the mucosa and can protect the 
mucosa in several ways (Herich, 2017). IgA binds pathogens and prevents their attachment 
to the epithelium, it may promote phagocytosis, it can enhance the entrapment of some 
bacteria in the mucus, it can neutralize toxins and interfere with pathogenic growth factors.  
A very important aspect of the mucosal immune system is that the immune response 
must be carefully balanced between the inflammatory response required for pathogen 
eradication and a tolerant reaction towards self-tissue and commensal bacteria (Petersen 
and Round, 2014). This intricate balance is determined by multiple factors, such as the 
residing microbiota and the host itself (Mowat and Agace, 2014). Pattern recognition 
receptors (PRRs) are able to recognize pathogen/microbe associated molecular patterns 
(PAMPs and MAMPs) and thereby distinguish between self and non-self. These PRRs, such 
as Toll-like receptors (TLRs), are an important interface between the microbiota and the 
immune system. Their activation is a trigger than can impact T-cell differentiation to effector 
or suppressor T-cells, and this is a crucial aspect of immune homeostasis (Nutsch and 
Hsieh, 2012; Swiatczak and Cohen, 2015). For example, polysaccharide A (PSA) from 
B.fragilis can activate TLR2 and enhance T-cell differentiation towards the immune-
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suppressive Treg cells (Nutsch and Hsieh, 2012; Round et al., 2011). A. muciniphila induces 
both pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells but its 
inflammation potential (TNF-α/IL-10) is lower than F.prausnitzii and L.plantarum and its 
cross-talk with the host could occur through activation of TLR2 and TLR4 (Ottman et al., 
2017d). 
Bacteria play an essential role in immune system development, especially in early life. 
Improper immune modulation in infants can have long lasting effects that can cause 
unbalanced immune responses. A study by Cahenzli et al. (2013) showed that microbial 
diversity during early-life colonization shapes long-term IgE levels, which play an essential 
role in atopic allergic diseases. 
1.1.3 Energy homeostasis 
The main job of the intestinal cells is not just regulating the bacteria and protecting our 
internal areas from invading pathogens, but also the absorption of nutrients and energy. 
Energy homeostasis is an important well-controlled process that involves the regulation of 
food intake (energy inflow) and energy expenditure (energy outflow) (De Silva and Bloom, 
2012). Multiple organs are involved in controlling energy homeostasis including the stomach, 
pancreas, intestine, brain (mainly hypothalamus) and liver, and they communicate using gut 
derived hormones, secreted by enteroendocrine cells (EEC) of the gastrointestinal tract and 
pancreas. A key function of these EECs is sensing the luminal content to modulate the 
hormone secretion that regulates food intake and energy storage (De Silva and Bloom, 2012; 
Greiner and Backhed, 2016; Spreckley and Murphy, 2015). 
L-cells are EECs primarily present in the epithelium of the ileum and colon and they 
can sense specific macronutrients, which modulate the secretion of anorectic gut hormones 
glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY) (Cheung et al., 2016). 
GLP-1 binds to specific receptors (GLP-1R) on β-cells of the pancreas, inducing the release 
of insulin. GLP-1 also increases insulin sensitivity of pancreatic α- and β-cells, liver cells and 
peripheral tissue and promotes β-cell proliferation while reducing apoptosis. By inhibiting 
gastric emptying, intestinal motility and glucagon secretion from pancreatic α-cells, GLP-1 
can delay nutrient absorption (Burcelin et al., 2007). PYY secretion occurs after nutrient 
ingestion and is proportionate to the caloric contact and macronutrient composition of the 
meal. PYY has been shown to reduce caloric intake and play a key role in regulating 
bodyweight by acting on appetite-regulating circuits in the brain. It also affects gut motility 
and leads to a sensation of fullness and satiety (Batterham et al., 2002). Obesity is 
associated with lower circulating levels of PYY and GLP1 deficiency, while remaining 
responsive to the anorectic and glucoregulatory effects. Interestingly, germfree mice – having 
a completely sterile gut – have been shown to take up 30% more calories compared to 
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colonized mice, while having 40% less body fat. This shows a clear involvement of gut 
microbiota in energy homeostasis regulation (Burcelin et al., 2007; De Silva and Bloom, 
2012; Greiner and Backhed, 2016).  
1.2 Microbial ecosystem homeostasis and dysbiosis 
The gut microbiota is often described as a microbial ecosystem that functions as a 
microbial organ and that can, when in homeostasis, promote health (Tasnim et al., 2017). An 
ecosystem is viewed as the complex of living organisms (microorganisms) in a defined space 
(colon) and their interaction with each other and their environment (host). Diversity is an 
important measure for maintaining ecosystem homeostasis in the colon, as ecological theory 
predicts communities with high diversity to be more resilient to perturbations (Elmqvist et al., 
2003; Hautier et al., 2009; Lozupone et al., 2012). Since the beginning of the 21st century, 
studies have revealed significant perturbations in gut microbial communities in patients 
suffering from inflammatory bowel diseases (Frank et al., 2011; Ni et al., 2017; Sokol et al., 
2017), diabetes (Karlsson et al., 2013; Kostic et al., 2015; Marino et al., 2017; Mullaney et 
al., 2018), obesity (Cotillard et al., 2013; Harakeh et al., 2016; Le Chatelier et al., 2013) and 
colorectal cancer (Gagniere et al., 2016). Considering the enormous capacity of the gut 
microbiota, it is possible that these changes in microbial composition contribute to the 
initiation and/or persistence of above-mentioned diseases. Since many studies only provide 
an associative link between gut microbial composition and disease and few can prove actual 
cause-and-effect, there is a need for more causal evidence.  
These perturbations in community structures are referred to as dysbiosis 
(dysbacteriosis). Dysbiosis is a term for microbial imbalance, qualitative and quantitative 
changes in the metabolic activity and local distribution of the gut microbiota (Holzapfel et al., 
1998). It can be characterized by the loss of beneficial microbes, the outgrowth of 
pathobionts and/or the loss of overall diversity (Petersen and Round, 2014). Some 
commensal bacteria can, for example, induce anti-inflammatory responses or reduce pro-
inflammatory cytokines and loss of these beneficial bacteria would impact homeostasis and 
gut health (Atarashi and Honda, 2011; Round and Mazmanian, 2009). It has been shown 
that a more complex and diverse collection of microorganisms elicits maximal gut health 
benefits, and loss of diversity, especially early in life, might predispose for diseases 
(Abrahamsson et al., 2013; Atarashi et al., 2013; Cahenzli et al., 2013). Dysbiosis may be 
caused by antibiotic use, metabolic alterations, psychological and physical stress, diet, and 
so on. The intestinal dysbiosis hypothesis proposes that the above-mentioned microbial 
imbalance is associated with and possibly caused by modern Western lifestyle and practices, 
which may thus, at least partly, underlie the increased risk for developing diseases such as 
IBD, Type-2 diabetes, colon cancer etc (Hawrelak and Myers, 2004; Mosca et al., 2016).  
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The microbial contribution to an increased disease risk is thus not only coming from 
one ‘bad’ microbe prompting disease, but more associated with an imbalance in the entire 
endogenous microbiome from which opportunistic pathogens may or may not take benefit 
and proliferate and further aggravate disease. A more in-depth look into the normal 
microbiome composition and microbiome functionality is required.  
2. Microbiome 
2.1 Interindividual variability in microbiome composition 
The bacterial colon community consists for 90% of bacteria belonging to the phyla 
Bacteroidetes and Firmicutes and the other 10% belong to Proteobacteria, Actinobacteria 
and Verrucomicrobia (Eckburg et al., 2005). At the moment A. muciniphila is the only 
identified member of the Verrucomicrobia phylum in the gut (Fujio-Vejar et al., 2017). The 
colon microbiota is characterized by high species richness, with more than 1500 species in 
total of which at least 160 species are shared among individuals (Lagier et al., 2016; Qin et 
al., 2010; Rajilic-Stojanovic and de Vos, 2014). True diversity is expected to be even higher 
since these numbers are obtained from relatively small cohorts (<1000 subjects) and it was 
estimated that for observing total richness around 45 000 individuals would require sampling 
(Falony et al., 2016).  
A variety of host and environmental factors influence gut microbial composition and 
establish inter-individual differences, such as age, diet, health status, gender and geography 
(Figure 1.3). An interesting study by De Filippo et al. (2010) showed substantial differences 
in the bacterial gut communities of children from Burkina Faso and Italy. The results point to 
diet being a driving factor with an increase in bacteria that can extract energy from the 
indigestible polysaccharide-rich diet in Burkinabe compared to Italian children. Ageing is 
typically linked with decreased microbial diversity and increased inflammatory status (Biagi et 
al., 2010) and in the early life of preterm infants gender was shown to significantly contribute 
to gut microbiota development (Cong et al., 2016). Of course, inter-individual variability is 
caused by the interaction of all these factors, making it a very complex issue that needs 
simplification. This was again confirmed in a cohort study (1106 individuals) where even with 
extensive metadata variables, such as medication, blood parameters, dietary and health 
information, only 16.4% of the microbiome variation could be explained (Falony et al., 2016). 
Interestingly, stool consistency and medication were identified as the most explanatory 





Figure 1. 3: Factors influencing the human gut microbiome in health and disease. Figure derived from 
(Kostic et al., 2015). 
 
The high complexity of the human microbiome and its interindividual variability make 
the development of modulation strategies, such as the pro- and prebiotics described in 
section 4.1, highly challenging. The success of such interventions, the fermentation of a 
prebiotic compound or the capacity of a probiotic, of course depends on the endogenous 
microbial community to which they are applied. The bacteria residing in the gut will determine 
how a compound is fermented and whether probiotic bacteria can fulfill their function and 
might get established in the gut. A study by Arumugam et al. (2011) suggested that the 
interindividual variability might manifest as a discrete amount of stable states, balanced 
communities. They identified 3 of those ‘stable states’, called enterotypes, characterized 
either by a predominance of Bacteroides, Prevotella or Ruminococcus. The concept of such 
enterotypes could be used as a predictive tool in treatments, for example establishing 
whether a certain enterotype associates with a positive outcome following drug or probiotic 
treatment. This could lead to a personalized microbiome-based diagnosis and therapy 
(Costea et al., 2018). However, an individual’s enterotype was demonstrated to be highly 
variable (Knights et al., 2014) and other human microbiome studies support continuous 
gradients of dominant taxa rather than discrete enterotypes (Jeffery et al., 2012). 
Furthermore, due to the functional redundancy it is more relevant to define microbiome 
subgroups based on functionality instead of composition.  
2.2 Bacterial functions in the colon 
The major bacterial functions in the colon are protective, metabolic and trophic         
(Figure 1.4). By competing for nutrients and preventing attachment the resident microbiota 
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offers protection from invasion by an incoming pathogen, known as colonization resistance. 
Also, the interaction between host and a healthy microbiota is critical for the development 
and homeostasis of the immune system (Macdonald and Monteleone, 2005). One of the 
metabolic functions is the synthesis of certain vitamins, such as vitamin K, by certain 
bacterial groups like Bacteroides, Eubacterium and Propionibacterium. A study showed that 
germ-free mice required supplementation of vitamin K and B12, since they did not have the 
bacteria to synthesize them (Canny and McCormick, 2008). 
 
 
Figure 1. 4: Key health function of the human gut microbiota. Figure derived from (Geirnaert, 2015). 
 
The major metabolic function of the bacterial community is probably its fermentative 
capacity. After the digestion of food in the stomach and small intestine, components that 
escaped digestion or were impervious to human enzymes, reach the large intestine with its 
1014 bacteria. This anaerobic microbial community is able to ferment these components and 
produce a variety of metabolites, reflecting the impressive biochemical capacity of the 
microbiota (Flint et al., 2012a; Flint et al., 2012h; Louis et al., 2007; Marcobal et al., 2013a; 
Marcobal et al., 2013d). The primary substrates for microbial fermentation are non-digestible 
carbohydrates such as resistant starch, plant cell walls and certain oligosaccharides. Since 
these non-digestible carbohydrates are diet-derived they vary widely in availability and 
structure and thus in the enzymatic capacity needed for degradation. In contrast, there is an 
almost constant supply of host-derived glycans, namely mucins, which differ less in structure 
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and availability. However not much is known yet on the nutritional aspect of these mucin 
glycans and further research is needed concerning the importance of mucin fermentation and 
the fermentation products for gut health. Major fermentation products of the saccharolytic 
fermentation are gasses and organic acids, especially short-chain fatty acids (SCFAs) 
acetate, propionate and butyrate (Bernalier-Donadille, 2010). They are typically formed in a 
3/1/1 ratio at a combined concentration of 50-150 mM in the colon, depending on diet and 
microbial composition. The third bacterial function in the colon concerns the trophic effects 
exerted by these SCFAs on the intestinal epithelium as they play a role in controlling 
epithelial cell proliferation and differentiation (Frankel et al., 1994).  
Once the carbohydrates are fermented, undigested proteins remain and the bacterial 
metabolism turns to proteolytic fermentation. End products of proteolytic fermentation are for 
example branched SCFA, amines, phenols, indoles, thiols, CO2, H2, and H2S, many of which 
have toxic properties. As digested material moves along the gut, carbohydrates become 
depleted and microbial metabolism of proteins and amino acids takes over, mainly in the 
distal colon. The latter process is thought to be linked with the increased prevalence of 
colonic disease at this site (Bernalier-Donadille, 2010; Nyangale et al., 2012; Windey et al., 
2012).  
The metabolic potency to carry out these fermentation processes, are redundantly 
present throughout the microbial community (Moya and Ferrer, 2016). For example, 
Bacteroides spp., Prevotella spp., Bifidobacterium spp., species belonging to Firmicutes 
Clostridium clusters IV and XIVa can degrade a variety of complex carbohydrates. So while 
qualitative and quantitative dietary changes or interindividual variability may lead to changes 
in community composition, they might not lead to functional changes. This phenomenon is 
known as functional redundancy and might protect the community from a dysbiosed state as 
it keeps the community functionally stable after perturbations. Stool samples of 242 
individuals were analyzed for microbial composition profile, which showed immense diversity 
in community structure, and for functional profile, which showed immense similarity between 
individuals (Huttenhower et al., 2012). Thus instead of looking for a core composition or 
compositional enterotypes, as described above, it is more relevant to define a functional core 
microbiome (Turnbaugh et al., 2009).  
 
2.3 Microenvironments and gradients in the colon 
Within the environment of the gastrointestinal tract and even within the colon, there are 
microenvironments that select for a distinctive microbial community due to their specific 
properties. The stomach, with its very acidic pH (pH 2-5) and strong peristalsis, is minimally 
colonized (101-103 cells.mL-1) and mainly by the pathobiont Heliobacter pylori and some oral 
Introduction 
15 
bacteria (Walter and Ley, 2011). The small intestine is characterized by secretion of 
bactericidal digestive enzymes, bile acids, short transit time (2-6h) and an active immune 
system, which restricts bacterial colonization and leads to a density of 103 -108 cells.mL-1. 
Since the small intestine is difficult to access, microbiota studies in healthy individuals are 
rare, but Streptococcus and Veillonella could be described as core members of the small-
intestinal community (van den Bogert et al., 2013). The large intestine or colon is the most 
densely colonized environment of the human body, with 1011 cells.mL-1. The conditions are 
optimal for bacterial growth and activity: less acidic pH (5-7), longer retention time (48-70h), 
low bile acid concentrations and a more tolerant immune system.  
Within the colon, a longitudinal and axial gradient is observed. The longitudinal 
gradation, from the proximal colon to the distal colon, is characterized by differences in pH, 
fermentation activity and increasing mucus thickness (Ermund et al., 2013). As described 
above, in the proximal colon saccharolytic fermentation takes place by bacteria such as 
Bacteroides spp., Prevotella spp., Bifidobacterium spp., Clostridium clusters IV and XIVa 
spp. These saccharolytic processes lead to the production of SCFA, which lower the pH. 
Autopsy samples from sudden death victims revealed SCFA concentration in the proximal 
colon (137-197 mmol/kg gut content) to be higher than in the distal colon (86-97 mmol/kg gut 
content) (Cummings and Englyst, 1987). In the distal colon, proteins and amino acids 
become the main energy source for the microbiota, since carbohydrates are depleted 
(Macfarlane et al., 1992). The distal colon has a more neutral pH compared to the proximal 
colon, due to the higher amount of pH increasing proteolytic fermentation products, such as 
ammonia and the lower amounts of SCFA. Bacteroides, Propionibacterium, Fusobacterium 
and Lactobacillus are examples of genera producing proteases and hydrolyzing proteins 
(Kovatcheva-Datchary and Arora, 2013). 
The axial gradient goes from the epithelial cells, through the mucus layer to the lumen 
and shows great differences in microbial diversity and density (Sommer and Backhed, 2013; 
Van den Abbeele et al., 2011g). The colonic mucus layer consists of an dense, firmly 
attached inner layer and a loosely attached outer layer. The inner layer is mostly devoid of 
bacteria and is 100 µm thick while the outer mucus layer is 300-400 µm tick and is colonized 
by 105-106 bacteria/mL mucus (Johansson et al., 2011; Johansson et al., 2008). Interestingly, 
a recent study posits a new view, of a mucus layer that covers the fecal surface instead of 
the epithelium, and keeps the microbiota confined to the feces (Kamphuis et al., 2017). The 
mucus environment differs from the lumen due to the high concentrations of host defense 
molecules (anti-microbial peptides and immunoglobulin-A) and an oxygen gradient, which 
required adaptation of the bacteria. Not only host factors but also microbial characteristics 
define microbial colonization of the mucus layer such as attachment to the mucus and the 
ability to gain nutrients from the host-derived mucins. This leads to a distinct mucus 
Chapter 1 
16 
associated microbial community (MAMC), that closely interacts with the host at the host-
microbial interface (Jones et al., 2018; Van den Abbeele et al., 2011g), and is enriched in 
Lachnospiraceae and Ruminococcaceae of the Firmicutes phylum. This MAMC is 
hypothesized to be crucial for immunological priming whereas the luminal microorganisms 
would be more involved in nutrient digestion.  
3. Bacterial glycan metabolism 
As mentioned before, the main function of the gut microbiota is the fermentation of 
dietary or host-derived components, mainly glycans, which leads to the production of 
beneficial SCFA. Given the structural variety of these glycans, a number of enzymes are 
involved and so many bacteria are part of this degradation process or can profit from it. 
3.1 Dietary glycans 
The recommended fiber intake for adults is between the 28 and 35 grams per day, 
however the diet in industrialized nations generally falls well below this recommendation and 
this deficit has been linked to several diseases (Desai et al., 2016; Sonnenburg and 
Sonnenburg, 2014). These undigested complex carbohydrates reach the colon, consisting of 
resistant starch, plant cell wall polysaccharides and fructans and oligosaccharides 
(Cummings et al., 2001; Silvester et al., 1995) (Figure 1.5). Dietary starch is mostly 
degraded by host amylases but a fraction is resistant due to either protection from plant cell 
wall polymers, its granular structure, retrogradation (which is caused by heating and cooling) 
or chemical cross-linking (Flint et al., 2012h). This resistant starch is the main source of diet 
derived energy for the colonic bacteria (Lockyer and Nugent, 2017), for example Bacteroides 
thetaiotaomicron, Bifidobacterium spp., and Roseburia intestinalis possess the ability to bind 
to and degrade these starch granules (Louis et al., 2007). Starch consists of a mixture of 
amylose and amylopectin, and a higher amylose content makes it more resistant to host 
degradation. Bacterial enzymes involved, are α amylases that hydrolyze α(1,4) bonds and 
type 1 pullulanases that hydrolyze α(1,6) bonds and amylopullulanases that do both (Flint et 
al., 2012a). 
Plant cell wall material includes cellulose, arbinoxylan, hemicellulose, lignin and 
pectins and they are degraded by variety of microbial hydrolases, esterases and lyases. 
Some of these structures, cellulose and lignin, cannot be fully degraded by human gut 
bacteria and these particles persist throughout the colon. Pectin and hemicellulose on the 
other hand are more fully degraded, in a two-step process. Primary degraders are able to 
degrade the pectin and hemicellulose structures present in cell wall matrices to soluble 
oligosaccharides. These include xylo-, galacto-, and manno-oligosaccharides, which can be 
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further metabolized by other bacteria (more details in 3.4). Primary degraders known to have 
the ability to degrade xylans, hemicellulose structure present in algae, are Bacteroides 
ovatus and Roseburia intestinalis (Flint et al., 2012a).  
Foods like onions, garlic, bananas and leek are rich in inulin type fructans, which are 
linear polymers of β-2,1 linked fructose residues, with a terminal glucose monomer and a 
degree of polymerisation (DP) between 3 and 60. Fructo-oligosaccharides (FOS) have the 
same structure but with a much lower DP (3-9). Both FOS and inulin are well studied 
prebiotics that stimulate the growth of Lactobacilli and Bifidobacteria and some Clostridium 
cluster XIVa bacteria like Roseburia inulinivorans (Eckburg et al., 2005; Van Loo, 2004). 
Bacterial utilization of fructans depends on β-fructofuranidases enzymes, which vary, in a 
strain dependent manner, in their ability to cleave the β-2,1 bonds in sucrose, FOS and 
inulin. 
 
Figure 1. 5: Structure of diet-derived polysaccharides and microbial carbohydrate degrading enzyme 
activities. Enzyme families are indicated as follow: GH glycoside hydrolase; PL polysaccharide lyase; CE 
carbohydrate esterase. G, glucose; F, fructose; X, xylose; GalU, galacturonic acid; GlaU, glucuronic acid. 
Figure adapted from (Flint et al., 2012a). 
 
3.2 Host glycans 
As opposed to dietary glycans that vary in composition and supply, the host-derived 
glycans from the mucus layer present a more continuous source of nutrients. Mucin 
glycoproteins are composed of O-glycosylated, and to a lesser extent N-glycosylated, protein 
backbones, with glycosyl chains of 2-12 monosaccharides, consisting of mainly galactose, 
fucose, N-acetylgalactosamine, N-acetylglucosamine and mannose (Figure 1.6) (Derrien, 




Figure 1. 6: (A) Monomeric and oligomeric structures of mucin: (a) mucin monomers (lines) linked 
together (circles) in an oligomeric gel, (b) linkage of the individual monomers is shown more clearly, (c) 
an individual monomer, with D domains which are involved in forming disulphide bonds between 
monomers, (d) more detailed structure of the monomer, containing many O- and N-linked 
oligosaccharides. Picture derived from (Wilson, 2005). (B) Mucin structure: composition of the glycosyl 
chains attached to the protein backbone. ((β)GlcNac: (β)N-acetylglucosamine; (β)Gal: (β)Galactose; 
(α)Fuc: (α)Fucose; (α)GalNac: (α)N-acetylgalactosamine) Figure derived from (Derrien, 2007). 
The addition of sulphate and sialic acids on the terminal side of these glycosyl chains 
results in higher viscosity and better protection against bacterial and host enzymes (Robbe et 
al., 2003). The protein backbone is rich in serine and threonine, and with proline, alanine and 
glycine they make up 80% of the total amino acid content (Schrager, 1970). Proline, serine 
and threonine make up the so called PTS domain, that occurs at least ones and is 
responsible for the variability in mucin length and extent of glycan attachment. The MUC 





(Dekker et al., 2002), of which MUC2 is the gel-forming mucin in colonic mucus (Johansson, 
2012) (Figure 1.6). Continuous mucin production by the goblet cells and mucus 
desquamation contribute both to mucin presence in the mucus layer as in the lumen of the 
colon (Atuma et al., 2001; Faure et al., 2002; Johansson, 2012). Previously, it was thought 
that mucin degradation was detrimental for gut health but it is now clear that it is part of a 
normal turn-over process (Norin et al., 1985). Due to the complexity of the mucin structure 
and the variation in glycosylation, a wide variety of specific enzymes are needed for its 
degradation, such as β-galactosidases, fucosidases, sialidases, fucosidases, N-
acetylglucosaminidase, N-acetylgalactosaminidase and proteases (Tailford et al., 2015a). 
This means that generally bacteria only possess a couple of these enzymes and complete 
degradation of these complex glycan structures requires cooperation of several species 
(Figure 1.7; Table 1.1) (Hoskins et al., 1985; Marcobal et al., 2013a; Marcobal et al., 2013d; 
Png et al., 2010; Ravcheev and Thiele, 2017).  
 
Figure 1. 7: Cleavage of a hypothetical mucin glycan by gut microbiota members. Figure adapted from 
(Ravcheev and Thiele, 2017). 
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Degradation of mucins leads to the release of less complex carbohydrates and the 
production of metabolites like acetate, lactate and propionate, some of which can be used by 
other bacteria, as part of a microbial food chain, to produce butyrate or other end products 
(Belzer and de Vos, 2012). The presence and the activity of mucin degrading species in the 
mucus layer, close to the host cells, may have strong effects, both positive and negative, on 
gut health.  
The mucin degradation process involves several steps (Figure 1.7) (Ravcheev and 
Thiele, 2017; Tailford et al., 2015a; Tailford et al., 2015e), such as the release of sialic acid 
(N-acetylneuraminic acid) through sialidase activity, since these terminal sialic acid 
residues might prevent action from other glycoside hydrolases. There are bacteria that have 
the genes to release and metabolize sialic acid, such as F. prausnitzii, R. gnavus and 
L. plantarum (Almagro-Moreno and Boyd, 2009). B. thetaiotaomicron on the other hand can 
release but not consume the free sialic acid, so it becomes available for other bacteria. 
Pathogen Salmonella thyphimurum  and pathobiont Clostridium difficile can use the free 
sialic acid but cannot release it themselves and so rely on others to profit from mucin 
degradation activity (Marcobal et al., 2013d). A second step is the cleaving of fucose from 
galactose or N-acetylglucosamine residues in the O-glycosidic chain. This fucosidase activity 
of B. longum subsp infantis, B. bifidum and R. gnavus is a crucial element in their ability to 
derive energy from mucins. B. thetaiotaomicron encodes for multiple fucosidases which 
leads to high fucose availability in the lumen, benefiting other bacteria (Martens et al., 2008). 
The third step, α-N-acetylgalactosaminidases cleave the glycan core structure from the 
serine/threonine amino acids in the protein backbone. These α-N-acetylgalactosaminidases 
vary in their specificity, for example the enzyme of B. bifidum is specific for the core 1 glycan 
while those of other bacteria have a broader spectrum (Katayama et al., 2005). This leaves 
the oligosaccharide chains of these core structures and the protein backbone free for 
further degradation. As opposed to the bacteria described above who could carry out parts of 
the mucin degradation process, mucin degrading specialist A. muciniphila can use up to 85% 
of the total mucin structure (Table 1.1, Table 1.2). It has a an entire repertoire of enzymes 
involved in this process (α-D-galactosidase, β-D-galactosidase, β-D-fucosidase, N-acetyl-β-
D-glucosaminidase, N-acetyl-α-D-galactosaminidase, N-acetyl-β-D-galactosaminidase, β-D-
glucosidase, α-L-fucosidase, β -D-mannosidase) with both extracellular and intracellular 
activity (Table 1.2) (Derrien, 2007).  
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Table 1. 2:Activity of mucrin-degrading enzymes of Akkermansia muciniphila grown in mucin-based 
medium for 24h. (ND: no activity detected.) Tabe derived from (Derrien, 2007). 
 
 
3.3 Glycan degrading bacteria 
As can be seen from the chapters above Bacteroides species have a very versatile 
metabolic spectrum, which can explain their prevalence as dominant species in the colon. A 
Starch Utilization System (Sus), an organization of enzymes related to starch degradation, 
was identified and studied in B. thetaiotaomicron and this Sus complex appears to be a 
paradigm for glycan uptake in other Bacteroides species (Martens et al., 2009) (Figure 1.8). 
Part of the Sus complex (SusCDEFG) is located at the cell surface where SusD, and likely 
also SusE and SusF, are responsible for the binding of starch molecules to the cell surface. 
SusG is an α-amylase that can hydrolyze the starch, after which the malto-oligosaccharides 
still bound to SusD, are translocated and released in the periplasm by SusC. There they are 
broken down by SusA and SusB to small saccharides, which are transported into the 
cytoplasm (Figure 1.8). This Sus-complex is a very efficient and selfish system that gives 
B. thetaiotaomicron an ecological advantage (Flint et al., 2012a; Martens et al., 2009). Also 
other Polysaccharide Utilization Loci (PULs), similar to the Sus complex, that are involved in 
the degradation of mucins, pectins and fructans have been discovered, making up 18% of 
the B. thetaiotaomicron genome. And in other Bacteroides species PULs have been 
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identified, involved in for example xylan and galactomannans degradation. Part of these Sus-
like PULs is the ability to efficiently sense which substrate is available so the bacteria can 
adapt their glycan utilization to the nutrients present. It was shown that B. thetaiotaomicron 
changes its metabolism between dietary nutrient, host glycan or human milk oligosaccharide 
(HMO) degradation depending on the availability (Bjursell et al., 2006; Mahowald et al., 
2009). 
 
Figure 1. 8: Bacteroides thetaiotaomicron sus system. (A) shows order of genes in the sus cluster. (B) 
shows the organization and action of the gene products on or near the cell surface (OM outer membrane, 
CM cytoplasmic membrane). Starch molecules are shown as sugar chains, at various stages of 
hydrolysis. Figure derived from (Flint et al., 2012a). 
 
Within the Bifidobacterium genus, many genes are conserved between species, and 
of these conserved genes 6.5% was dedicated to carbohydrate metabolism (Bottacini et al., 
2010). But, despite this conserved bifido-genome, the substrate-specificity is species and 
strain dependent. B. breve and B. adolescentis are specialized in degradation of resistant 
starch while B. bifidum possesses specific enzymes related to degradation of galacto-
oligosaccharides (Flint et al., 2012a; Ryan et al., 2006). Some bifidobacteria are unable to 
degrade any fructans (B. bifidum and B. breve), while others are able to use FOS or both 
FOS and short chain inulin (B. adolescentis). B. longum responded to a prebiotic treatment 
with long-chain arabinoxylans in humanized rats and the B. bifidum genome contains many 
genes dedicated to host glycan degradation (Turroni et al., 2010; Van den Abbeele et al., 
2011a).  
Within the Firmicutes phylum, Lachnospiraceae and Rumminococcaceae are the most 
abundant families accounting for 50-70% of the bacterial community in the fecal samples of 
healthy individuals. Ruminococcus bromii is a keystone species in the initial stages of 
particulate resistant starch degradation, demonstrating greater capabilities than even 
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B. thetaiotaomicron (Ze et al., 2012) and R. torques possesses mucin-degrading capabilities 
(Hoskins, 1993). Within the Lachnospiraceae family, there are two important clusters of 
butyrate producing bacteria, Clostridium cluster IV and XIVa. Starch degradation is mostly 
achieved by member of the Clostridium cluster IV, for example Roseburia inulinivorans, 
which can also grow on FOS, inulin and on the sugar fucose, abundant in mucins (Scott et 
al., 2008). Other inulin degraders are Eubacterium rectale (cluster IV) and F. prausnitzii 
(cluster XIVa) (Ramirez-Farias et al., 2009). F. prausnitzii is also able to utilize N-acetyl 
glucosamine for growth, so it might be involved in the host glycan degradation food chain, 
together with R. inulinivorans (Lopez-Siles et al., 2012). 
However, these bacteria are not alone but part of a complex microbial community and 
their behavior will be different and dependent on the presence and activity of other bacteria.  
3.4 Cross-feeding interactions 
In the chapters above, mainly the ‘primary degraders’ have been mentioned, the 
bacteria with the ability to degrade a wide range (Bacteroides spp.) or a more select range 
(Bifidobacterium spp.) of complex carbohydrates. However, there are many species that are 
not able to metabolize complex carbohydrate structures and grow on the fermentation 
products of primary degraders, and this is termed cross-feeding. Cross-feeding has been 
mainly described as the metabolic interactions between bifidobacterial species and butyrate 
producing species to explain the unexpected butyrogenic effects of some prebiotics observed 
in vivo (Riviere et al., 2016) (Figure 1.9). To study this, bacteria were grown in co-culture on 
prebiotic substances and degradation and production activity was monitored. A first type of 
cross-feeding is based on the requirement of butyrate producing species like R. intestinalis, 
R. inulinivorans and F. prausnitzii for exogenous acetate to degrade oligofructose and 
produce butyrate. In co-culture experiments, acetate was provided by bifidobacterial growth 
on oligofructose, after which the oligofructose was further degraded by the combined efforts 
of both bifidobacterial and butyrate producing species (Falony et al., 2009; Falony et al., 
2006; Moens et al., 2016). Of course, in the more complex environment of the gut the 
exogenous acetate can be provided by many more species.  
Another type of cross-feeding takes place when butyrate producing species not only 
need acetate but are also unable to degrade the available substrate. Bifidobacterial growth 
on oligofructose was shown to provide short chain oligosaccharides, like fructose, and 
lactate which were consumed by R. hominis and Anaerostipes caccae, respectively, and led 
to growth and butyrate production (Belenguer et al., 2006). A third type of cross-feeding has 
been described for growth on arabinoxylan-oligosaccharides (AXOS), similar to the first type 
of cross-feeding where both bifidobacterial and butyrate producing strains are capable of 
degrading the substrate. But in this case the bifidobacterial strain is additionally stimulated by 
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consumption of the monosaccharides released by the metabolism of an E. rectale strain, 
which benefits from the acetate produced by B. longum. 
 
Figure 1. 9: Different types of cross-feeding that can take place between Bifidobacterium spp. and 
species of butyrate producing colon bacteria in the human colon. (….) indicate consumption of 
oligofructose, inulin and AXOS; (- - -) indicate production of carbohydrate breakdown products and/or 
metabolic end products; (−) indicate cross-feeding interaction between bifidobacterial strain and butyrate 
producing strains. Figure derived from (Riviere et al., 2016). 
 
In this last case there is actual cross-feeding, with both strains benefitting from 
products the other produced (Riviere et al., 2015; Riviere et al., 2016). Another example of 
such a bidirectional feeding interaction was observed between A. muciniphila and 
Eubacterium hallii when grown on mucin (Figure 1.10). The liberation of mucin derived 
oligosaccharides by A. muciniphila metabolism, could be used to sustain E. hallii growth and 
butyrate production. Besides butyrate, E. hallii also produced vitamin B12 which resulted in 
propionate production by A. muciniphila. Cross-feeding with A. muciniphila on mucin was 
also shown for A. caccae and F. prausnitzii, benefitting from both the released 




Figure 1. 10: Schematic overview of mucus-dependent cross-feeding network. Keystone mucolytic 
bacteria, such as A. muciniphila, degrade mucin glycans resulting in oligosaccharides (mainly, galactose, 
fucose, mannose and N-acetylglucosamine) and SCFA (acetate, propionate and 1,2-propanediol) that can 
be used for growth, as well as propionate, butyrate and vitamin B12 production by cross-feeding partners. 
Figure derived from (Belzer et al., 2017). 
 
Besides oligosaccharides and SCFA, also H2 gas is used in important metabolic 
interactions. Hydrogenotrophic microorganisms are not abundant in the colon, but they 
perform a fundamental task for maintaining efficient microbial fermentation: the removal of H2 
gas, which is a byproduct of fermentation activity (Rios-Covian et al., 2016; Stilling et al., 
2016). Acetogens, like Blautia spp., convert hydrogen into acetate by using CO2. 
Methanogenesis, performed by archaea Methanibrevibacter smithii, is the conversion of H2 
into methane using CO2 (Bik et al., 2017). A third group of H2 removers are the sulfate 
reducing bacteria (SRB), in the human gut represented by Desulfovibrio species. They 
convert H2 to H2S by using free sulfate as an electron acceptor and depend on other bacteria 
for both the H2 and the free sulfate, which can come from mucins or food derived products 
(Rey et al., 2013). 
The above mentioned examples of cross-feeding, and many more, describe important 
metabolic interactions between gastrointestinal bacteria and indicate the difficulty of 
predicting the effect of a dietary treatment in a complex microbial community; because 
changes in activity or metabolism in one species will affect many others. 
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4. Maintaining host-microbe homeostasis 
4.1 Modulation of the microbiome 
Considering the various and far-reaching consequences of changes in microbial 
community composition and activity, there is a need to investigate ways to modulate the 
microbial community. A well-known way is by using antibiotics, but these are very disruptive 
and can have long lasting effects on the community homeostasis.  
The most straightforward approach to modulate the gut microbiota is through 
prebiotics, which are defined as ‘substrates that are selectively utilized by host 
microorganisms conferring a health benefit’ (Gibson et al., 2017). Well-documented 
examples are fructo- and galactooligosaccharides, inulin and long-chain arabinoxylans that 
because of their difference in structure require different bacteria or bacterial consortia for 
degradation. Besides these well-studies carbohydrates, also other compounds such as 
polyphenols have been described to display prebiotic properties (Bindels et al., 2015). The 
impact of prebiotic consumption has, until now, been mainly described for Bifidobacterium 
and Lactobacillus species (Riviere et al., 2016). More recent studies however demonstrate 
that prebiotics stimulate many other bacteria as well and may not be as selective as 
previously assumed (Bindels et al., 2015), since inulin type fructans can be consumed by 
some butyrate producing colon bacteria as well (Falony et al., 2009; Falony et al., 2006; 
Moens et al., 2016; Riviere et al., 2016) (As described above). Also cross-feeding 
interactions on these complex carbohydrate structures would lead to the involvement of 
many more species than initially thought. The fermentation of prebiotic compounds leads to 
production of specific SCFA, vitamins and other products (Graf et al., 2015), which confer 
their own health effects toward the host. Due to their structural complexity, fermentation goes 
slowly and this prolongs the saccharolytic activities into to the distal colon, thereby reducing 
the production of toxic metabolites from protein and lipid metabolism (Grootaert et al., 2009; 
Neyrinck et al., 2011). 
While prebiotics target the endogenous microbiota, it is possible that a dysbiosed 
community lacks the microorganisms that need to be targeted by prebiotics. An alternative 
way to modulate the microbiome is therefore a probiotic strategy. Probiotics are defined as 
‘live microorganisms which, when administered in adequate amounts, confer a health benefit 
on the host’ (Hill et al., 2014; WHO/FAO, 2006). These probiotic bacteria can benefit the host 
through their presence, through their fermentation products or by affecting the resident 
bacteria (Scott et al., 2015). At the moment, probiotic formulations are limited to 
Bifidobacterium, Lactobacillus species and other lactic acid bacteria or yeasts, usually 
delivered in a yoghurt, milk or cheese matrix (Besseling-van der Vaart et al., 2016). The 
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evaluation of the “health benefit that is conferred to the host”, as mentioned in the definition, 
is the responsibility of the European Food Safety Authority (EFSA). Since the implementation 
of EU legislation on health claims in 2009, only one claim has been approved: the benefit on 
lactose digestion when consuming live Lactobacillus delbrueckii subsp. Bulgaricus and 
Streptococcus thermophiles strains present in yogurt or fermented milk (El Hage et al., 
2017). More than 400 claim have been discarded since 2008, so while these products are 
available for consumption, no reference to the claimed health effect is allowed. Since the 
definition of a probiotic itself inherently suggests a health benefit, the term probiotic is 
banned for commercial purposes since 2012, to avoid the misleading of consumers. 
However in the scientific community, this research included, the term probiotic is still used, 
without the restrictions on the aspect of health benefits. 
Instead of modulating the endogenous microbial community, it is also a possibility to 
remove the endogenous community and replace it with the fecal microbial suspension from a 
healthy donor, i.e. fecal microbial transplantation (FMT). This was already used in fourth-
century China where this “yellow soup” was used to treat diarrhea. FMT has regained 
interest as is has proven to be effective in treating recurrent Clostridium difficile infections 
(van Nood et al., 2013). However, in other pathologies with a more complicated etiology, like 
IBD, FMT has not yet been as successful (Colman and Rubin, 2014; Geirnaert, 2015).  
4.2 Microbes with health promoting potential 
The probiotic definition does not exclude microbial species coming from a more diverse 
phylogenetic background. Scientists have been searching for microbes that support the host-
microbiome homeostasis either by supporting the normal microbial ecosystem, preventing it 
from tipping over towards a dysbiosed state or by fulfilling key functions for the host. Such 
microorganisms with key functionality and from phylogenetic origin other than conventional 
lactic acid producing microbes are being considered as next-generation probiotics. 
Akkermansia muciniphila, Faecalibacterium prausnitzii, Butyricicoccus pullicaecorum, 
Eubacterium hallii, Bacteroides fragilis and several others are being proposed. However, 
these next-generation probiotic candidates require a rigorous safety assessment and 
elucidation of their mode of action to persuade regulatory bodies to approve these bacteria or 
bacterial mixes as biotherapeutic agents. Two species, Faecalibacterium prausnitzii and 
Akkermansia muciniphila, both correlating with human health and being considered as the 




4.2.1 Faecalibacterium prausnitzii 
Faecalibacterium prausnitzii is a gut bacterium, member of the Firmicutes phylum, 
Clostridium leptum group. It is abundantly present in healthy people, making up 
approximately 5% of the microbial community. It has been proposed as a sensor and actor in 
human intestinal health, due to its anti-inflammatory effects and its inverse correlation with 
IBD symptoms (Miquel et al., 2013). Not only is it less abundantly present in patients 
suffering from inflammatory bowel diseases (IBD) but also irritable bowel syndrome (IBS), 
colorectal cancer (CRC), coeliac disease (CD) and obesity (Balamurugan et al., 2010; De 
Palma et al., 2010; Furet et al., 2010; Neish, 2009; Rajilic-Stojanovic et al., 2011; Sokol et 
al., 2008b). Administration of F. prausnitzii or its culture supernatant was shown to be 
protective against chemically induced colitis in different rodent models (Miquel et al., 2013; 
Sokol et al., 2008b). The anti-inflammatory effects can be partly explained by the production 
of certain metabolites that could i) inhibit NF-kB activation and IL-8 production, ii) upregulate 
anti-inflammatory cytokine and Treg cell production and iii) improve intestinal barrier integrity. 
F. prausnitzii is able to produce acetate, D-lactate and formate but is mainly known for its 
high production of butyrate. Due to the inhibitory effect of butyrate on histon deacetylases in 
colonocytes and immune cells and butyrate interacting with G-protein coupled receptor 109A 
(GPR109A) on the surface of the colonocytes, butyrate exerts anti-inflammatory and anti-
carcinogenic effects. It leads to a downregulation of pro-inflammatory cytokines, promotion 
Treg cells and IL-10 producing T-cells and selective induction of cell apoptosis (Guilloteau et 
al., 2010). 
Butyrate production by F. prausnitzii thus explains some of its protective effects in 
colitis, but also other factors have been identified that can contribute to its anti-inflammatory 
effects. A microbial anti-inflammatory molecule (MAM) protein (15 kDa) produced by 
F. prausnitzii, is able to inhibit the Nf-kB pathway and exert anti-inflammatory effects in DSS- 
and DNBS- induced colitis in mice (Breyner et al., 2017; Quevrain et al., 2016a; Quevrain et 
al., 2016b). Additionally, the extra-polysaccharide matrix (EPM) produced by the biofilm 
producing F. prausnitzii HTF-F strain could reduce the production of pro-inflammatory IL-12 
and this strain was shown to be more protective to DSS-induced colitis in mice compared to 
the type strain (Rossi et al., 2015). F. prausnitzii or one of its secreted bioactive compounds 
may thus lead to the development of innovative therapeutic strategies for preventing or 
treating colitis. 
4.2.2 Akkermansia muciniphila 
Akkermansia muciniphila is an abundant member of the human gut microbiota (1-4%), 
using mucin as its sole carbon, nitrogen and energy source (Collado et al., 2007; Tailford et 
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al., 2015a). It is the only intestinal member of the Verrucomicrobia phylum and its abundance 
has been linked with gut health in several human in vivo correlation studies (Collado et al., 
2007; Png et al., 2010; Wang et al., 2011; Zhang et al., 2013).  
A study of its genome shows 61 proteins predicted to be involved in mucin degradation 
(2.8% of all proteins) and its high mucin-degrading capacity in an in vivo mice study (Berry et 
al., 2013; van Passel et al., 2011). Mucins are the preferred substrate of A. muciniphila, 
yielding acetate and propionate as by-products of their fermentation (Derrien et al., 2004). 
Acetate and propionate enter the portal vein more efficiently than butyrate, and exert their 
effects partly outside the gut. Acetate can be used as a substrate for fatty acid synthesis and 
cholesterol in the liver, increases colonic blood flow and oxygen uptake, and it is important to 
protect from enteric infections (Fukuda et al., 2011). In contrast, propionate inhibits the 
incorporation of acetate into fatty acids and cholesterol and has been related with specific 
health benefits. Propionate induces satiety and it may therefore play an important role in 
energy homeostasis (Hosseini et al., 2011; Nishina and Freedland, 1990; Ruijschop et al., 
2008). In monoculture, A. muciniphila produces acetate and propionate (60:40 molar ratio) 
from mucins, subsequently impacting the host genes involved in lipid metabolism (Hnf4α) 
and proliferation (Tp53 and Tp73) (Derrien et al., 2004; Lukovac et al., 2014). 
A. muciniphila abundance has been negatively correlated with many diseases, but only 
for diabetes and obesity have there been studies showing a beneficial/protective effect of 
A. muciniphila. In a study with obese mice on a high-fat diet, it was shown that administration 
of A. muciniphila reversed insulin resistance, dyslipidemia, metabolic endotoxemia and fat 
mass gain (Everard et al., 2013). Plovier et al. (2017) discovered that the beneficial effects 
are at least partly due to a specific outer membrane protein, Amuc_1100, which is involved in 
the formation of pili by A. muciniphila. This protein could be involved in the interaction 
between A. muciniphila and Toll-Like Receptor 2, which is an immunoregulatory protein that 
modulates intestinal homeostasis and host metabolism (Cani and de Vos, 2017). A study 
with CaCo-2 cell lines showed that A. muciniphila improved the integrity of the epithelial cell 
layer, suggesting its ability to strengthen an impaired gut barrier (Reunanen et al., 2015). 
Metabolic endotoxemia results from impaired barrier function and by strengthening the gut 
barrier, A. muciniphila could reverse metabolic endotoxemia as described above (Everard et 
al., 2013). Apart from oral administration of A. muciniphila, uptake of dietary compounds 
such as fish oil and cranberry extract also increased A. muciniphila abundances and led to 
healthier mice (Anhe et al., 2015; Caesar et al., 2015). However, other studies have shown 
increased abundance of A. muciniphila to be correlated with colon cancer and DSS-induced 
colitis, which might be explained by the overexpression of certain mucin types in colon 
cancer and DSS colitis and the reduced food intake in colon cancer (Berry et al., 2012; Berry 
et al., 2013; Borges-Canha et al., 2015; Weir et al., 2013a). 
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A. muciniphila shows great promise for use as a next generation probiotic or in obesity 
and diabetes therapies. However, questions remain regarding the effect of A. muciniphila 
administration on the resident microbial community, its dependency on mucin or is 
susceptibility to environmental changes in the colon environment.  
4.3 Potential role of mucus in maintaining homeostasis 
Besides diet derived substrates, also host derived substrates such as colonic mucins 
are to be considered as an opportunity for microbiota modulation. Given the complexity of the 
general mucin structure only about 1% of the gut microbiota is able to degrade mucin, but 
many more species may be indirectly involved since 90% of the mucin structure consists of 
specific carbohydrates, making it amenable to microbial fermentation and cross-feeding 
interactions. As mucin breakdown and fermentation will at least in part take place in proximity 
of the epithelial layer, putative health effects can be expected. Prebiotic action of mucins 
could potentially stimulate endogenous A. muciniphila or aid in the establishment of 
exogenous A. muciniphila, increasing the health promoting impact of this bacterium and 
inducing cross-feeding interactions with butyrate producing bacteria. However, the prebiotic 
potential of mucin in stimulating endogenous or probiotic A. muciniphila and the impact on 
the microbial ecosystem in the gut is poorly understood. The ecological function of host-
glycan degradation and its position together with A. muciniphila in the microbial gut 




5. Objectives and outline of this research 
Studies linking changes in the gut microbiota composition to human health status have 
reported an inverse correlation between Akkermansia muciniphila and disorders such as 
IBD, obesity and diabetes, while it is present at high abundances (1-4%) in the healthy 
human population. Key characteristic of A. muciniphila is its mucin degradation capacity, 
which leads to the production of acetate and propionate and may be part of cross-feeding 
networks resulting in butyrate production. A. muciniphila has been positioned as a health 
biomarker and is currently explored as a therapeutic agent for obesity or a new generation 
probiotic. However, more information is required about its behavior in the complex microbial 
ecosystem in the colon, about the potential role of mucins to influence A. muciniphila 
behavior and the impact of its probiotic administration on the microbial ecosystem and the 
host, which is the aim of this PhD research. In vitro technology used in this research, such as 
the simulator or the human intestinal ecosystem (SHIME®) and the transwell co-culture cell 
model, allowed for mechanistic research and helped to overcome some confounding 
elements of in vivo studies, such as variations in mucin availability.  
Chapter 2 evaluated the colonization behavior of A. muciniphila in a mucin rich 
environment in the presence of a complex microbial community. To ensure efficient and 
abundant colonization of A. muciniphila a donor was selected with high amounts of 
A. muciniphila previously shown to successfully colonize the SHIME. Using this inoculum 
guaranteed that we could dynamically monitor its ecological behavior and investigate the 
impact of variable conditions on A. muciniphila, such as the stabilization period, differences 
in colon pH, prebiotic supplementation and variable mucin supply. Since this study explored 
the effect of mucin and pH towards A. muciniphila in one microbial background, Chapter 3 
aimed at testing the biological reproducibility of our previous findings. This enabled us to 
elucidate whether the gut microbial response and A. muciniphila sensitivity to changes in 
host-glycans and pH is dependent on the microbial background or not.  
To study microbial cross-feeding and competition interactions of A. muciniphila more in 
detail, Chapter 4 investigated different primary degraders for host or dietary glycan 
degradation and their effect on butyrate production. These interactions are difficult to study in 
a complex bacterial community and so a synthetic microbial community was used, with 
A. muciniphila and B. thetaiotaomicron as the primary glycan degraders.  
Chapter 5 aimed at investigating the impact of A. muciniphila administration on the 
endogenous community and taking into account its nutritional specificity, treatment was 
investigated with and without addition of mucin. This allowed us to elucidate the importance 
of mucin presence to modulate the efficiency of the probiotic supplementation with 
A. muciniphila. At the end of these treatments, an antibiotic pulse was administered after 
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which the microbial community was allowed to recover. The goal was to establish whether 
treatment with either A. muciniphila and/or mucin would lend resilience towards an antibiotic 
induced disturbance or mediate a faster ecosystem recovery. Before this antibiotic pulse, 
supernatant samples were taken from these microbial communities shaped by the pro-, pre- 
and synbiotic treatments, to study their effect on the intestinal epithelium and the underlying 
immune cells in Chapter 6. By combining Caco-2 epithelial cell line with activated THP-1 
cells (macrophages) this co-culture cell model offered the possibility to study exposure effect 
on epithelial barrier function and pro-or anti-inflammatory responses of the epithelium. The 
goal was to evaluate whether A. muciniphila addition and/or the presence of a host-glycan 
degradation niche changed the communities in such a way that would impact gut barrier 
function and immune response.  
In Chapter 7 an overview of the obtained research outcomes is given in combination 
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Host mucin is the main constituent of the mucus layer that covers the gut epithelium of 
the host, and an important source of glycans for the bacteria colonizing the intestine. 
Akkermansia muciniphila is a mucin-degrading bacterium, abundant in the human gut, that is 
able to produce acetate and propionate during this degradation process. A. muciniphila has 
been correlated with human health in previous studies, but a mechanistic explanation is 
lacking. In this study, the main site of colonization was characterized alongside additional 
conditions, such as differences in colon pH, prebiotic supplementation and variable mucin 
supply. A dynamic in vitro gut model, the Simulator of the Human Intestinal Microbial 
Ecosystem (SHIME®) was used to perform this in-depth exploration of the ecological 
behavior of A. muciniphila in one biological environment and to overcome the limitations of in 
vivo studies. A. muciniphila was found to colonize the distal colon (±8 log copies mL-1) more 
abundantly than the proximal colon (±4 log copies mL-1) and this colonization pattern was 
pH-dependent. The addition of mucin caused a specific increase of A. muciniphila (±4,5 log 
increase over two days), far exceeding the response of any other bacteria present, together 
with an increase in propionate. Our results indicate the preference of A. muciniphila for the 
distal colon environment due to its higher pH and uncovered the quick and stable response 
of A. muciniphila to mucin supplementation. 
  
2 CHAPTER 2 
In vitro colonization of the distal colon by 
Akkermansia muciniphila is largely mucin and pH 
dependent. 
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1. Introduction 
Over recent decades, multiple correlations have been established between human 
health and the composition of the gut microbiota (Round and Mazmanian, 2009). 
Akkermansia muciniphila is a commensal gut bacterium that represents 1-3% of the total 
microbiota (Derrien et al., 2008) and has been associated with beneficial health effects in 
several studies. It was shown to be absent in patients suffering from inflammatory bowel 
disease (IBD), while being abundantly present in healthy individuals (Png et al., 2010). Lower 
A. muciniphila numbers have been encountered in patients with obesity, autism and type 2 
diabetes (Wang et al., 2011; Zhang et al., 2009; Zhang et al., 2013), and the initial correlation 
with type 2 diabetes (Qin et al., 2012) could be attributed to the confounding effect of 
metformin, which stimulates the growth of A. muciniphila  (Forslund et al., 2015; Lee and Ko, 
2014; Shin et al., 2014). A. muciniphila supplementation reversed fat mass gain, metabolic 
endotoxemia, adipose tissue inflammation, and insulin resistance in obese mice that 
received a high-fat diet (Everard et al., 2013). Not only probiotic treatment with A. muciniphila 
but also treatment of mice with dietary compounds such as cranberry extract and fish oil, rich 
in polyphenols and omega-3 fatty acids respectively, resulted in higher abundances of A. 
muciniphila and metabolically healthier mice/phenotypes (Anhe et al., 2015; Caesar et al., 
2015). The direct impact of A. muciniphila on the host, its interactions with other beneficial 
intestinal microbes and its susceptibility to prebiotics remain to be elucidated. 
Mucins are the preferred substrate of A. muciniphila, yielding acetate and propionate 
as by-products of their fermentation (Derrien et al., 2004). Mucin glycans constitute 80% of 
the dry weight of the mucus layer that covers the intestinal epithelium (Johansson et al., 
2008). They are composed of O-glycosylated protein backbones, with chains of 2 to 12 
monosaccharides, mostly galactose, fucose, N-acetylgalactosamine, N-acetylglucosamine, 
mannose and sialic acid. They may also be N-glycosylated with the same compounds to a 
lesser extent (Lai et al., 2009). Mucins are not only confined to the mucus layer but are also 
present in the luminal content, due to the continuous mucin production, roughly between 6 
and 15 g per day, and the constant mucus desquamation (Atuma et al., 2001; Faure et al., 
2002; Johansson, 2012; Wilson, 2005). The degradation of host- and diet-derived glycans 
results in production of short-chain fatty acids (SCFA), mainly acetate, propionate and 
butyrate. Butyrate serves as an energy source for colonocytes, while it may also protect from 
inflammatory disorders and suppress the growth of colonic tumors (Guilloteau et al., 2010). 
Acetate and propionate enter the portal vein more efficiently than butyrate. Acetate can be 
used as a substrate for fatty acid synthesis and cholesterol in the liver, increases colonic 
blood flow and oxygen uptake, and it is important to protect from enteric infections (Fukuda 
et al., 2011). In contrast, propionate inhibits the incorporation of acetate into fatty acids and 
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cholesterol and has been related with specific health benefits. Propionate induces satiety and 
it may therefore play an important role in obesity (Hosseini et al., 2011; Nishina and 
Freedland, 1990; Ruijschop et al., 2008). In monoculture, A. muciniphila produces acetate 
and propionate (60:40 molar ratio) from mucins, which impacts the host genes involved in 
lipid metabolism (Hnf4α) and proliferation (Tp53 and Tp73) (Derrien et al., 2004; Lukovac et 
al., 2014). Although multiple studies associate A. muciniphila with human health indicators 
(Anhe et al., 2015; Belzer and de Vos, 2012; Png et al., 2010; Santacruz et al., 2010; 
Schneeberger et al., 2015; Swidsinski et al., 2011; Wang et al., 2011; Zhang et al., 2009), 
the specific factors that govern A. muciniphila colonization within a mixed community and its 
contribution to the overall acetate, propionate and/or butyrate production have not been 
addressed.  
Production of mucin by the host epithelium is dependent on specific food ingredients 
(Van den Abbeele et al., 2011a), drugs (Wlodarska et al., 2011) or disease states (Fyderek 
et al., 2009), thus interfering with the abundance of mucin degraders. For example, 
consumption of prebiotics was shown to shift mucin degradation to the distal colon (Van den 
Abbeele et al., 2011a). Therefore, sampling along different sites of the intestine becomes 
essential for understanding the ecological behavior and colonization potential of mucin 
degraders in the gut. Also, in patients with Crohn’s disease and ulcerative colitis the mucus 
layer is three times thinner than in healthy people (Fyderek et al., 2009) and antibiotic 
treatment with metronidazole resulted in a thinner inner mucus layer (Wlodarska et al., 
2011). These are confounding factors that can be overcome with dynamic in vitro gut 
models, like the SHIME®, that exclude the host environment and allow simulating different 
sites of the intestine. Such in vitro models provide a great opportunity for mechanistic 
research that aims at unraveling the ecology of mucin degraders, such as Bacteroides sp. 
and A. muciniphila, which have been shown to thrive in these models (Van den Abbeele et 
al., 2010).  
The aims of this study were to evaluate the colonization behavior of A. muciniphila in a 
mucin rich environment in presence of a complex microbial community. Since this research 
serves as a start to characterize A. muciniphila, a donor was selected with high amounts of 
A. muciniphila previously shown to successfully colonize the SHIME (Van den Abbeele et al., 
2013; Van den Abbeele et al., 2010; Van den Abbeele et al., 2011g). Hence this inoculum 
guaranteed that we could see the effects of the variable conditions, such as the stabilization 
period, differences in colon pH, prebiotic supplementation and variable mucin supply, on 
A. muciniphila and dynamically monitor its ecological behavior. However, this only provides 
us with results from one microbial background and further research considering multiple 
donors, will need to be performed to investigate the effect of the microbial parameter on 
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A. muciniphila. We assessed the overall microbial and metabolic changes associated with 
evolving numbers of A. muciniphila. 
2. Materials and methods 
2.1 Chemicals and growth media 
Chemicals were obtained from Sigma (Bornem, Belgium), unless stated otherwise. The 
nutritional medium for the SHIME consisted of (in g L-1) arabinogalactan (1.0), arabinoxylan 
(2.0) (BioActor, Maastricht, The Netherlands), starch (2) (Anco, Roeselare, Belgium), xylan 
(1.0), pectin (2.0), D-(+)-glucose (0.4), yeast extract (3.0), peptone (1.0), cysteine (0.5) and 
commercial pig gastric mucin (4.0). Composition of pig gastric mucin is typically around 20% 
hexosamine, 18% total hexose, 48% protein, and 9% sialic acid. The monosaccharide 
composition of mucin was determined (in g 100 g-1 DM): L-arabinose (0.05), D-xylose (0.04), 
D-mannose (0.28), D-galactose (7.47) and D-glucose (1.95). This medium was autoclaved 
and acidified to pH 2.0. The pancreatic juice contained (in g/L) NaHCO3 (12.5), bile salts 
(6.0) (Difco, Bierbeek, Belgium) and pancreatin (0.9). 
Our previous experience with a fecal microbial inoculum from a 28-year old male 
individual (Van den Abbeele et al., 2013; Van den Abbeele et al., 2010; Van den Abbeele et 
al., 2011g) showed that A. muciniphila colonization was consistently abundant and efficient. 
Hence, this was an ideal inoculum to subject A. muciniphila to variable conditions and 
dynamically monitor its ecological behavior. Fecal samples were collected and prepared 
within 1h according to standard procedures (Molly et al., 1993). In short, aliquots (20 g) of 
freshly voided fecal samples were diluted and homogenized with 100 mL 0.1 M phosphate 
buffer (8.8 g K2HPO4.L-1 and 6.8 g KH2PO4.L-1, pH 6.8) containing 1 g.L-1 sodium 
thioglycolate as reducing agent. After removal of the particulate material by centrifugation (2 
min, 500 g) the fecal suspension was used as inoculum. 
2.2 Long term dynamic in vitro gut model for the luminal colon microbiota 
(SHIME) 
The long-term colonization of A. muciniphila within a mixed human gut microbiota was 
assessed in the dynamic in vitro gut model, SHIME® (ProDigest-Ghent University, Ghent, 
Belgium). The model consists of five compartments that simulate the stomach, the small 
intestine and three or two colon regions (namely ascending, transverse and descending 
colon or proximal and distal colon, respectively) (Van den Abbeele et al., 2010). Each 
anaerobic compartment was continuously stirred at 37°C and flushed with N2 (15 min/day) to 
ensure anaerobic conditions after sampling. On day 0, the colon compartments were filled 
with nutritional medium and inoculated with 40 mL of 20% (w/v) fecal slurry. Following an 
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overnight static incubation of the colon compartments (16 h), the stomach and small intestine 
compartments operate on the fill and draw principle, with peristaltic pumps adding 140 mL 
nutritional medium and 60 mL pancreatic juice three times a day and gradually emptying the 
small intestine compartment into the colon compartments after gastro-intestinal digestion. 
The volume in the colon compartments is kept constant by the simultaneous fluid flow in and 
out of compartments (Possemiers et al., 2004). Samples were taken from the vessels, daily 
(10h00) before new feed entered the colon compartments. 
By applying relevant environmental conditions (retention time, nutrition and pH) to each 
colon region, the fecal microbiota evolves to establish region-specific microbial communities. 
This stabilization process requires two weeks and it is reproducible for SHIME-units that are 
run simultaneously (Van den Abbeele et al., 2010). 
Samples from a previous experiment were analyzed to provide the preliminary data for 
the experiments performed in this study (Van den Abbeele et al., 2010). A. muciniphila 
colonization was studied in the three colon regions of the SHIME, using A. muciniphila-
specific primers and qPCR on samples of a published SHIME-study using the same donor 
(Van den Abbeele et al., 2010). Samples were collected on day 19 and 26 after inoculation 
from two stable SHIME-units run simultaneously. The net SCFA production was determined 
to link the SCFA production to the numbers of A. muciniphila in specific colon regions. As 
steady conditions prevailed upon stabilization, the net SCFA production equals to the 
difference between the concentrations in subsequent colon regions.  
Three SHIME experiments were performed in this study. For the purpose of the first 
one, the “stabilization experiment”, investigating the stabilization of A. muciniphila, the 
SHIME set-up consisted of two colon compartments, proximal and distal (Supplementary 
Figure 2.1A). The second one, the “pH and inulin experiment”, focusing on pH and 
prebiotics, consisted of three parallel distal colon vessels at different pH intervals: 6.6 to 6.9 
(Distal-high pH, Dh), 6.15 to 6.4 (Distal-medium pH, Dm) and 5.6 to 5.9 (Distal-low pH, Dl) 
(Figure 2.1A). The same proximal colon vessel (PC) was used to feed all three to ensure 
identical nutritional conditions in the different distal colon vessels. After 11 days of normal 
nutritional feeding, 5 g L-1 of inulin were supplemented to the feed. This allowed the 
investigation of the prebiotic effect of inulin in the proximal colon and in the distal colon at 
different pH intervals. For the third one, the “Mucin experiment” evaluating the effect of 
mucin supplementation, the set-up of the experiment consisted of one proximal (PC) and 
three parallel distal colon vessels (Distal 1-3) (Figure 2.6A). After supplementing a mucin-
free nutritional medium during the first 10 days, 8 g L- 1 of mucin were delivered to the 
proximal colon vessel on day 10, and from day 12 to 15, 4 g L- 1 mucin were supplied.  
A. muciniphila numbers were quantified with qPCR and mucin and SCFA 
concentrations were determined (cfr. supra). Based on qPCR results of the pH and mucin 
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experiment, respectively 32 and 20 samples of the most important time points , were 
characterized using next-generation sequencing (cfr. supra). 
2.3 Microbial community analysis 
The DNA extraction procedure was adapted from Boon et al. (2003) with modifications 
to increase the release of DNA from microbial cells. 1% SDS was added during the first 
extraction step and mechanic lysis was performed. Copy number of the16S rRNA gene of 
A. muciniphila was estimated by quantitative PCR on 10-or 100-fold diluted DNA, using 
specific primers for A. muciniphila (AM1 and AM2) (Collado et al., 2007). Primer 
concentration was 300 nM. Standard curves were constructed with serial dilutions (102 to 108 
copies.μL-1) of plasmid DNA from clones of A. muciniphila. PCR was performed to amplify 
the plasmid containing the sequence insert using described protocols (Collado et al., 2007). 
The specificity of all primers was verified by the amplification of amplicons of the correct size 
from the target products in all samples. Quantitative PCR was performed in a StepOnePlus 
Real-Time PCR system (Applied Biosystems, Ghent, Belgium) using Power SYBR® Green 
PCR 2X Master Mix (Applied Biosystems, Ghent, Belgium) according to the manufacturer’s 
instructions. The results were expressed as log copies mL-1  of initial sample. 
Biodiversity was analyzed using Illumina high throughput sequencing (MiSeq, Illumina, 
Hayward, CA,USA). The V5-V6 hypervariable region of the 16S rRNA gene was amplified 
using primers 807F and 1050R (Bohorquez et al., 2012). Libraries were prepared by pooling 
equimolar ratios of amplicons (200 ng of each sample), and tagged with a unique barcode 
(Camarinha-Silva et al., 2014). Resulting libraries were sequenced on a Miseq (Illumina, 
Hayward, CA, USA) using 250 bp single-end sequencing chemistry. Single reads were 
trimmed to 120 nucleotides and quality filters were performed as previously described 
(Camarinha-Silva et al., 2014). Samples from both experiments were analyzed separately. 
From the pH experiment (32 samples) and the mucin experiment (20 samples), 905284 and 
544294 operational taxonomic units (OTUs), respectively, were retrieved and were clustered 
into 132 unique taxa. Sequence composition was compared using the RDP Classifier tool 
(Wang et al., 2007)(Wang et al., 2007) and SILVA database (Pruesse et al., 2007). Data 
were randomly subsampled to the sequence count of the sample with the lowest sequence 
count using the function rarefy_even_depth from the phyloseq package from R (McMurdie 
and Holmes, 2013); relative abundances of the top twelve taxa, with their deepest possible 
RDP classification up to the family level were determined (Kerckhof et al., 2014). Rarefaction 
curves, richness and biodiversity indices were obtained with the vegan package in R 
(Oksanen et al., 2011). Sequences are deposited and publically available in the European 
Nucleotides Archives under the accession numbers LN832064-LN832188. 
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2.4 Metabolic activity analysis 
For mucin quantification, SHIME samples were diluted in PBS in a 1:20 ratio and 
determined fluorimetrically, as described by Bovee-Oudenhoven et al. (1997). Briefly, 
oligosaccharides were liberated from mucin via β-elimination with dilute alkali and 
subsequently reducing ends were derivatized with 2-cyanoacetamide. Mucin levels are 
expressed as mM oligosaccharide equivalents using standard solutions of N-
acetylgalactosamine. 
Acetate, propionate, butyrate, valerate, caproate, isobutyrate, isovalerate and 
isocaproate were measured as described previously (Andersen et al., 2014). Data were 
analysed using the SPSS 19 software (SPSS Inc., Chicago, USA). Normality was determined 
with a Kolmogorov-Smirnov test before investigating probability of intergroup differences. 
Significant differences between treatments were detected using one-way ANOVA or the non-
parametric Mann-Whitney U test in case of non-normality. Post hoc analysis was performed 
using the Bonferroni correction for equal variances or Dunnett test when variances were 
assumed to be different., Pearson correlation coefficients were calculated to investigate the 
relation between the SCFA and A. muciniphila. Significance was set at 0.05. 
 
2.5 Multivariate statistical analysis 
Multiple Factor Analysis (MFA) was employed to assess the variations on the relative 
bacterial abundances in the pH experiment on each SHIME vessel at different pH, following 
inulin supplementation. MFA was employed to simplify the data by reducing the 
dimensionality of the dataset encompassing the bacterial families and the qualitative 
descriptors (pH and sampling time). In this way, MFA allowed for balancing the influence of 
each group of bacterial families, for investigating the associations between time and pH, and 
to produce a representation of the individual samples grouped according to their similarities 
regarding the relative bacterial abundances. Bacterial abundances were weighted on a 
global PCA and results were explained in a factor map (de Tayrac et al., 2009), where the 
value of the abundance of each bacterial family (vector) for the corresponding pH (factor) 
was plotted (Grunert et al., 2016). The function MFA from the FactoMineR package (Le et al., 
2008) was performed in R. Parametric bootstrapping was applied to construct confidence 
ellipses around the barycentre of the abundances on each SHIME vessel to visualize 
whether the bacterial abundances were significantly different among colon vessels. 
Confidence intervals of the average coordinates of the bacterial abundances were 
represented by the ellipses, indicating 95% of similarity among bacterial abundances. If the 
ellipses were not overlapping, the bacterial abundances were significantly different; 
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incomplete overlap indicated that bacterial abundances were significantly different in the 
samples outside the ellipse (Dehlholm et al., 2012). Hence, non-overlapping confidence 
“ellipses” denoted that two vessels differed at significant level (P > 0.05).  
Correspondence analysis (CA) using the Single Value Decomposition (SVD) highlighted the 
variations in relative bacterial abundance in the mucin experiment of the 3 distal colon vessel 
on the SHIME pre- and post-mucin treatment. Computations were performed in the R 
language, using the ca package (Nenadic and Greenacre, 2007). The percentages of 
explained variance (inertias) for the bacterial abundances (rows) and time point (columns) on 
each dimension of the CA were determined. Total variance was explained in 4 factors or 
dimensions. The graphical display of the CA showed relationships among the relative 
abundances of specific bacterial groups (Hernandez-Sanabria et al., 2013). The area of the 
point symbols plotted in the CA indicates the mass. Masses are the marginal proportions of 
the relative bacterial abundances (row variable). These proportions are used to weight all the 
bacterial abundances when computing the distance between the abundance of an “x” 
bacterial family to the centroid of the abundance of all bacterial families. This weighting has 
the effect of compensating for unequal numbers of cases (Nenadic and Greenacre, 2007). 
Therefore, the area of a point in the graph will indicate the relative contribution of a particular 
bacterial family to the total variance. The color intensity of the point symbol and that of the 
arrow are proportional to the absolute contribution of the points in terms of a percentage of 
explained variance. Darker colors of the arrows indicate higher percentages of variance 
attributed to a particular time point. Point symbols with darker color represent the bacterial 




3.1 Stabilization of A. muciniphila in the colon environment 
We previously demonstrated an 8-fold increase of A. muciniphila in the complex 
microbial community of the distal colon regions (transverse and descending) compared to the 
proximal colon by applying a phylogenetic microarray (HITChip) on consecutive colon 
regions of a stabilized SHIME-model (19-26 days after inoculation with a fecal sample) 
(Supplementary Table 2.1) (Van den Abbeele et al., 2010). QPCR analysis of A. muciniphila 
confirmed that A. muciniphila increased in the distal colon regions (>105–fold increase), with 
no difference between transverse and descending colon compartments (P=0.102) 
(Supplementary Table 2.1). During the stabilization experiment, we monitored A. muciniphila 
copy number and mucin degradation upon inoculation of the in vitro gut model with a human 
fecal sample to gain insight in the temporal patterns of A. muciniphila colonization in the 
distal colon (Supplementary Figure 2.1B-C). Initially (day 0-3), A. muciniphila increased in 
both the proximal and the distal colon region, coinciding with efficient mucin degradation in 
both compartments. Starting from day 3 after inoculation, A. muciniphila washed out from the 
proximal colon, as measured with qPCR and mucin started to accumulate in this colon 
region. At the same time, A. muciniphila abundantly colonized the distal colon, which was 
characterized by almost complete mucin degradation. A. muciniphila numbers stabilized 6 
days after inoculation. 
 
3.2 Effect of pH and inulin on A. muciniphila in the distal colon 
As previous experiments showed that A. muciniphila proliferates in the distal but not 
the proximal colon compartment of the SHIME (Van den Abbeele et al., 2010), we focused 
on the distal colon during the pH experiment to evaluate the effect of pH on A. muciniphila 
colonization (Figure 2.1A). Quantitative PCR analysis confirmed that A. muciniphila was 
present the proximal colon compartment, yet at abundances close to the detection limit 
(Figure 2.1B). Moreover, a strong pH-dependent colonization of the distal colon was 
observed; the average abundance over time was measured at 7.98 ± 0.07 log copies ml-1 
with pH between 6.15-6.4 (Dm) and 8.35 ± 0.05 log copies ml-1 at pH 6.6-6.9 (Dh). Despite 
the identical nutritional conditions in the distal colon region with low pH (5.6-5.9), 
A. muciniphila numbers decreased dramatically to around the detection limit (= 4 log copies 
ml-1), similar to the abundances in the proximal colon. A. muciniphila thrived at neutral pH 
values. Further, prebiotic treatment with inulin at day 11 did not significantly affect 
A. muciniphila numbers (Supplementary Table 2.2).  
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SCFA analysis revealed that the distal colon regions at higher pH (Dh/Dm) contained 
high acetate, propionate and initially also valerate/branched SCFA levels and low butyrate 
levels (Figure 2.2). Administration of inulin resulted in increased acetate and butyrate in 
comparison with levels of branched SCFA in the proximal colon and a slight increase in 
butyrate and propionate levels in the distal colon vessels. 
 
 
Figure 2.1: pH and inulin experiment. (A) Experimental set-up of the SHIME run to investigate the effect of 
pH on the colonization of A. muciniphila. After receiving normal nutritional medium during the first 11 
days, 5g L-1 inulin was supplemented to the feed from day 11 until day 15. (B) A. muciniphila abundance 
(log (copies ml-1)) measured with qPCR as a function of time after inoculation (days) for the proximal 
colon (PC) and the three distal colon regions on different pH values: Distal-high pH (6.6-6.9), Distal-






Figure 2.2: Short chain fatty acid (SCFA) concentration (mM) as a function of time after inoculation (days) 
in the different colon regions, proximal and distal with high, medium and low pH. Inulin (5g L-1) was 
supplemented to the feed from day 11 until day 15. Distal-high pH (6.6-6.9), Distal-medium pH (6.15-6.4) 
and Distal-low pH (5.6-5.9). 
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3.3 Microbial composition analysis of the colon environment 
Illumina sequencing showed high relative abundance of A. muciniphila in the distal 
colon with medium and high pH, compared to the distal colon with low pH and the proximal 
colon, confirming the qPCR results (Figure 2.3A). This increase of A. muciniphila is at the 
expense of several other species like Clostridium sp. and Bacteroides sp. and coincides with 
higher relative abundances of Alistipes, Parabacteroides and Bilophila species (Figure 2.3). It 
is remarkable that the differences in the pH lead to such a strong response in one species, 
A. muciniphila, compared to the other species in this complex microbial community. 
Multiple factor analysis was employed to interpret how the differences in pH impacted 
the bacterial abundances in each region of the colon and whether the relative abundances 
remained stable before and after the supplementation with inulin (Figure 2.3B). The goal of 
this analysis was to discriminate whether the relative abundances of each colon fraction were 
similar among them. In the figure the colored symbols, representing the bacterial 
abundances in the different environments at different time points, were plotted in a two 
dimensional space. The variables described on each dimension are included in 
Supplementary Table 2.3. The first dimension comprised of the relative bacterial abundances 
associated with day 6 in particular, and in the distal colon with high pH, while the second 
dimension explained the relative abundances in the distal colon on day 10 (Supplementary 
Table 2.3). These two dimensions accounted for 54% of the differences among relative 
abundances on the different locations and time points. The third dimension included the 
relative abundances that are correlated with days 14 and 15 and it accounts for 14% of the 
total variance. It may be suggested that the first dimension describes the initial colonizers, 
because it is significantly correlated with day 6, whereas the second dimension explains the 
genus correlated with high pH (distal colon) and the third dimension describes the genera 
correlated with the inulin treatment, because day 14 and 15 are comprised in this dimension. 
Genera that are positively correlated with the second dimension are Alistipes, Bilophila and 
Akkermansia and with the third dimension are Lactobacillus, Succiniclasticum, Propionispora 
and Lachnoclostridium whereas Bacteroides is negatively correlated with this dimension 
(Supplementary Table 2.3). The fourth dimension included the genera correlated with 
location with low pH (distal colon).  
At day 6, the bacterial abundances are different between locations, which can be due 
to the initial adaptation to pH and other environmental conditions (Figure 2.3B). Proximal and 
distal colon (with low pH) partially overlap, which indicates that the relative bacterial 
abundances are similar in the time points inside the overlapping area. The partial overlap 
may be explained by the pH, which is low in both locations. The area of the confidence 
ellipse is smaller in the high pH, indicating that the relative abundances in high pH tended to 
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be not significantly different (Figure 2.3B). MFA showed that in the distal colon with higher 
pH, the relative abundances on day 8 and 10 (pre-inulin) are significantly different from the 
relative abundances on day 14 (post-inulin). However, the effect was not consistent when pH 
was low.  
 
Figure 2. 3: Illumina sequencing results of the pH and inulin experiment. Inulin (5g/L) was supplemented 
to the feed from day 11 until day 15. Distal-high pH (6.6-6.9), Distal-medium pH (6.15-6.4) and Distal-low 
pH (5.6-5.9). (A) An overview of the relative abundance (% of the total community) of the 11 most 
abundant genera in the different colon vessels for the different time points (days). (B) Multiple Factor 
Analysis (MFA) was employed to assess the relative bacterial abundances detected in each SHIME vessel 
and for the different time points based on the Illumina data from the different samples (p<0.05). 
  A. muciniphila colonization in the distal colon 
49 
3.4 The effect of variable mucin concentration in the colon environment on 
A. muciniphila abundance 
To further unravel the behavior of A. muciniphila in a complex microbial community, the 
effect of mucin presence was investigated. In this mucin experiment, the aim was to wash 
out A. muciniphila from the distal colon compartment by feeding mucin-free nutritional 
medium to the SHIME (Figure 2.4A). Based on qPCR, A. muciniphila decreased during 
administration of mucin-free feed but did not wash out entirely from the distal colon at day 10 
(Figure 2.4B). The initial high numbers are probably caused by growth on mucins present in 
the inoculum. Upon the supplementation of mucin, A. muciniphila numbers increased (3.03 ± 
0.13 log copies mL-1 from day 10 to 11) in all distal colon regions (P=0.0006) but not in the 
proximal colon (P=0.3) (Figure 2.4B). There was a distal increase of acetate, propionate, 
butyrate, valerate and branched SCFA upon addition of mucins (Figure 2.5). Only acetate, 
valerate and especially propionate increased in the distal colon compartment when 
accounting for the proximal SCFA production, while butyrate and branched SCFA were 
already produced in the proximal colon compartment. The A. muciniphila increase in the 
distal colon on day 11 thus correlates with increased propionate levels. As can be seen from 







Figure 2. 4: Mucin experiment. (A) Experimental set-up of the SHIME run to investigate the effect of mucin 
depletion and administration on the colonization of A. muciniphila. After receiving mucin depleted 
nutritional medium during the first 10 days, 8g/ L-1 was dosed to the proximal colon on day 10, while 4g L-
1 was dosed from day 12-15. (B) A. muciniphila abundance (log (copies mL-1)) measured with qPCR as a 
function of time (days) after inoculation for the proximal colon and the three replicate distal colon regions 
(Distal 1-3). Technical variation was never higher than 3%. 
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Figure 2. 5: SCFA levels (mM) as a function of time (days) after inoculation for the proximal colon and the 
three distal colon regions that were fed a mucin-free feed until day 10 after which 8g L-1 (day 10-12) and 




3.5 Microbial composition analysis of the colon environment with variable 
mucin supply 
Illumina sequencing data showed a strong increase in relative abundance of 
A. muciniphila  after mucin addition, confirming the qPCR results (Figure 2.6A). This increase 
coincides with a decrease of almost all the other genera, except for Parabacteroides, which 
increase together with A. muciniphila. Lactobacillus and some Clostridium species are 
significantly more abundant after mucin supplementation (Supplementary Table 2.4). 
Correspondence analysis was used to further explain the variations in relative abundances 
(Figure 2.6B). The area of the points in the figure indicates the relative frequency of a 
particular genus and darker colors of the arrows indicate higher percentages of variance 
attributed to a particular time point. Point symbols with darker color represents the bacterial 
abundances that contributed more to the variance among time points (Supplementary Table 
2.5). The presence of a distinctive microbial community before and after the supplementation 
with mucin was validated based on the relative abundances of the bacteria associated with 
each time point. It is clear that dimension 1, which accounted for 87% of the total variance 
among samples, shows the distinction between the community before and after mucin 
supplementation. Day 8 and 10 are characterized by Lachnoclostridium, Bacteroides and 
Parasutterella whereas day 12 and 15 are characterized by Akkermansia, Parabacteroides 
and Lactobacillus (Supplementary Table 2.5). Changes in the abundance of Akkermansia 
alone explain 53.76% of total variance. Dimension 2 accounts for 9% of the total variance 
and is mostly characterized by the community in transition. 
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Figure 2. 6: Illumina sequencing results of the mucin experiment where a mucin-free feed was fed until 
day 10 after which 8g L-1 (day 10-12) and 4g L-1 mucin (day 12-15) was administered. (A) An overview of 
the relative abundance (% of the total community) of the 11 most abundant genera in the distal colon 
vessels (averaged) for the different time points (days). (B) Correspondence analysis (CA) using the Single 
Value Decomposition (SVD) was employed to highlight the variations in relative bacterial abundance of 
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We used a dynamic in vitro gut model (SHIME) to gain insight in the colonization and 
metabolic performance of the mucin-degrading gut symbiont A. muciniphila within the three 
regions of the human colon and in the presence of a complex gut microbiota. This overcame 
limitations that are inherently associated with human in vivo studies, such as the difficult 
access to the different regions of the colon and confounding effects of processes that may 
indirectly impact host mucin production and fitness of mucin degraders. Due to the 
successful and abundant colonization of A. muciniphila, we created an ideal biological 
environment to study the ecological behavior of A. muciniphila and the impact of pH and 
mucin. 
Using the in vitro SHIME model and a specific inoculum with high abundances of A. 
muciniphila, the combination of qPCR analysis, HITChip and Illumina sequencing 
demonstrated the preferential colonization of the distal colon ecosystem by A. muciniphila. 
The preference of A. muciniphila for distal colon colonization was shown, yet partial mucin 
degradation also took place in the proximal colon. This process was probably performed by 
Bacteroides species, which are colonizers of the proximal colon compartment (Figure 2.3A, 
Supplementary Figure 2.2) and which are known as versatile glycan-degrading microbes 
(Martens et al., 2009; Salyers et al., 1977). In contrast, our results suggested that 
A. muciniphila was the specialist mucin degrader in the distal colon compartment, because 
its abundant colonization significantly correlates with mucin concentrations (Supplementary 
Figure 2.1, Figure 4, Figure 6) and mucin degradation (Supplementary Figure 2.1). 
Propionate is a major end product of A. muciniphila metabolism, hence the increase in 
propionate after mucin supplementation indicated that A. muciniphila was degrading mucin in 
the distal colon (Derrien et al., 2004) (Figure 2.5). When the food bolus arrives in the distal 
colon, the carbohydrates are already fermented and the proteolytic fermentation starts. This 
leads to the formation of phenols, branched short chain fatty acids, ammines and other end 
products, many of which have toxic effects (Macfarlane and Macfarlane, 2012; Nyangale et 
al., 2012). The presence of A. muciniphila in the distal colon and its production of beneficial 
short chain fatty acids from mucins can thus be a protective strategy by prolonging the 
saccharolytic fermentation and maybe counteracting some of the deleterious effects of the 
proteolytic fermentation.. This location preference of A. muciniphila for the distal colon 
compartment of the SHIME can derive from parameters, such as pH, nutrient availability, 
residence time, and the microbial community, which differ between colon regions.  
Further research into these different parameters, shows that the preferential 
colonization of A. muciniphila seems to be determined by the pH, because A. muciniphila 
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numbers were different between distal colon vessels that only differ in pH. This confirms 
results from A. muciniphila grown in monoculture, where the optimum pH for growth was 6.5 
and no growth was observed below pH 5.5 or above pH 8 (Derrien et al., 2004). So 
A. muciniphila thrives at the more neutral pH (6.6 to 6.9) of the distal colon compartment and 
is less competitive in the proximal colon with lower pH (5.6 to 5.9) (Cummings, 1997). 
A. muciniphila might be locally outcompeted by Bacteroides species, which have the ability to 
grow and compete across a broad pH range (Macfarlane et al., 1995). A. muciniphila prefers 
colon environment with high pH and is correlated with higher acetate and propionate 
production but lower butyrate concentration. In the vessels with pH 6.6 to 6.9, more acetate 
and propionate were produced but less butyrate, which has been previously reported (Walker 
et al., 2005). The decrease in butyrate may be a direct effect of pH as butyrate producers 
proliferate at lower pH (Duncan et al., 2009). The increase in propionate may be attributed to 
higher A. muciniphila abundances, as other genera correlated with higher pH in this 
experiment are not known for their high propionate production. Bilophila and Alistipes have 
been previously associated with undesirable gut health traits, like most species that thrive at 
more neutral pH in the distal colon (Cummings, 1997; da Silva et al., 2008; Nyangale et al., 
2012; Rautio et al., 2003). However, it cannot be ruled out that other factors play a role. For 
instance, the pH may have an effect on the mucin structure or its enzymatic accessibility and 
also the microbial background may play a role since we only tested it in one microbial 
environment. 
Not only was the effect of pH and inulin investigated, but also the effect of variable 
mucin availability. The most obvious result of the administration of mucin after mucin 
depletion was the increase in A. muciniphila numbers in the distal colon compartment. Mucin 
supplementation also produced an increase in butyrate production in the proximal colon 
(Figure 2.5). This increased butyrate production was potentially established via cross-feeding 
with Bacteroides and other species that can degrade mucin (Martens et al., 2008; Martens et 
al., 2009; Salyers et al., 1977). An increase in the relative abundance of Bifidobacterium 
species was observed in the proximal colon at day 15. This may indicate that those species 
are capable of partial mucin degradation and they could also contribute to the increase in 
butyrate (Hoskins et al., 1985; Killer and Marounek, 2011; Png et al., 2010) (Supplementary 
Figure 2.2). In the distal colon compartment, the mucin administration caused a significant 
increase in propionate production that can be attributed to A. muciniphila and 
Parabacteroides species, which both characterize the new mucin-associated community 
(Figure 2.6). Parabacteroides sp. produce acetate and succinate, which can be used by 
other species to produce propionate, for example Phascolarctobacterium, which relies for its 
carbon-source on succinate (Deldot et al., 1993; Sakamoto and Benno, 2006; Watanabe et 
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al., 2012). Increase in propionate production in a mucin degrading environment might thus be 
a biological marker for A  muciniphila. 
We observed that colonization of A. muciniphila using this specific inoculum in our in 
vitro system is dependent on pH and mucin, but not on inulin.. In a rat study (Van den 
Abbeele et al., 2011a) it was shown that inulin shifted A. muciniphila from the caecum to 
more distal regions and increased the fecal numbers of A. muciniphila. As mentioned above, 
the colonization of A. muciniphila is very pH dependent. Therefore, as inulin supplementation 
is known to lower pH (Van den Abbeele et al., 2011a; Welters et al., 2002), it might force 
A. muciniphila to colonize more distal regions in the rats. Inulin does not only affect pH but it 
also stimulates mucin secretion by the host (Barcelo et al., 2000; Schmidt-Wittig et al., 1996; 
Shimotoyodome et al., 2000). Since A. muciniphila is a known mucin degrader and 
susceptible to changes in mucin availability, this is another way by which inulin can exert an 
indirect effect on A. muciniphila numbers. In our in vitro study however, the pH and the mucin 
concentration were maintained constant and no effect of inulin on A. muciniphila could be 
observed. Inulin treatment did stimulate Lactobacillus species, which has been described in 
many other studies (Kleessen et al., 2001; Macfarlane et al., 2006; Makras et al., 2005; Sghir 
et al., 1998). Also propionate producing bacteria Succiniclasticum and Propionispora 
increased after inulin treatment, which can explain the higher propionate concentration 
(Abou-Zeid et al., 2004; van Gylswyk, 1995). The increased butyrate concentration however 
could not be linked to higher abundances of butyrate producing bacteria (Supplementary 
Table 2.2).  
Our experiments showed the mechanism behind the effect of inulin, pH and mucin on 
the colonization of A. muciniphila and confirmed our hypothesis. In this way, prebiotics like 
inulin may exert a beneficial effect along the entire length of the colon, by stimulating mucin 
secretion and shifting the mucin degradation to distal regions. This process may yield higher 
propionate and acetate production. Other dietary compounds that can favor A. muciniphila 
are for example cranberries, which are rich in polyphenols and have been shown to increase 
the A. muciniphila population in diet-induced obese mice (Anhe et al., 2015). Also in mice fed 
with fish-oil, rich in omega-3 fatty acids, A. muciniphila was enriched (Caesar et al., 2015). 
The manner in which these products stimulate A. muciniphila is not yet clear and, like with 
inulin, the effect might not be the same in our in vitro system. Human milk oligosaccharides 
(HMO) resemble mucins in their structure and A. muciniphila has the capacity to grow on 
these HMOs. So treatment with human milk oligosaccharides might directly affect 
A. muciniphila, just like mucin treatment, and thus be useful in our in vitro SHIME model. 
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For the experiments performed in this paper a microbial environment was created with 
pronounced A. muciniphila colonization to ensure the study of its ecological behavior. The 
experiments were carried out in the in vitro SHIME model that is perfect for these 
mechanistic studies. Although there were hundreds of other species present, only 
A. muciniphila reacted that strongly to the changes in the SHIME environment, i.e. different 
pH and mucin concentration. Further research considering multiple donors, providing 
different microbial environments with different A. muciniphila abundances, should be 
performed to elucidate whether the sensitivity of A. muciniphila is dependent on the microbial 
background or not. The results shown in this paper are indicative of a high sensitivity of 
A. muciniphila to environmental changes. This high sensitivity could explain why its 
abundance changes drastically in vivo when the conditions in the colon change, for example 
due to certain disease states (Everard et al., 2011; Png et al., 2010; Wang et al., 2011; 
Zhang et al., 2009). This could clarify why A. muciniphila is so often correlated with diseases 
and might be an indicator species for gut health.  
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6. Supplementary information 
  
Supplementary Figure 2.1: Stabilization experiment. (A) Set-up of experiment in which the dynamic 
colonization of A. muciniphila during stabilization of a faecal sample in the SHIME was investigated. As 
earlier studies demonstrated that the three colon regions of the a conventional L-SHIME can be 
distinguished in a proximal (ascending) and distal (transverse and descending) colon, the setup was 
simplified to a 2-compartment simulation. On day 0, colon vessels are filled with nutritional medium and 
inoculated with a faecal slurry. By applying relevant conditions (retention time, nutrition, pH), the faecal 
microbiota evolve reproducibly to colon region-specific microbial communities. (B) Average (± SEM) A. 
muciniphila abundance (log (copies/mL)) measured with qPCR as a function of time after inoculation 
(days) for the proximal colon and the distal colon region. (C)Average (± SEM) mucin concentration, 
expressed as mM oligosaccharide equivalents, in the nutritional medium (feed) coming in, the proximal 
and distal colon as a function of time (days) after inoculation 




Supplementary Figure 2. 2: An overview of the relative abundance (% of the total community) of the 11 
most abundant genera in the proximal colon vessel for the different time points (days) with mucin 




Supplementary Table 2. 1: The average (± SEM) abundance (%) of A. muciniphila based on the HITChip 
analysis, as reported by Van den Abbeele et al. (2010), and the average (± SEM) absolute numbers (log 
copies/mL reactor volume) based on A. muciniphila-specific qPCR in the proximal and distal colon 
regions of a stabilized SHIME (day 19 and 26 after inoculation) (n = 4). Average (± SEM) absolute (mM) and 
proportional (mol %) net SCFA production in the proximal and distal colon regions of a stabilized SHIME 
(day 19, 21, 23 and 26 after inoculation), based on the absolute SCFA concentrations reported by Van den 
Abbeele et al. (2010). Values indicated with a different superscript are significantly different (a or b). 
  
 
Proximal colon Distal colon 
Ascending Transverse Descending 
HITChip (%) 







qPCR (log copies/mL) 









Acetate 31.7 ± 0.2
a 
+ 2.9 ± 0.3
a 
+ 3.9 ± 0.3
a 
Propionate 11.6 ± 1.3
a 
+ 2.5 ± 0.1
b 
+ 0.5 ± 0.1
a 
Butyrate 3.0 ± 0.8
a 
+ 1.3 ± 0.1
b 
+ 1.0 ± 0.1
b 
Proportional 
values of net 
production 
(mol%) 
Acetate 68.5 43.3 72.1 
Propionate 25.1 37.7 9.8 
Butyrate 6.5 19.0 18.1 
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Supplementary Table 2.2: Table of the significant increased or decreased OTUs after inulin 
supplementation. OTUs belonging to the Akkermansia genus are not included in this table since 
Akkermansia numbers were not significantly changed with inulin supplementation. P-value is the result of 
a two tailed T-test with unequal variance and the level of change is the abundance after inulin 




Locat ion  Genus O T U . i de nt i t y  P.Value  leve l.of.change  
P r o x ima l      
 Faeca l ibac t e r iu m  O T U 2 6  a n d  3 7  0.02 0.07 
 Fus ica t en ibac t e r  O T U5 3 ,  8 6  a nd  1 14  0.04 5.40 
 P a r a ba c t e r o id e s  O T U1 0  a nd  2 1  0.00 12.94 
 P r o p io n is p o r a  OTU24 0.01 8.14 
 Succ in ic las t icu m  OTU12 0.01 10.70 
 Veillonella  OTU13 0.03 0.01 
D is t a l- lo w pH      
 Ac hr o mo ba c t e r  OTU42 0.05 9.00 
 Bact ero ides  OTU15 0.02 0.00 
 Bact ero ides  OTU58 0.05 10.25 
 Bact ero ides  OTU127 0.02 2.88 
 Bact ero ides  OTU36 0.02 0.00 
 Bact ero ides  OTU1 0.02 2.02 
 Bact ero ides  OTU43 0.02 0.10 
 Bact ero ides  OTU16 0.04 0.03 
 B if ido bac t e r iu m O T U1 9  a nd  1 0 5  0.00 0.11 
 B la u t ia  OTU91 0.03 0.24 
 C lo s t r id iu m  OTU50 0.01 0.14 
 Coll inse lla  OTU41 0.02 0.13 
 Co pro co ccus  OTU62 0.01 0.09 
 E u ba c t e r iu m  OTU51 0.02 0.23 
 Faeca l ibac t e r iu m  O T U 2 6  a n d  3 7  0.01 0.09 
 H u ng a t e l la  O T U2 3 ,  3 2 ,  a nd  1 2 4  0.01 0.36 
 Lac to bac i l lu s  OTU25 0.05 0.03 
 M e g a s p ha e r a  OTU22 0.02 0.04 
 Osc i l lo bac t e r  OTU70 0.02 0.03 
 P r o p io n is p o r a  OTU24 0.01 13.10 
 R u mino c o cc u s  o be u m  OTU68 0.01 0.55 
 Succ in ic las t icu m  OTU12 0.02 13.89 
 Veillonella  OTU13 0.00 0.06 
D is t a l - me d iu m p H      
 Bact ero ides  OTU130 0.05 0.14 
 B if ido bac t e r iu m O T U1 9  a nd  1 0 5  0.02 0.12 
 C lo s t r id iu m  OTU101 0.01 13.80 
 C lo s t r id iu m  OTU76 0.04 4.08 
 Coll inse lla  OTU41 0.02 0.16 
 D ia l is t e r  OTU8 0.04 1.49 
 Faeca l ibac t e r iu m  O T U 2 6  a n d  3 7  0.01 0.35 
 Lac to bac i l lu s  OTU25 0.02 7.73 
 P a r a su t t e r e l la  OT U123,  125,  128,  129 ,  18,  27,  69 ,  72,  115,  117 and  118  0.02 0.60 
 P r o p io n is p o r a  OTU24 0.01 13.85 
 Succ in ic las t icu m  OTU12 0.01 12.84 
 Veillonella  OTU13 0.02 0.07 
D is t a l- h ig h pH      
 B if ido bac t e r iu m O T U1 9  a nd  1 0 5  0.03 0.06 
 C lo s t r id iu m  OTU56 0.04 0.23 
 C lo s t r id iu m  OTU76 0.04 2.22 
 E u ba c t e r iu m  OTU51 0.01 0.28 
 Faeca l ibac t e r iu m  O T U 2 6  a n d  3 7  0.01 0.25 
 Lac to bac i l lu s  OTU25 0.03 7.88 
 P r o p io n is p o r a  OTU24 0.01 10.66 
 P s e u do bu t yr iv ib r io  OTU111 0.02 0.11 
 Succ in ic las t icu m  OTU12 0.01 10.49 




Supplementary Table 2.3: Correlations between relative bacterial abundances and dimension of the 
Multiple Factor Analysis. For the descriptors, a one-way analysis of variance was performed using the 
coordinates of the bacterial abundances by pH, by time point and by location. Student T-test was used to 
compare the average of the relative bacterial abundances of the pH/time point/location with the total 
average of all bacterial abundances. The value of the correlation of the with the dimension is indicated 
(***, P < 0.0001; **, P < 0.05; *, P < 0.1). Negative values indicate negative correlations. 
 
  






Day 6 3,9 0,0003 Faecalibacterium 0,508**
High pH 2,38 0,0009 Pseudomonas 0,502**
1 31,9 Distal colon 1,94 0,0009 Akkermansia 0,430**
Low pH -1,78 0,001 Veillonella 0,239**













Distal colon 1,83 0,003 Anaeroglobus 0,410**
High pH 1,46 0,003 Eisenbergiella 0,280**
Day 10 1,74 0,07 Parasutterella 0,248**
2 23 Low pH -1,51 0,001 Lactobacillus 0,224**
Proximal colon -1,87 0,002 Propionispora 0,103**














Day 15 2,19 0,002 Ruminococcus 0,241**
Day 14 1,57 0,04 Parasutterella 0,205**
3 14,1 Day 11 -1,69 0,03 Bilophila 0,203**
Day 8 -1,49 0,05 Prevotella 0,133**










4 10 Distal low 1,14 0,005 Faecalibacterium 0,499**
Distal high -0,762 0,07 Bacteroides 0,394**
Akkermansia -0,574**
Pseudomonas -0,418**
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Supplementary Table 2.4: Table of the significant increased or decreased OTUs in the distal colon 
compartment after mucin supplementation. P-value is the result of a two tailed T-test with unequal 
variance and the level of change is the abundance after mucin supplementation compared with the 




Genus O T U . i de nt i t y  P.value  leve l.of.change  
Alist ipes  OTU39 0,010670229 0,56022409 
Ac hr o mo ba c t e r  OTU42 0,038095805 0,293877551 
Ak k e r ma n s ia  OTU2 0,000604632 167,0666667 
Anaer o g lo bus  O T U 4  a n d  1 0 3  0,018926045 0,621920563 
Bac t ero ides  OTU130 0,001607348 ? 
B if ido bac t e r iu m OTU19 0,008738608 0,066079295 
Bilophi la  OTU6 0,000521956 0,207740239 
B la u t ia  OTU28 0,002104784 0,169289962 
Co ll inse lla  OTU41 0,004417081 0,282051282 
C lo s t r id iu m  OTU46 0,004367185 0,21969697 
C lo s t r id iu m  OTU107 0,027220304 2,024509804 
C lo s t r id iu m  O T U 11 3  0,036193876 0 
C lo s t r id iu m  OTU106 0,000253595 0,438645276 
C lo s t r id iu m  OTU56 0,010313308 0,320610687 
C lo s t r id iu m  OTU104 0,0136114 0,152380952 
C lo s t r id iu m  OTU76 0,00548313 0,273015873 
C lo s t r id iu m  OTU92 0,010534356 0,256410256 
C lo s t r id iu m  OTU71 0,011394601 0,28125 
C lo s t r id iu m  OTU35 0,017257706 0,206751055 
C lo s t r id iu m  OTU89 0,013896494 0,47826087 
C lo s t r id iu m  OTU40 9,16704E-06 0,187242798 
P a r a ba c t e r o id e s  O T U1 0  a nd  2 1  0,004815559 3,933333333 
E nt ero co ccus  OTU61 0,0304484 0,140350877 
Et hano l ige ne ns  OTU81 0,006439547 0,193333333 
E u ba c t e r iu m  OTU51 0,0260356 0,181818182 
E u ba c t e r iu m  OTU17 0,01771176 0,265432099 
Fu s o ba c t e r iu m  OTU34 0,034105022 0,300405954 
Faeca l ibac t e r iu m  O T U 2 6  a n d  3 7  0,001370181 0,45014245 
H u ng a t e l la  O T U3 2 ,  2 3  a nd  1 24  0,012552626 0,226415094 
Lac to bac i l lu s  OTU25 0,022205942 5,015873016 
P a r a su t t e r e l la  OT U123,  125,  128,  129 ,  18,  27,  69 ,  72,  115,  117 and  118  0,00061688 0,48 
R u mino c o cc u s  OTU57 0,015788228 0,208333333 
R u mino c o cc u s  OTU116 0,028513763 0,108333333 
T er r is p o r o ba c t e r  OTU95 0,016929752 0,111111111 
Veillonella  OTU13 0,000582873 0,077294686 
Vict iva l laceae  OTU83 0,0132379 0,315789474 
    




Supplementary Table 2. 5: Correspondence analysis (CA) using the Single Value Decomposition (SVD) 
was employed to highlight the variations in relative bacterial abundance of the distal colon vessel on the 
SHIME pre- and post-mucin treatment. (upper) Relative bacterial abundances in distal colon vessels 
supplemented with mucin. The value of the correlation of the with the dimension is indicated (***, P < 
0.0001; ; **, P < 0.05; *, P < 0.1). Negative values indicate negative correlations. (lower) Relative bacterial 











































































(% of the total) Time point
Variance
(% of the total)
Lachnoclostridium 3.23 Day 8 17.40
Eubacterium 0.26 Day 10 20.65
Ruminococcus 1.13 Day 11 9.25
Dialister 0.99 Day 12 13.23
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Akkermansia muciniphila, an abundant mucolytic colon microorganism, has been 
correlated with human health in various studies. To identify the optimal conditions for 
successful in vivo application as a potential probiotic, the in vitro SHIME model was used to 
reach a mechanistic understanding of A. muciniphila’s colonization preferences and its 
response to environmental parameters such as colon pH and host glycans. After a period of 
mucin deprivation, we found that mucin supplementation results in significantly different 
microbial communities, with more Akkermansia, Bacteroides and Ruminococcus, compared 
to the mucin-deprived communities. Mucin treatment accounted for 26% of the observed 
variation in the microbial community at OTU level (p=0.001), whereas the donor effect was 
limited (8%) (p=0.035), indicating host glycans to constitute an important ecological niche 
shaping the microbiota composition. The effect of colonic pH had a less profound impact on 
the microbiome with both pH and donor origin explaining around 10% of the variability in the 
dataset. Yet, higher simulated colonic pH had a positive impact on Akkermansia abundance 
while SCFA analysis displayed a preference for propionate production with higher colonic 
pH. Our results show that host glycans as nutritional resource are a more important 
modulator of the gut microbiome than colon pH as environmental factor.   
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1. Introduction 
Akkermansia muciniphila is an abundant mucin-degrading member of the human gut 
microbiota and its abundance has been linked with gut health in several studies over the past 
decade (Collado et al., 2007; Png et al., 2010; Wang et al., 2011; Zhang et al., 2013). In a 
study with obese mice on a high-fat diet, it was shown that administration of A. muciniphila 
reversed insulin resistance, dyslipidemia, metabolic endotoxemia and fat mass gain (Everard 
et al., 2013). Plovier et al. (2017) discovered that the beneficial effects are at least partly due 
to a specific outer membrane protein. Apart from oral administration of A. muciniphila, uptake 
of dietary compounds such as fish oil and cranberry extract also increased A. muciniphila 
abundances and led to healthier mice (Anhe et al., 2015; Caesar et al., 2015). Other studies 
have shown an increased abundance of A. muciniphila in subjects with colon cancer, which 
might be explained by the overexpression of certain mucin types in colon cancer (Borges-
Canha et al., 2015; Weir et al., 2013b). Considering the various and far-reaching 
consequences of changes in microbial community composition and activity, there is a need 
to investigate the many forces that shape the microbial community, including various nutrient 
sources, antimicrobial compounds, ionic conditions and gut pH (Duncan et al., 2009). 
One dominant factor that influences the gut microbial community composition is the 
influx of glycans into the colon, both from diet and host mucosal secretions. As opposed to 
dietary glycans that vary in composition and supply, the host derived glycans from the mucus 
layer present a more continuous source of nutrients. Mucin glycans are composed of O-
glycosylated, and to a lesser extent N-glycosylated, protein backbones, with glycosyl chains 
of 2-12 monosaccharides, consisting of mainly galactose, fucose, N-acetylgalactosamine, N-
acetylglucosamine, mannose and sialic acid (Lai et al., 2009). Continuous mucin production 
by the goblet cells and mucus desquamation contribute both to mucin presence in the mucus 
layer as in the lumen of the colon (Atuma et al., 2001; Faure et al., 2002; Johansson, 2012). 
Previously, it was thought that mucin degradation was detrimental for gut health but it is now 
clear that it is part of a normal turn-over process (Norin et al., 1985). Due to the complexity of 
the mucin structure and the variation in glycosylation, a wide variety of specific enzymes are 
needed for its degradation, such as galactosidase, sialidase, fucosidase and N-
acetylgalactosaminidase (Tailford et al., 2015a). This means that only few species have the 
enzymatic capacity for initiating partial or full mucin degradation, including A. muciniphila, 
Bacteroides thetaiotaomicron, B. fragilis, Ruminococcus gnavus, R. torques, Bifidobacterium 
bifidum, … (Hoskins et al., 1985; Marcobal et al., 2011; Martens et al., 2008; Png et al., 
2010). Degradation of mucins leads to the release of less complex carbohydrates and the 
production of organic acids like acetate, lactate and propionate, some of which can be used 
by other bacteria, as part of a microbial food chain, to produce butyrate or other end 
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products. The presence and the activity of host glycan degrading species in the mucus layer, 
close to the host cells, may have strong effects, both positive and negative, on gut health. 
The role of host glycans in microbial community dynamics and host-microbe interactions 
therefore requires further study.  
Using SHIME as a dynamic model of the human gut and a human microbial inoculum 
with high reported Akkermansia abundance (Van den Abbeele et al., 2013; Van den Abbeele 
et al., 2012; Van den Abbeele et al., 2011g), we previously showed that mucin is a profound 
parameter impacting colonization ability of Akkermansia. Additionally, its ability to colonize 
different in vitro colon regions was also highly dependent on the prevailing pH (Chapter 2). 
Colonic pH is determined by host secretions and microbial fermentation products, such 
as pH-lowering by SCFA synthesis. In the proximal colon, pH is slightly lower compared to 
the distal colon, due to active carbohydrate fermentation leading to high amounts of SCFA 
(Macfarlane et al., 1992). Besides the effect on the microbiota, pH also influences bile acid 
solubility and cation availability (Scholz-Ahrens and Schrezenmeir, 2007). Information about 
the impact of colonic pH towards the residing microbiota is rare and in the context of 
determining growth optimum mostly focused on the effect towards single species (Duncan et 
al., 2009; Walker et al., 2005). 
As our previous work only explored the effect of mucin and pH towards A. muciniphila 
in one microbial background (=microbial inoculum from 1 human donor) (Chapter 2), the 
current study aims at testing the biological reproducibility of our previous findings. SHIME 
experiments were performed to study the effect of pH and the presence or absence of a 
host-glycan degradation niche in colon compartments separately inoculated with the 
microbiota from eight donors. This enabled us to elucidate whether the gut microbial 
response and A. muciniphila colonization sensitivity to changes in host-glycans and pH is 
dependent on the microbial background or not.  
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2. Materials and methods 
2.1 Long-term dynamic in vitro gut model for the luminal colon microbiota 
(SHIME) 
The long-term colonization of A. muciniphila within a mixed human gut microbiota was 
assessed in the dynamic in vitro gut model, SHIME® (ProDigest-Ghent University, Ghent, 
Belgium). The model and its nutritional medium is described in Chapter 2. Fecal samples 
were collected from healthy donors between the age of 25-35 and prepared within 1h 
according to standard procedures (Molly et al., 1993) (Chapter 2) and used for inoculation. 
Two SHIME experiments were performed in this study. The set-up of the mucin 
experiment, which evaluates the effect of mucin deprivation and subsequent 
supplementation, is shown in Figure 3.1. Eight colon vessels, with a retention time of 40 
hours and a pH between 6.6-6.9 (distal colon pH), were inoculated with the fecal suspension 
of eight donors. After supplementing a mucin-free nutritional medium during the first 8 days, 
of mucin (8 g L-1) was delivered to the proximal colon vessel on day 8, and from day 9 to 11, 
4 g L-1 mucin were supplied. The set-up of the second experiment, the pH experiment, is 
shown in Figure 3.2. Here eight colon vessels were inoculated with the fecal suspension of 
four donors, with four colon vessels being kept at pH 6.6-6.9 (high pH, distal colon pH) and 
four at pH 5.6-5.9 (low pH, proximal colon pH). All colon vessels had the same retention time 
(40h) and were fed normal nutritional medium during 11 days. This experiment was repeated 
with four different donors so that in total the pH experiment was carried out with eight fecal 
inocula.  
Samples were taken for SCFA analysis, as described previously (Andersen et al., 
2014) and for DNA extraction (Geirnaert, 2015) so 16S rRNA gene amplicon sequencing 
(Illumina MiSeq) (De Paepe et al., 2017) and A. muciniphila qPCR quantification (Collado et 





Figure 3.1: Experimental set-up of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) 
system for the mucin experiment. 
 
 






















Day 0: Inoculation of the 8 colon vessels with 8 fecal samples (1-8)
Day 0-8: Study the effect of mucin deprivation on
the different microbial communities
Day 8: Administration of mucins (8g/L)
Day 8-11: Study the effect of mucin supplementation (4g/L)












60mL 3x/day 60mL 3x/day
Colon vessels A-H









Day 0: Inoculation of the colon vessels
with 4 fecal samples (A-D)
Day 0-11: Study the effect of pH on
the different microbial communities
This experiment was repeated with 4 more donors, so in 
total 8 fecal samples were used (A-H)
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2.2 Microbial community analysis 
DNA-extraction was performed by a combination of chemical and mechanical lysis 
through a beat beating step as reported by (Geirnaert, 2015). As starting material, the pellet 
obtained after centrifuging 1 mL of luminal sample at 5,000 g for 10 min was used. The DNA 
quality was verified on a 1.5 % (w/v) agarose gel. 
Total bacterial 16S rRNA gene and the species-specific 16S rRNA gene of 
A. muciniphila was quantified with qPCR on 100- and 10- fold diluted DNA extracts, 
respectively, using a StepOnePlus Real-Time PCR system (Applied Biosystems, Carlsbad, 
CA). Primers for total bacteria (338F ACTCCTACGGGAGGCAGCAG, 518R 
ATTACCGCGGCTGCTGG) were used with the following cycling program: 3 min at 95°C 
followed by 40 cycles of 1 min at 95°C, 40 s at 56°C and 40 s at 72°C (Ovreas et al., 1997). 
A. muciniphila specific primers (AM1 GAGCACGTGAAGGTGGGGAC, AM2 
CCTTGCGGTTGGCTTCAGAT) were used with the following cycling program: 5 min at 95°C 
followed by 40 cycles of 15 s at 95°C, 40 s at 60°C and 30 s at 72°C and a final extension at 
72°C for 5 min (Collado et al., 2007). The qPCR mix consisted of 14.19 µL sterile nuclease-
free water (Sigma-aldrich, St. Louis, MO, US) and 2.5 µL Taq buffer (10x, with KCl) 
containing 0.025 units Recombinant Taq DNA-polymerase µL−1, 0.2 mM dNTP Mix, 1.5 mM 
MgCl2 (Fermentas Molecular Biology Tools, Waltham, MA, US), 0.2 µM Primer F, 0.2 µM 
Primer R, 0.05 µg µL−1 BSA (Roche Applied Science, Penzberg, Germany) and 0.125 µL 20 
x SYBR green (1:500 diluted from a 10 000 x SYBR green I nucleic acid stain concentrate in 
DMSO, Sigma Aldrich, St. Louis, MO, US). For each sample, 5 µL diluted DNA extract was 
added to 20 µL PCR-mix in technical triplicate in a qPCR plate and for each qPCR assay, 
standard curves were created by a 10-fold dilution series of DNA of a plasmid containing the 
targeted 16S rRNA gene fragment. 
 
The bacterial community after 4, 8 and 11 days of incubation in the mucin experiment 
and after 4 and 11 days of the pH experiment was assessed using amplicon sequencing of 
the 16S rRNA gene (De Paepe et al., 2017). DNA samples were sent out to LGC Genomics 
(Teddington, Middlesex, UK) for library preparation and sequencing on an Illumina Miseq 
platform, as described by De Paepe et al. (2017). The V3-V4 region of the 16S rRNA gene 
was amplified by PCR using primers (341F CCTACGGGNGGCWGCAG, 785R 
GACTACHVGGGTATCTAAKCC) derived from Klindworth et al. (2013), with a slight 
modification to the reverse primer by introducing another degenerated position (K) to make it 
more universal. The sequencing data has been submitted to the NCBI (National Center for 
Biotechnology Information) database under accession code SRP126579. The mothur 
software package (v.1.39.5) and guidelines were used to process the amplicon data 
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generated by LGC Genomics, as described in detail by De Paepe et al. (2017); (Kozich et al., 
2013).   
2.3 Statistical analysis 
All statistical analysis were performed in R, version 3.2.2.  
To visualize differences in microbial community composition between donors and 
conditions (mucin deprived vs. rich and high vs. low pH), the most abundant genera were 
visualized in bargraphs (Figures 3.4 and 3.9) and ordination and clustering techniques were 
applied. For these purposes, the shared file was further processed to remove OTU’s with too 
low abundance according to the arbitrary cut-off’s described by McMurdie and Holmes 
(2014). An OTU is defined in this manuscript as a collection of sequences, that are found to 
be more than 97% similar to one another in the V3-V4 region of their 16S rRNA gene after 
applying hierarchical clustering (Chen et al., 2013; Schloss and Westcott, 2011; Schloss et 
al., 2009; Wang et al., 2012). To deal with differences in sampling depth, proportional data 
transformed on the common scale to the lowest number of reads was used (McMurdie and 
Holmes, 2014). A table with the most abundant OTUs classified to the species level using 
both RDP Seqmatch tool and NCBI BLAST is given in Supplementary Table 3.1 and a table 
with the first 300 OTUs classified to the deepest taxonomic level is given in Supplementary 
Table 3.4.  
Principle Coordinate Analysis (PCoA; package stats) was conducted based on the 
abundance-based Jaccard dissimilarity matrix (package vegan and visualized with ggplot2 
(Anderson et al., 2006; Cox, 2001; Oksanen, 2016; Ramette, 2007) (Figures 3.6 and 3.11). 
This procedure was repeated on OTU and genus level focusing on both the comparison 
between the donors and between the applied conditions. On the genus level, weighed 
averages of genera abundances were a posteriori added to the ordination plot using the 
wascores function in vegan (Oksanen, 2016). To confirm the trends, observed data was 
clustered by means of an Unweighed Pair-Grouped Method using arithmetic Averages 
(UPGMA) clustering method (Maechler, 2016). The significance of observed group 
separations was assessed with a Permutational Multivariate Analysis of Variance 
(PERMANOVA) using distance matrixes (package vegan) (Oksanen, 2016). Prior to this 
formal hypothesis testing, the assumption of similar multivariate dispersions was evaluated, 
using betadisper function (package vegan).  
Interpretation of the results is preceded by a permutation test of the db RDA results to 
confirm that a relationship exists between the response data and the exploratory variables. 
Using the same principle, the significance of the first two constrained axis was evaluated. 
The constrained fraction of the variance, explained by the exploratory variables is adjusted 
by applying a subtractive procedure (Borcard et al., 2011; Peres-Neto et al., 2006). The 
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results of the db RDA were visualized in a type 2 scaling correlation triplot (Supplementary 
Figures 3.3 and 3.9; Supplementary Tables 3.2 and 3.3). The two first canonical axes were 
annotated with the proportional constrained eigenvalues. Site scores were displayed as 
weighed sums of species and the factor levels of the habitat explanatory variable were 
represented as centroids. In order to improve readability of the graph, the number of OTUs 
represented as vectors in the triplot were limited to the most relevant taxa. 
In order to find statistically significant differences in species abundance between the 
different conditions (mucin deprived vs. rich and high vs. low pH) the DESeq package was 
applied (α=0.01) as suggested by McMurdie and Holmes (2014) and results are shown in 
Figures 3.5 and 3.10 (Love et al., 2014). The factors mucin and pH were used in the design 
formula. More information on the DESeq methodology is given in Figure 3.3.  
The abundance data of bacterial community at operational taxonomic unit (OTU) level 
was used to construct the co-occurrence networks in a similar fashion as described in De 
Vrieze et al. (2016). Co-occurrence networks were built with similarity-based techniques, 
using Pearson correlation for OTU absolute abundance data in a pair-wise manner. The 
threshold of p-values was set at 0.05 for all networks construction. The threshold of 
coefficient correlation coefficients (r) for all network was set to 0.70 (positive interactions) and 
-0.70 (negative interactions). The data from the mucin experiment (eight donors) at day 4, 8 
and 11 as well as from the pH experiment (eight donors, high and low) at day 11 were used 
to construct the five co-occurrence networks (Supplementary Figures 3.4-3.6 and 3.10-3.11) 
to reveal the succession patterns of the interaction among microorganisms over time in 








Figure 3. 3: DESeq methodology Figure derived from (De Paepe, 2018). 
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3. Results 
3.1 Impact of mucin addition on the bacterial community structure 
The mucin experiment studies the effect of mucin deprivation and mucin 
supplementation on the bacterial community of eight donors, as shown in the experimental 
set up (Figure 3.1). 
Amplicon sequencing of the 16S rRNA gene was performed on samples taken at the 
end of the mucin deprivation period (day 8) and at the end of the mucin supplementation 
period (day 11). The relative abundances of the most abundant genera are shown in Figure 
3.4. The addition of mucin to the feed clearly induced changes to the bacterial community 
and increased the microbial diversity (p<0.01) (Supplementary Figure 3.1), but total bacterial 
count, as measured by qPCR, remained stable (Supplementary Figure 3.2). For some 
genera the shifts in relative abundance were apparent for all eight donors, such as the 
increase the relative abundance of the Bacteroides, Parabacteroides and Ruminococcus 
genera and a decrease in the relative abundance of the genera Escherichia/Shigella (Figure 
3.4). Other observed shifts were more dependent on donor, emphasizing the importance of 
studying inter-individual variability. For example, the relative abundance of Clostridium 
cluster XIVa was increased in donors 1, 6,7, and 8 but decreased in donors 4 and 5 (Figure 
3.4). DESeq hypothesis testing was performed, which shows the significantly (p<0.01) 
affected OTUs over all eight donors by supplementation of mucin (Figure 3.5). This analysis 
showed that for example the DESeq normalized abundance of Akkermansia, Bacteroides, 
Ruminocuccus and Sutterella were significantly increased in the mucin rich bacterial 
community whereas the abundance of the Escherichia/Shigella and Roseburia genera was 
significantly decreased by the addition of mucin (Figure 3.5).  
PCoA analyses at the genus level (Figure 3.6) revealed that the bacterial communities 
clustered together based on mucin enrichment or mucin deprivation, and not based on 
donor. The cluster of mucin-deprived and mucin-rich bacterial communities were significantly 
different from each other, as confirmed by Permutational Multivariate Analysis of Variance 
(p=0.001). The mucin-deprived bacterial community is characterized by, among others, 
representatives of the genera Roseburia, Alistipes and Esherichia/Shigella while the mucin-
rich bacterial community is characterized by a higher relative abundance of representatives 
of the genera Ruminococcus, Bacteroides and Akkermansia (Figure 3.6). 
To quantify and distinguish between donor and treatment effects a partial distance 
based rda analysis was performed, showing that mucin treatment accounted for 26% of the 
observed variation in the microbial community at OTU level (p=0.001), whereas the donor 





Figure 3. 4: 16S rRNA sequencing results of the mucin experiment where mucin-free feed was fed until 
day 8, after which 8g/L (day 8) and 4g/L (day 9-11) mucin was added to the feed. Overview of the relative 
abundance (%) of the total bacterial community of the 13 most abundant genera in the SHIME colon 
vessels inoculated with the fecal sample of 8 different donors at the end of the mucin deprivation (day 8) 
and mucin supplementation (day 11). “Other” refers to the remainder of relative abundance at the genus 
level which are summed together. 
 
Figure 3. 5: Boxplots of the relative abundance of bacterial genera that are significantly different, as 
determined with DESeq hypothesis testing, between the mucin deprived community (day 8) and the 
mucin rich community (day 11) over all eight donors (P<0.01). 
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Figure 3. 6: A PCoA biplot revealed a distinct mucin rich (triangles) and mucin deprived (circles) microbial 
community for all 8 donors (colors). Squared represent bacterial communities at day 4 (mid-mucin 
deprivation). Weighted average scores of the most abundant genera characteristic of the mucin deprived 
and mucin rich bacterial community were a posteriori projected. 
 
Co-occurrence network analysis was performed on the bacterial communities at day 4, 
day 8 and at day 11 (Supplementary Figure 3.4, 3.5, 3.6). Comparing the networks at day 4 
and day 8 shows a reduction in network complexity during mucin deprivation, with a 
decrease in edge to node ratio from 2.22 at day 4 to 1.34 at day 8 and a decrease in 
interaction clusters. Upon mucin administration, the network complexity increases with an 
edge to node ratio of 1.34 at day 8 to 1.87 at day 11 and an increase in interaction clusters is 
observed. Also, A. muciniphila appears in center of an interaction cluster after mucin 
supplementation, which might indicate that it become a ‘hub’ or keystone species in the 
mucin rich bacterial community. 
Akkermansia muciniphila is a known mucin degradation specialist and was in previous 
experiments shown to strongly respond to mucin supplementation (Ottman et al., 2017a) 
(Chapter 2). In this study, qPCR analysis revealed that for six out of the eight donors 
(1,3,4,5,7,8), A. muciniphila abundances decreased during mucin deprivation and increased 
rapidly as soon as mucin was supplemented to the feed, with an average increase of 1.2*104 
(± 2*103) (n=6) (Figure 3.7). This response was independent of the abundance of 
A. muciniphila at the beginning of the experiment, since in the case of donor 3, A. muciniphila 
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abundance was below the quantification limit at the start the experiment, but upon mucin 
supplementation, its relative abundance increased ten thousand fold. Donor 2, on the other 
hand, started with a higher initial abundance of A. muciniphila but did not respond to the 
mucin treatment. The relative abundance of A. muciniphila in donors 2 and 6 were close or 
under the qPCR detection limit and also with 16S rRNA gene sequencing no A. muciniphila 
was detected (Figure 3.7). 
The relative abundance of the SCFA produced during the mucin experiment did not 
vary much between the donors, with an average of 70% (± 3%) acetate, 21% propionate 
(±3%) and 7% (±2%) butyrate (Figure 3.8). During mucin deprivation, there is a significant 
decrease in proportional and absolute concentrations of acetate (p<0.01) and butyrate 
(p<0.01) levels but addition of mucin to the feed did not significantly impact the SCFA 
composition (p>0.05). No difference could be observed between the SCFA profile for donors 
with an A. muciniphila response to the mucin treatment (1,3,4,5,7,8) compared to the donors 
without this response (2 and 6), so the increase in A. muciniphila did not affect the SCFA 




Figure 3. 7: Log (base 10) scaled relative abundance of A. muciniphila over total bacteria over time (days), 
measured with qPCR. SHIME vessels (inoculated with fecal inoculum from donors 1-8) were fed mucin 
free SHIME feed during 8 days (dotted line), after which mucin was supplemented to the feed (4g L-1) (full 
line). Light red dots indicate values below the quantification limit. 
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Figure 3. 8: Proportional values of short chain fatty acids acetate, propionate, butyrate and branched 
SCFA (BSCFA), produced overt time (days). SHIME vessels (inoculated with fecal inoculum from donors 
1-8) were fed mucin free SHIME feed during 8 days, after which mucin was supplemented to the feed (4g 
L-1).  
3.2 Impact of pH on the bacterial community structure 
The pH experiment (Figure 3.2) was set up to investigate whether the colonization 
preference of A. muciniphila for the distal colon due to its high pH, is dependent on initial 
A. muciniphila abundances and/or on the composition of the bacterial community.  
16S rRNA gene amplicon sequencing showed that the differences between the 
bacterial communities at high (6.6-6.9) and low pH (5.6-5.9) are dependent on the donor 
(Figure 3.9). Bacteroides spp. was more abundant at high pH in donor 4, more abundant at 
low pH in donor 5 and 7 and equally abundant at both pH ranges in the other donors. 
Clostridium cluster XIVa species were less abundant at low pH in donors 1,3,4 and 6 but 
more abundant at high pH in donors 2 and 5 (Figure 3.9). A. muciniphila on the other hand, 
is, when detected, always more abundant at high pH (Figure 3.9). Microbial diversity in the 
communities was similar at high and low pH (p>0.05) as was the total bacterial count 
(Supplementary Figure 3.7 and 3.8) Using DESeq hypothesis testing, genera were identified 
that were significantly different in abundance between low and high pH over all eight donors 
(Figure 3.10). Most pronounced differences were higher relative abundances of 
Akkermansia, Escherichia/Shigella and Ruminococcus at high pH (Figure 3.10). A PCoA 
biplot showed both donor and pH act as determining factors for bacterial community 
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composition, with clustering of the communities according to pH, while maintaining high 
variability between donors (Figure 3.11). To quantify and distinguish between donor and pH 
effects a partial distance based rda analysis was performed, showing that pH (10%) and 
donor (9%) effects were limited but significant (p=0.006, resp. p=0.046) (Supplementary 
Table 3.3; Supplementary Figure 3.9). 
 
Figure 3. 9: Relative abundances at the genus level of the pH experiment at day 11. Colon vessels, 
inoculated with fecal inoculum from donors A-H,  were kept at high pH (6.6-6.9) or at low pH (5.6-5.9) for 
11 days after inoculation. Overview of the relative abundance (%) of the total community of the 13 most 
abundant genera in the SHIME colon vessels at day 11. ). “Other” refers to the remainder of relative 
abundance at the genus level which are summed together. 
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Figure 3. 10: Boxplots of the relative abundance of genera that are significantly different, determined with 
DeSEQ hypothesis testing, between the colon vessel at high and low pH at day 11 over all eight donors 
(α=0.01). 
 
Figure 3. 11: A PCoA biplot of the microbial community  at high pH (squares) and low pH (circles) for all 8 




Co-occurrence network analysis at day 11 resulted in a high and low pH network 
(Supplementary Figure 3.10, 3.11). Both networks are of similar complexity with an edge to 
node ratio of 1.49 for the low pH co-occurrence network and of 1.56 for the high pH network. 
qPCR analysis of A. muciniphila relative abundances over time, shows that for all 
donors except one, A. muciniphila colonizes the distal colon compartment at high pH (6.6-
6.9) more abundantly than at low pH (5.6-5.9) (p=0.02), with average relative abundances of 
2.33*10-2 (± 2.2*10-2) and 6.76*10-6 (±1.28*10-5 ) respectively (Figure 3.12). This difference 
was not observed for donor A, where A. muciniphila abundances were very low at both low 
and high pH (Figure 3.12). pH also impacted the fermentation activity, with high pH values 
resulting in significantly more acetate and propionate and low pH values resulting in more 
butyrate (p<0.01). Yet, no significant differences in branched SCFA were observed (Figure 
3.13). Only for donor A at low pH a proportionally higher propionate level was observed than 




Figure 3. 12: Log (base 10) scaled Relative abundance of A. muciniphila compared to total bacteria over 
time (days), measured with qPCR. SHIME vessels (inoculated with fecal inoculum from donors A-H) were 
kept at either high pH (6.6-6.9), shown as the full line, or at low pH (5.6-5.9), shown as the dotted line. 
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Figure 3. 13: Proportional values of short chain fatty acids acetate, propionate, butyrate and branched 
SCFA, produced over time (days). SHIME vessels (inoculated with fecal inoculum from donors A-H) were 
kept at either high pH (6.6-6.9) or low pH (5.6-5.9). 
 
4. Discussion 
Our finding that mucins as nutritional resource are a more important modulator of the 
gut microbiome than colon pH as environmental factor indicates that host glycan degradation  
represents a relevant ecological niche shaping the composition of the simulated colon 
microbiota. With (relatively) higher levels of Akkermansia, Bacteroides, Ruminococcus, 
Sutterella and Arthrobacter, the cluster of mucin-rich bacterial communities was significantly 
different from the mucin-deprived communities. Microbiome variation explained by host 
glycan presence (26%) exceeded the variability in microbiome composition that is explained 
by donor (8%), whereas the variance explained by the environmental factor (pH) did not 
(10% resp., 9%). This finding was characterized by a high biological reproducibility across 
the microbiota from 8 human donors. In spite of the increased nutritional value of the feed 
(addition of a host glycan) the total bacterial count remained constant, indicating that the 
carrying capacity of the in vitro colon ecosystem had been reached. This was also illustrated 
by the increase in above-mentioned genera corresponding with a decrease of for example 
Roseburia, Alistipes and Escherichia/Shigella. The addition of mucin and the change it 
caused in the bacterial community composition did not coincide with a change in SCFA 
production profile. Rather than an increase in microbial metabolic activity this could indicate 
that mucin supplementation induces a shift in microbial metabolism from fiber degradation 
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during the mucin deprivation period to proportionally more host glycan degradation during the 
mucin supplementation period. Changing the profile of substrate degradation is not a 
common trait across all members of the microbiota, but primarily reserved for ‘glycan-
generalists’ like Bacteroides species. These have broad glycan-degradation abilities, both 
diet- and host-derived, and they can change their metabolism upon changing nutrient 
availability (Koropatkin et al., 2012; Marcobal et al., 2011; Marcobal et al., 2013d; Salyers et 
al., 1977). It was already shown in germfree mice, fed a high fat/low fiber diet and colonized 
with E. rectale and B. thetaiotaomicron, that B. thetaiotaomicron changes its metabolism to 
host glycan degradation (Mahowald et al., 2009). In our study however, the fiber content 
remained constant and mucin was supplemented as an additional energy source. This 
indicates some Bacteroides spp. to have a preference for mucin degradation compared to 
fiber degradation. The higher abundances of Akkermansia and Ruminococcus in the mucin 
rich community are expected since A. muciniphila specialized in mucin degradation and 
several Ruminococcus spp. are known to degrade mucin, although the extent of the 
degradation varies between species and strains (Crost et al., 2013; Png et al., 2010). 
A. muciniphila has been mentioned in multiple studies as correlated with human health 
and a potential probiotic, with recently promising results for the treatment of diabetes and 
obesity (Plovier et al., 2017). In this study, the abundance of Akkermansia spp. was 
specifically influenced by the mucin treatment, as demonstrated with a specific qPCR assay 
and 16S rRNA gene sequencing, with a decrease in abundance during mucin deprivation 
and a sharp increase during mucin supplementation (Figure 3.4, 3.7). Akkermansia spp. are 
known as mucin degrading specialists, as reflected by the high percentage of mucin-
consumption related functions encoded in the small genome of Akkermansia, as opposed to 
Bacteroides (Marcobal et al., 2013d). Due to its specialization in mucin degradation it is 
expected that Akkermansia abundances would decrease when no mucin in available and 
respond rapidly to mucin supplementation. This was already shown for one donor with 
specifically high Akkermansia abundance in a previous study (Chapter 2). In the present 
study we show a similar response of Akkermansia to the mucin treatment in 6 out of 8 
donors. Importantly, this response is independent of Akkermansia’s initial abundance (Figure 
3.7). However, the strength of the increase in abundance does vary between donors and this 
might be due to the presence of other bacteria that can compete for the mucin degradation. 
Moreover, several studies have suggested that bacteria adjust their metabolism depending 
on the identity of other bacteria in the environment (Mahowald et al., 2009; Sonnenburg et 
al., 2006). This was exemplified by Png et al. (2010) who showed that A. muciniphila grown 
on mucins in co-culture with non-mucolytic B. fragilis, was less abundant and degraded less 
mucins compared to monoculture. So it is possible that some species have the ability to 
discourage A. muciniphila from thriving on mucins, without actually competing for the mucins. 
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Our results show the dependence of A. muciniphila on mucin and thus future in vivo 
(probiotic) applications of A. muciniphila might benefit from prebiotics that show resemblance 
to mucin structures or compounds that can increase the mucin concentration, to ensure 
abundant colonization. Promising results regarding the former strategy have already been 
obtained by (Ottman, 2015) who demonstrated Akkermansia’s capacity to grow on human 
milk oligosaccharides.  
Co-occurrence networks showed a decreased complexity in network structure during 
mucin deprivation, which increased again after mucin supplementation. This increased 
complexity in co-occurrence network clusters may be an indication of mucin structural 
complexity requiring enhanced cross-feeding interactions between bacteria in order to 
consume it as a nutritional resource. In contrast, the co-occurrence networks of the pH 
experiment, showed no difference in complexity between high pH (6.6-6.9) and low pH (5.6-
5.9). In contrast to mucin, the effect of colonic pH had a less profound impact in the 
microbiome with donor origin and pH explaining the variability in the dataset equally;  among 
others Bacteroides, Clostridium cluster XIVa and Parabacteroides preference for high or low 
pH varied between the donors (Figure 3.9). To our knowledge, previous studies did not 
address these inter-individual differences in response to pH, although not many studies have 
been done regarding the impact of pH variation on specific bacteria within different complex 
microbial communities.  
Some interesting observations were noted: Bacteroides species typically display lower 
growth rates at pH values lower than 6.5 and even become undetectable at pH lower than 
5.5 (Duncan et al., 2009; Walker et al., 2005). However, this study showed Bacteroides 
species from donors 5 and 7 to have a preference for pH 5.6-5.9 over pH 6.6-6.9 . Secondly, 
members from the Clostridium cluster XIVa were previously shown to better tolerate lower 
pH and to profit from the decrease in Bacteroides by exploiting the available nutrients and 
increasing in numbers (Duncan et al., 2009). In our study, this trade-off between Bacteroides 
and Clostridium cluster XIVa was not visible, but at the phylum level, Firmicutes abundance 
was higher at low pH and Bacteroidetes at high pH for all donors except donor 5. Thirdly, 
some differences in community composition between high and low pH were consistent for all 
donors. The increased relative abundance of Escherichia/Shigella, Ruminococcus and 
Akkermansia at high pH and of Bifidobacterium at low pH are supportive of previous findings 
(Duncan et al., 2009; Roe et al., 1998; Van Herreweghen et al., 2017; Walker et al., 2005). 
The metabolic differences (SCFA profile) between high and low pH were apparent for all the 
donors and show more butyrate at low pH and more propionate and acetate at high pH. 
Butyrate production by human gut microbes typically occurs at the expense of acetate. Our 
findings are in line with previous studies (Walker et al., 2005) (Chapter 2) but the metabolic 
profile can only partially be linked to the bacterial composition. For example, the increased 
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propionate production at high pH may be due to higher amounts of propionate-producing 
Akkermansia and Ruminococcus species (Crost et al., 2013; Derrien et al., 2004). 
Faecalibacterium might contribute to the higher butyrate concentration at low pH, but 
butyrate producing Clostridium cluster XIVa was not more abundant at low pH in every 
donor. Thus the pH might affect the metabolic activity of certain species more than their 
actual abundance. Indeed, while the metabolic profile shows clear differences between low 
and high pH and almost no variations between donors, the clustering of the bacterial 
communities according to pH is less clear (Figure 3.11), and much more subjected to donor 
variability. 
Inter-individual variability is a hallmark of microbiome composition in the human gut. 
While many factors shape the microbiome over time, our study demonstrates that host 
glycan presence, rather than colonic pH is a more important driver of microbiome 
composition. Microbiome variation explained by host glycan presence even exceeds the 
variability in microbiome composition that is commonly observed between individuals. The 
addition of host-glycans results in microbial communities with higher abundance of 
Akkermansia, while simultaneously increasing the complexity of the co-occurrence networks 
and potentially making A. muciniphila a key player. Our previous findings of Akkermansia 
taking clear benefit from mucin presence and higher colonic pH (Chapter 2), holds true for 
different biological backgrounds from different donors.  
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6. Supplementary information 
Supplementary Table 3. 1:RDP Seqmatch and NCBI BLAST results for the most abundant species in the 
microbial communities, as determined by amplicon sequencing. The similarity score (Sab) as calculated 
by RDP, and the NCBI BLAST output for the best hit and the next best hit(s) are shown. 








OTU1 Escherichia coli 1 100 0 100 
 Shigella sonnei 1 100 0 100 
OTU2 Bacteroides ovatus 0.966 100 0 99 
 Bacteroides xylanisolvens 0.877 100 0 98 
 Bacteroides thetaiotaomicron 0.857 100 0 97 
OTU3 Bacteroides dorei 1 100 0 100 
 Bacteroides vulgatus 0.951 100 0 99 
OTU4 Bacteroides uniformis 1 100 0 100 
 Bacteroides rodentium 0.906 100 0 97 
OTU5 Clostridium boltaea 1 100 0 100 
 Clostridium clostridioforme 0.977 100 0 100 
 Clostridium citroniae 0.964 100 0 99 
OTU6 Phascolarctobacterium 
faecium 
1 100 0 100 
 Phascolarctobacterium 
succinatutens 
0.734 100 0 93 
OTU7 Fusobacterium mortiferum 0.995 100 0 100 
 Fusobacterium nucleatum 0.964 100 0 95 
OTU8 Fusobacterium nucleatum 1 100 0 100 
 Fusobacterium simiae 0.946 100 0 99 
OTU9 Bilophila wadsworthia 0.973 
   
 Desulfovibiro simplex 0.701 100 0 92 
OTU10 Bacteroides thetaiotamicron 1 100 0 100 
 Bacteroides faecichinchillae 0.947 100 0 99 
OTU11 Alistipes onderdonkii 1 100 0 100 
 Alistipes shahii 0.882 100 0 97 
OTU12 Bacteroides fragilis 1 100 0 100 
 Bacteroides thetaiotaomicron 0.827 100 0 94 
OTU13 Akkermansia muciniphila 1 100 0 100 
 Verrucomicrobium spinosum 0.567 99 0 84 
OTU14 Parabacteroides distasonis 0.939 100 0 99 
 Parabacteroides gordonii 0.696 100 2E-147 93 
OTU15 Klebsiella variicola 1 100 0 100 
 Klebsiella quasipneumoniae 0.968 100 0 99 
OTU16 Faecalibacterium prausnitzii 0.918 100 0 99 
 Subdoligranulum variabile 0.735 100 1E-165 93 
OTU17 Bacteroides cellulosilyticus 0.966 100 0 100 
 Bacteroides intestinalis 0.934 100 0 99 
OTU18 Bacteroides massiliensis 1 100 0 100 
 Bacteroides finegoldii 0.797 100 0 95 
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OTU19 Sutterella wadsworthensis 1 100 0 100 
 Sutterella stercoricanis 0.793 100 0 94 
OTU20 Prevotella copri 0.84 100 0 97 
 Prevotella albensis 0.714 100 5E-175 93 
OTU21 Rumiococcus torques 0.98 100 0 99 
 Ruminococcus faecis 0.89 100 0 98 
OTU22 Pseudomonas aeruginosa 1 100 0 100 
 Pseudomonas otitidis 0.959 100 0 99 
OTU23 Bacteroides caccae 0.983 100 0 99 
 Bacteroides faecis 0.867 100 0 98 
 Bacteroides finegoldii 0.86 100 0 98 
OTU24 Parabacteroides merdae 1 100 0 100 
 Parabacteroides johnsonii 0.896 100 0 98 
OTU25 Sutterella stercoricanis 0.928 100 0 99 
 Sutterella parvirubra 0.763 100 0 94 
OTU26 Parasuttelrella 
excrementihominis 
1 100 0 100 
 Parasutterella secunda 0.603 100 4E-166 91 
OTU27 Phascolarctobacterium 
succinatutens 
1 100 0 100 
 Phascolarctobacterium 
faecium 
0.72 100 0 93 
OTU28 Megamonas funiformis 0.93 100 0 98 
 Megamonas rupellensis 0.908 100 0 98 
OTU29 Cloacibacillus evryensis 1 100 0 100 
 Cloacibacillus porcorum 0.832 100 0 97 
OTU30 Clostridium saccharolyticum 0.849 100 0 97 
 Clostridium xylanolyticum 0.849 100 0 97 
 Clostridium asparagiforme 0.838 100 0 97 
 
 
Host glycans as nutritional resource  
89 
 
Supplementary Figure 3. 1: Alpha-diversity for the bacterial communities at OTU level for the different 
days. Alpha-diversity was significantly higher in the mucin-rich compared to the mucin deprived 
communities (p<0.01) 
 
Supplementary Figure 3. 2: Log (base 10) scale of total bacterial counts over time (days), measured with 
qPCR. SHIME vessels (inoculated with fecal inoculum from donors 1-8) were fed mucin free SHIME feed 




Supplementary Figure 3. 3: Partial distance based redundancy analysis correlation triplot. Treatment 
significantly (p=0.001) contributes to variation in species community composition. 
(OTU1~Eschericia/Shigella; OTU2, OTU3~Bacteroides; OTU8~Fusobacterium; OTU13~Akkermansia; 
OTU15~Klebsiella; OTU21~Ruminococcus; OTU24~Parabacteroides) 
 
Supplementary Table 3. 2: Partial distance based redundancy analysis. The contribution of the different 
factors (mucin treatment and donor), and their significance level, to the variation in species level 
community composition. 
 % variance explained p-value 
Mucin 26% 0.001 
Donor 8% 0.035 
 
Host glycans as nutritional resource  
91 
Supplementary Figure 3. 4: Co-occurrence network at OTU level for the eight donors after 4 days of mucin 




























































Supplementary Figure 3. 5: Co-occurrence network at OUT level for the eight donors after 8 days of mucin 
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Supplementary Figure 3. 6: Co-occurrence network at OUT level for the eight donors after 4 days of mucin 
supplementation. (α=0.05, |r|>0.7) 
 
Supplementary Figure 3. 7: Alpha-diversity for the bacterial communities at OTU level for the different 
days and at high (6.6-6.9) and low (5.6-5.9) pH. Alpha-diversity was not significantly different, at neither 























































Supplementary Figure 3. 8: Log (base 10) scale of total bacterial counts over time (days), measured with 
qPCR. SHIME vessels (inoculated with fecal inoculum from donors 1-8) were kept at either low (5.6-5.9) or 
high (6.6-6.9) pH. 
 
 
Supplementary Figure 3. 9: Partial distance based redundancy analysis correlation triplot. pH and donor 
display limited effects on variation in species community composition. (OTU1~Eschericia/Shigella; 
OTU3,OTU4,OTU10,OTU12~Bacteroides;OTU13~Akkermansia;OTU20~Prevotella; OTU21~Ruminococcus; 
OTU32~Anaeroglobus) 
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Supplementary Table 3. 3: Partial distance based redundancy analysis. The contribution of the different 
factors (pH and donor), and their significance level, to the variation in species level community 
composition. 
 % variance explained p-value 
pH 10% 0.006 




Supplementary Figure 3. 10: Co-occurrence network at OTU level for the eight donors after 11 days 











































Supplementary Figure 3. 11: Co-occurrence network at OTU level for the eight donors after 11 days 
















































Supplementary Table 3.4: 
Deepest level of taxonomic 
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Glycan degradation is considered an important driver of microbial metabolic networks 
in the human colon, facilitating the production of for instance butyrate, a fermentation product 
with health-modulatory potential. Using a synthetic microbial community, the competitiveness 
of the primary degraders A. muciniphila and B. thetaiotaomicron to occupy different glycan 
degrading functional niches (dietary vs. host glycans) under altered physicochemical (neutral 
vs. slightly acidic pH) conditions and the subsequent impact on a population of cross-feeding 
butyrate producers was evaluated. Trimming down ecosystem complexity to eight-species 
consortia allowed us to monitor the individual microbial species. Joint presence of both 
primary degraders did not lead to a competitive exclusion in the presence of mucin and 
A. muciniphila was not outcompeted. Shifts in pH and primary degrader abundance was 
selective for butyrate producers (A. caccae as opposed to F. prausnitzii) while the butyrate 
producing functionality was maintained. This indicates that functional redundancy facilitating 
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A synthetic gut ecosystem demonstrates that 
variable ratios of primary degraders do not impact 
butyrate producing functionality despite 
phylogenetic shifts 
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1. Introduction 
The human gut microbiome is characterized by enormous species richness and diverse 
functionality, determining ecosystem dynamics, interaction with the human host and 
eventually impacting human health. A hallmark feature of the gut microbiome is its functional 
redundancy, putatively facilitating functional stability and ecosystem resilience during periods 
of stress (Moya and Ferrer, 2016), but also allowing specific microorganisms to respond in a 
versatile manner during changing nutrient conditions. A dominant factor influencing 
community composition and functionality is the influx of glycans, both from dietary as host 
origin into the colon.  
On the one hand, dietary fiber presents a functional niche that can be occupied by 
several gut microorganisms and that can trigger the proliferation of primary and secondary 
carbohydrate degraders, subsequently stimulating cross-feeding microorganisms that 
become part of a larger microbial metabolic network. The recommended daily intake of 
dietary fiber is 28-35 grams but in many cases – especially in industrialized countries – the 
actual uptake is much lower (Burkitt, 1987; Sonnenburg and Sonnenburg, 2014). Dietary 
fiber can be composed of complex carbohydrates like resistant starch, pectins and xylans. As 
these compounds are mostly indigestible in the upper digestive tract, they reach the colon in 
an intact manner (Cummings and Englyst, 1987; Silvester et al., 1995). Their complex 
structure typically requires a variety of bacterial enzymes to be fully degraded and this glycan 
degrading capacity is typically determined at species and strain level. Bacteria with limited 
enzymatic capacity are therefore susceptible to dietary changes or dependent on other 
bacteria for cross-feeding. Other bacteria display a much broader glycan degrading capacity 
with Bacteroides thetaiotaomicron being the best-studied species. It was shown that B. 
thetaiotaomicron can change its metabolism between dietary nutrient, host glycan or human 
milk oligosaccharide (HMO) degradation depending on glycan availability (Bjursell et al., 
2006; Mahowald et al., 2009). With respect to the functional niche of glycan degradation 
Bacteroides species are generally considered highly versatile microorganisms, possibly 
explaining their prevalence as dominant species in the colon. 
On the other hand, host glycans derived from the mucus layer present a more 
continuous source of nutrients to the gut microbiota, unlike dietary glycans that are more 
variable in supply and composition. Mucin glycans are composed of O-glycosylated, and to a 
lesser extent N-glycosylated, protein backbones, with glycosyl chains of 2-12 
monosaccharides, mainly consisting of galactose, fucose, N-acetylgalactosamine, N-
acetylglucosamine, mannose and sialic acid (Lai et al., 2009). Only few species have the 
enzymatic capacity for initiating partial or full mucin degradation, including A. muciniphila, 
B. thetaiotaomicron, B. fragilis, Ruminococcus gnavus, R. torques, and Bifidobacterium 
Chapter 4 
102 
bifidum (Hoskins et al., 1985; Marcobal et al., 2013d; Martens et al., 2008; Png et al., 2010). 
A. muciniphila is considered a mucin-degrading specialist and its high mucin-degrading 
capacity was shown in an in vivo mice study (Berry et al., 2013; Ottman et al., 2017a). Other 
in vitro studies, studying A. muciniphila in a complex microbial community, have shown its 
high dependency on mucin availability and its sensitivity to pH changes (Chapter 2, Chapter 
3). So as opposed to B. thetaiotaomicron, which is flexible in its glycan degrading portfolio 
and tolerates a wider pH range (Duncan et al., 2009), A. muciniphila has more stringent 
growth conditions. Interestingly, research over the last decade has seen a remarkable 
correlation between A. muciniphila abundance and gut health (Collado et al., 2007; Png et 
al., 2010; Wang et al., 2011; Zhang et al., 2009). In a study with obese mice on a high-fat 
diet, it was shown that administration of A. muciniphila reversed insulin resistance, 
dyslipidemia, metabolic endotoxemia and fat mass gain (Everard et al., 2013). This 
biotherapeutic potential of Akkermansia has triggered questions around its interaction with 
other bacteria, its response to changing nutritional conditions and its competitiveness with 
bacteria that can occupy the functional niche of mucin metabolism.  
Glycan degradation is considered an important driver of microbial metabolic networks 
facilitating the production of for instance butyrate, a fermentation product with health-
modulatory potential (Brahe et al., 2013; Guilloteau et al., 2010). Following up on our 
previous findings (Chapter 2, Chapter 3) we studied the competitiveness of the primary 
degraders Akkermansia and Bacteroides to occupy different glycan degrading functional 
niches (dietary vs. host glycans) under altered physicochemical (neutral vs. slightly acidic 
pH) conditions. The subsequent impact on a population of cross-feeding butyrate producers 
was also evaluated. As one-on-one microbial interactions are often difficult to discern in the 
complex background of human gut microbiota, we used a synthetic ecosystem approach, 
similar to the approach of Desai et al. (2016). Trimming down ecosystem complexity to eight-
species consortia allowed us to monitor the individual microbial species.  
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2. Materials and methods 
2.1 Growth media and bacterial strains 
Chemicals were obtained from Sigma (Bornem, Belgium), unless stated otherwise. The 
nutritional medium for the experiment, in which the synthetic community was grown, 
consisted of (in g L-1) arabic gum* (1.0), starch (1) (Anco, Roeselare, Belgium), xylan* (1.0) 
(Carl Roth, Germany), pectin* (2.0), D-(+)-glucose (0.4), yeast extract (3.0) (Oxoid Ltd., 
Basingstoke, Hampshire, UK), peptone (1.0) (Oxoid Ltd., Basingstoke, Hampshire, UK), and 
commercial pig gastric mucin° Type II (4.0).  
Depending on the imposed nutritional conditions of the experiment either mucin° alone, 
fibers* alone or both°* were added. Depending on the imposed pH either 8.66 g L-1 KH2PO4 
and 13.67 g L-1 Na2HPO4 (High pH, pH 7.0) or 18.91 g L-1 KH2PO4, 2.98 g L-1 Na2HPO4 
and 4.2 g L-1 NaHCO3 (Low pH, pH 6.1) were added. The bacteria were grown as pure 
cultures in anaerobic M2GSC medium at pH 6 prepared as described by Miyazaki et al. 
(1997) using 15 % (v/v) of clarified rumen fluid instead of 30 % (v/v).  
The synthetic community consisted of 5 species as a standard inoculum, being 
butyrate producers Butyricicoccus pullicaecorum (LMG 24109), Anaerostipes caccae (DSMZ 
14662) and Faecalibacterium prausnitzii (DSMZ 17677) and lactate producers 
Bifidobacterium longum (LMG 11047) and Lactobacillus plantarum (LMG 9211). To this 
standard inoculum, different ratios of mucin degrader Akkermansia muciniphila (DSMZ 
22959) and versatile glycan degrader Bacteroides thetaiotaomicron (LMG 11262) were 
added.  
After 24h growth the pure cultures were washed with anaerobic PBS (0.8 g L-1 NaCl 
and 0.2 g L-1 KCl) in an anaerobic (10 % CO2 and 90 % N2) workstation (GP Campus, 
Jacomex, Dagneux, France). Using flow cytometry (cfr. infra), the bacteria were quantified 
and 1*106 bacteria mL-1 of each species was inoculated at the start of the experiment. For the 
inoculum A:B(1000:1) (cfr. infra) 106 bacteria mL-1 of A.muciniphila and 103 bacteria mL-1 of 
B.thetaiotaomicron were added. 
 
2.2 Experimental set-up 
To study the competition and cross-feeding interactions between the bacteria in this 
synthetic bacterial community, several environmental conditions and different primary 
degraders were tested (Table 4.1). Three media with different carbohydrate sources (fibers, 
mucin or both), at low (6.1) and high (7) pH, were inoculated with a synthetic microbial 
community. This community consists of several butyrate producing bacteria, such as 
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A. caccae, which can use lactate to produce butyrate; F. prausnitzii, which is capable of 
degrading more complex carbohydrate structures; and B. pullicaecorum, which has been 
shown to be a very successful colonizer. Besides the butyrate producing bacteria, two lactic 
acid bacteria where present, B. longum and L. plantarum to enable the butyrate production 
pathway over lactate. This microbial community was  supplemented with primary degraders 
Akkermansia muciniphila, a mucin degradation specialist and B. thetaiotaomicron, a versatile 
glycan degrader. To inoculum A:B(1:1), both primary degraders were added in the same 
concentration and in inoculum B only B. thetaiotaomicron was added. Inoculum A:B(1000:1) 
is the inoculum to which A. muciniphila and B. thetaiotaomicron are added in a different ratio, 
with 1000 times less B. thetaiotaomicron than A. muciniphila. 
 
Table 4. 1: Experimental conditions: media, inoculum and pH. 
 
Standard inoculum  
+ A. muciniphila  
+ 
B. thetaiotaomicron  
Unequal amounts  
(A:B(1000:1)) 
Standard inoculum  
+ A. muciniphila  
+ 
B. thetaiotaomicron  
Equal amounts  
(A:B(1:1)) 
Standard inoculum  
 
+ 
B. thetaiotaomicron  
 
(B) 
Fiber + mucin 
3 x pH 6,1 
3 x pH 7 
3 x pH 6,1 
3 x pH 7 
3 x pH 6,1 
3 x pH 7 
Fiber 
3 x pH 6,1 
3 x pH 7 
3 x pH 6,1 
3 x pH 7 
3 x pH 6,1 
3 x pH 7 
Mucin 
3 x pH 6,1 
3 x pH 7 
3 x pH 6,1 
3 x pH  7 
3 x pH 6,1 
3 x pH 7 
 
 
The experiment lasted for 58h and samples were taken for short chain fatty acid 
(SCFA) analysis, pH measurement, denaturating gradient gel electrophoresis (DGGE) and 
quantitative polymerase chain reaction (qPCR). Sampling for SCFA analysis, as described 
previously (Andersen et al., 2014), and pH occurred 0,10,23,24,30,34,47,48,54 and 58h after 
inoculation and for DNA extraction (qPCR and DGGE) at 0 and 58h. At 24h and 48h fresh 
growth medium was supplemented to replace the volume taken by sampling. 
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2.3 Analysis 
DNA-extraction was performed by a combination of chemical and mechanical lysis 
through a bead beating step as reported by (Geirnaert, 2015). As starting material, the pellet 
obtained after centrifuging 1 mL of luminal sample at 5,000 g for 10 min was used. The DNA 
quality was verified on a 1.5 % (w/v) agarose gel. 
2.3.1 PCR-DGGE 
To analyze the composition of the synthetic bacterial community at time 0 and after 58h 
of growth in different environmental conditions, PCR was performed with general bacterial 
primers with GC-clamp to amplify a 16S rRNA gene fragment (338F-GC and 518R). PCR 
amplicons were separated by denaturing gradient gel electrophoresis (DGGE) using an 
Ingeny phorU2X2 DGGE-system (Ingeny, Goes, the Netherlands). After electrophoresis, gels 
were stained for 20 min in dark in a 33x SYBR Green (Life Technologies, Invitrogen) 1x Tris-
Acetate-EDTA buffer (Applichem). Stained gels were immediately photographed on a UV-
transillumination table with camera (OptiGo 600, Isogen) and software ProXima AQ-4 
(Isogen Life Sciences, the Netherlands). Normalization and further analysis of the gels was 
carried out using BioNumerics software version 5.10 (Applied Maths, Sint-Martens-Latem, 
Belgium). 
2.3.2 qPCR 
Total bacterial 16S rRNA gene and the species-specific 16S rRNA gene of 
A.°muciniphila, F.prausnitzii, A.caccae and B.pullicaecorum, genus-specific Lactobacillus 
and phylum-specific Bacteroidetes was quantified with qPCR on 10- fold diluted DNA 
extracts, using a StepOnePlus Real-Time PCR system (Applied Biosystems, Carlsbad, CA). 
Relative and absolute abundances of community members are shown in Figures 4.3, 4.5, 4.7 
and Supplementary Figures 4.3, 4.4, 4.5. The primers (Table 4.2) were used with the 
following cycling program: 5 min at 95°C followed by 40 cycles of 15 s at 95°C and 1 min at 
60°C. The amplification reactions were carried out in triplicate in a volume of 20 μL which 
contained 18 μL of mastermix and 2 μL of DNA template. The mastermix (per mL) consisted 
of 555 µL iTaq™ Universal SYBR® Green Supermix, 0.44 µM of each primer and 356 µL of 
PCR water. For each qPCR assay, standard curves were created by a 10-fold dilution series 
of DNA of a plasmid containing the targeted 16S rRNA gene fragment. qPCR with 
B. pullicaecorum primers showed some amplification of L. plantarum DNA as well, however 
this only amounted to 0.001%-0.01% of amplified DNA with B. pullicaecorum primers that 











































2.3.3 Flow cytometry 
Bacterial counts were measured by flow cytometry as described by Van Nevel et al. 
(2013). Samples of the pure cultures were diluted in a filter sterile phosphate buffered 
solution to obtain cell numbers within the detection range (103-106 cells/mL). Next, the 
samples were stained with SYBR Green I (10000x diluted from stock, Invitrogen) and 
incubated for 13 min at 37°C before measurement. The flow cytometer (BD Accuri C6 flow 
cytometer, BD, Erembodegem, Belgium) was equipped with a 488 nm solid-state laser and 
Milli-Q was used as sheath fluid. Cell counts were done by measuring the number of 
particles in a set volume and quality control of cell counting was done with standardized 
beads. Background was monitored by measuring a filtered sample, equally diluted as the test 
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3. Results 
Different glycan sources (fiber as dietary glycan, mucin as host glycan) were presented 
to a synthetic community of primary degraders (A. muciniphila and/or B. thetaiotaomicron), 
butyrate producers (Anaerostipes caccae, Butyricicoccus pullicaecorum and 
Faecalibacterium prausnitzii) and lactate producers (Lactobacillus plantarum and 
Bifidobacterium longum). To discern the response from the primary degraders to differential 
glycan availability different ratios of primary degraders were studied: either 
B. thetaiotaomicron (B) alone, A. muciniphila and B. thetaiotaomicron in equal amounts 
(A:B(1:1)) or A. muciniphila and B. thetaiotaomicron, added in unequal amounts 
(A:B(1000:1)).  
While all incubations were pH-buffered, slight acidification was observed depending on 
medium and synthetic community (Supplementary Figure 4.2). Incubations at high pH started 
from pH 6.9-7 and dropped to 6.7-6.5, while incubations at low pH conditions started at pH 
6.1-6.2 and dropped to 6.1-5.5. Incubations with both fiber as mucin displayed the highest 
acidification (pH drop to 5.5), corresponding with the highest production of short chain fatty 
acids (SCFA) (Figure 4.1). These altered nutrient and pH conditions also impacted 
community composition, as revealed by DGGE profiles and qPCR analyses (Figure 4.2, 
Figure 4.3, Figure 4.5, Figure 4.7). F. prausnitzii and A. muciniphila showed a preference for 
a high pH environment while A. caccae thrived better at low pH. In contrast B. pullicaecorum 
did not display any profound environmental preferences, thriving at all pH and medium 
conditions or growing in the presence of any primary degrader. Although B. longum was 
added at the start of the experiment, it was detected in none of the samples after 58 hours. 
 
Figure 4. 1: Short chain fatty acids (SCFA) produced after 58h growth in mucin, fiber of mucin+fiber 




Figure 4. 2: DGGE profile of different synthetic communities after 58h growth in mucin, fiber of 
mucin+fiber medium, at high or low pH. By comparing the profiles with that of the monocultures 
(Supplementary Figure 4.1), bands could be assigned to species used in the synthetic community. The 
bands of B. thetaiotaomicron and L. plantarum overlap and are difficult to distinguish from each other. 
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3.1 Cross-feeding and competition of mucin-rich medium 
The main goal of this set of incubations was to see whether B. thetaiotaomicron could 
thrive with mucin as main carbon source and compete with or even displace the mucin-
degrading specialist A. muciniphila. In absence of A. muciniphila, B. thetaiotaomicron indeed 
occupied the functional niche of mucin degradation (Figure 4.3, Supplementary Figure 4.3). 
When inoculated at equal amounts, no real competition was observed at high pH as 
Akkermansia and Bacteroides both thrived very well in the community. Akkermansia did get 
outcompeted at low pH, yet this was primarily attributed to Akkermansia’s intrinsic sensitivity 
to acidic pH as it was not able to grow either at low pH when inoculated as initially dominant 
primary degrader (A:B (1000:1)). At high pH A. muciniphila dominated the entire population. 
Interestingly, Bacteroides did not benefit from the lack of A. muciniphila at low pH conditions. 
At low Bacteroides inoculum density it was even Butyricicoccus pullicaecorum that became 
the most dominant species in the community.  
Conditions with joint presence of B. thetaiotaomicron and A. muciniphila resulted in 
more acetate production compared to when Bacteroides was the sole primary degrader 
(Figure 4.4). B. thetaiotaomicron and A. muciniphila can both produce propionate: this was 
confirmed by consistent propionate levels, independently of the initial primary degrader 
abundance. However, absence of propionate at high A. muciniphila inoculation and at low pH 
was again indicative of Akkermansia’s sensitivity to slightly acidic environments. Finally, 
butyrate production was highly consistent throughout all incubations. As none of the 
supplemented butyrate producers are able to grow on mucin (Belzer et al., 2017; Desai et al., 
2016), the observed butyrate production must be the result from cross-feeding, either via 
acetate or lactate or the consumption of oligosaccharides released upon mucin degradation. 
Interestingly, DGGE and qPCR showed a high abundance of A. caccae, which produces 
butyrate via lactate consumption. This coincided nicely with more intense DGGE bands of 
lactate-producer L. plantarum, which increased with 2.5 log units/µL during growth on mucin 
(qPCR) (Figure 4.3, Supplementary Figure 4.3). Butyrate production in this community may 




Figure 4. 3:qPCR results of total bacteria (copies/µL) and of the members of the synthetic community 
(relative abundance) for the experiment in mucin-rich medium. (Akker= A.muciniphila, Bact= 
B.thetaiotaomicron, Lacto= L.plantarum, Faecali= F.prausnitzii, Anaer= A.caccae, Butyr= B.pullicaecorum) 
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Figure 4. 4:SCFA (mM) during growth on mucin-rich medium (n=3).  
 
3.2 Cross-feeding and competition of fiber-rich medium 
Presence of fiber as main carbon source should confirm Bacteroides’s functional niche 
occupation as main fiber degrader. Indeed, no growth of A. muciniphila could be detected in 
the fiber-rich medium (Figure 4.5, Supplementary Figure 4.4). B. thetaiotaomicron on the 
other hand, dominated at high pH, independent from initial concentrations. Interestingly, 
L. plantarum, A. caccae and B. pullicaecorum abundances increased significantly during all 
incubations at low pH (Supplementary Figure 4.4), and especially when B. thetaiotaomicron 
started from lower concentration B. pullicaecorum became the most abundant species 
(A:B(1000:1)) (Figure 4.5).  
Acetate and butyrate were produced at high pH, but production was slower when 
B. thetaiotaomicron was inoculated at lower abundance and this difference was overcome by 
the end of the experiment (Figure 4.6). Interestingly, the fiber-rich medium did not result in 
pronounced propionate production, certainly not at low pH. With respect to butyrate 
producers, consistent Butyricicoccus abundance was noted from DGGE and qCPCR 
analysis; interestingly, F. prausnitzii was abundant at high pH while A. caccae was more 
abundant at low pH (Figure 4.5, Supplementary Figure 4.4). This is indicative of 
F. prausnitzii’s butyrate production benefitting from acetate and A. caccae’s butyrate 
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production using lactate via cross-feeding. Indeed low pH incubations did not reveal any 
acetate production while butyrate levels were similar compared with the high pH incubations. 
Butyrate production may thus be the result from lactate production (not measured), which is 
also confirmed by above-mentioned increase of L. plantarum at all low pH incubations, or 
from acetate being directly consumed for butyrate production by B. pullicaecorum, that 
dominated at low pH and low B. thetaiotaomicron inoculation. 
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Figure 4. 5: qPCR results of total bacteria (copies/µL) and of the members of the synthetic community 
(relative abundance) for the experiment in fiber-rich medium. (Akker= A.muciniphila, Bact= 
B.thetaiotaomicron, Lacto= L.plantarum, Faecali= F.prausnitzii, Anaer= A.caccae, Butyr= B.pullicaecorum) 
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Figure 4. 6:SCFA (mM) during growth on fiber-rich medium (n=3). 
 
3.3 Cross-feeding and competition of fiber- and mucin-rich medium 
When both fibers and mucin were present, B. thetaiotaomicron and A. muciniphila were 
both abundant at high pH, but at low pH was B. thetaiotaomicron the only dominant one. In 
this medium, B. thetaiotaomicron had no problem overcoming its disadvantage at inoculation 
(A:B(10000:1)) and showed no pH preference. L. plantarum did not grow well, probably due 
to competition with B. thetaiotaomicron and/or A. muciniphila (Figure 4.7, Supplementary 
Figure 4.5).  
There was more propionate and acetate produced when both B. thetaiotaomicron and 
A. muciniphila were abundant compared to B. thetaiotaomicron dominance, indicating that 
additional fermentation takes place and no competition between the two species occurs 
(Figure 4.8). This additional fermentation might in part explain the slightly higher butyrate 
concentrations at high pH (both species abundant) compared to low pH (only 
B. thetaiotaomicron abundant). However, when only B. thetaiotaomicron was inoculated (B), 
also more butyrate was produced at high pH.  
In the DGGE profile no bands were detected for any butyrate producer at low pH but 
qPCR analyses showed an increase in abundance of A.caccae and B.pullicaecorum, and 
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butyrate was produced (Figure 4.2, Figure 4.7, Figure 4.8, Supplementary Figure 4.5). The 
lower abundance of butyrate producers in these sample might be explained by the bigger 
drop in pH, to pH 5.5, as more SCFA were formed during growth in this medium. Bands of 
less abundant species are difficult to detect, especially when other species 




Figure 4. 7: qPCR results of total bacteria (copies/µL) and of the members of the synthetic community 
(relative abundance) for the experiment in mucin- and fiber-rich medium. (Akker= A.muciniphila, Bact= 
B.thetaiotaomicron, Lacto= L.plantarum, Faecali= F.prausnitzii, Anaer= A.caccae, Butyr= B.pullicaecorum) 
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Figure 4. 8:SCFA( mM) during growth on fiber- and mucin-rich medium (n=3). 
 
 





This study again confirmed Akkermansia muciniphila’s status as mucin degrading 
specialist and its sensitivity to slightly acidic environments. Bacteroides thetaiotaomicron on 
the other hand proved a versatile organism, increasing its growth both on fiber as mucin. It 
did however display a larger affinity for fiber since it could overcome its initial disadvantage 
(A:B(1000:1)) when grown on fibers but not on mucin. In the latter case it was overgrown by 
A. muciniphila at high pH and by B. pullicaecorum, A. caccae and L. plantarum at low pH. 
Neither B. pullicaecorum nor A. caccae are known to have the ability to, even partly, degrade 
mucin and since they grow mostly on simple sugars, their observed growth in this medium 
might indicate cross-feeding (Belenguer et al., 2007; Eeckhaut et al., 2008; Geirnaert, 2015; 
Moens et al., 2016). L. plantarum encodes a cluster of genes involved in sialic acid 
metabolism, whereby the sialic acid is released from the mucin structure and used as a 
carbon and nitrogen source, which can explain its growth in the mucin-rich medium 
(Almagro-Moreno and Boyd, 2009). We thus conclude that occupation of the mucin-
degrading functional niche depends on initial primary degrader abundance and pH 
environment.  
Interestingly, the joint presence of Akkermansia and Bacteroides under mucin rich 
conditions and similar levels of Bacteroides in mucin or mucin+fiber medium indicates no 
competition between the two, at least not when mucin is sufficiently present. The production 
of acetate from the mucin-rich medium in presence of A. muciniphila was independent of 
B. thetaiotaomicron presence and higher than the incubations with B. thetaiotaomicron as 
sole degrader. This indicates A. muciniphila to be a more efficient mucin degrader than 
B. thetaiotaomicron. In medium with fibers and mucin, more acetate was produced when 
both Akkermansia and Bacteroides were abundant compared to Bacteroides alone. This 
shows  that degradation of mucin and fibers is complementary when different primary 
degraders are present.  
In the fiber-rich medium, no growth of A. muciniphila was detected and we expected 
dominance of B. thetaiotaomicron at both high and low pH, independent from the inoculum. 
This was the case at high pH, but at low pH B. thetaiotaomicron had to compete with 
L. plantarum and the latter even became equally abundant when B. thetaiotaomicron was 
inoculated at a lower density (A:B(1000:1)). Interestingly, B. pullicaecorum dominated the 
synthetic community at low pH, in both fiber-rich and mucin-rich medium when 
B. thetaiotaomicron was inoculated at lower density. Previous studies indicate that it relies on 
other species to degrade complex substrates to simple sugars, so B. pullicaecorum 
dominance in these conditions probably results from cross-feeding (Eeckhaut et al., 2008; 
Geirnaert, 2015; Moens et al., 2016). L. plantarum can metabolize a large diversity of carbon 
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sources, including all major types of oligosaccharides (Ganzle and Follador, 2012) and it was 
suggested that it might have its own extracellular enzyme system for breakdown of complex 
carbohydrates (Siezen et al., 2006). Despite the fact that B. thetaiotaomicron is a very 
efficient fiber degrader, the higher competition with L. plantarum could confirm previous 
findings that Bacteroides may suffer from growth inhibition due to lactate at pH values closer 
to its pKa (Duncan et al., 2009).  
We hypothesized that the different ratios in primary degraders would also affect cross-
feeding towards butyrate. While differences in butyrate production were noticed between 
different growth media (mucin vs. fiber vs. mucin+fiber), butyrate producing functionality for 
the same medium remained constant under variable primary degraders ratios. Nevertheless 
some shifts in the butyrate producing community were observed. A. caccae abundance 
consistently coincided with increased growth of L. plantarum. The latter benefitted from the 
lack of A. muciniphila growth at low pH in mucin-rich medium and Lactobacillus got enriched 
at low pH in the fiber-rich medium for all primary degrader ratios. The initial degradation 
activity by L. plantarum, will result in the production of lactate and release of monomers, and 
could thus deliver the ideal substrates for butyrate producing A. caccae. No such specific 
interaction between primary degrader and butyrate producer was observed for the other 
bacteria. F. prausnitzii showed preference for conditions at high pH, but no specific response 
towards nutrients or primary degrader. In contrast to A. caccae, which has a narrow 
metabolic range, F. prausnitzii can metabolize a variety of oligosaccharides, such as 
fructose, arabinose, galactose and N-acetylglucosamine, and needs acetate for the 
production of butyrate (Desai et al., 2016; Rios-Covian et al., 2016). These carbohydrates 
are released by both fiber and mucin degradation and the acetate can be provided by both 
A. muciniphila and B. thetaiotaomicron, which explains why F. prausnitzii does not seem to 
be affected by medium or primary degrader. The same was observed for B. pullicaecorum 
which proved to be an even more efficient colonizer displaying no particular pH preference. 
Interestingly, butyrate production was generally higher at high pH which seems to contrast 
with other studies (Walker et al., 2005) (Chapter 2, Chapter 3). The fact that these studies 
were carried out with complex microbial communities may explain this discrepancy. In our 
synthetic consortium primary degraders are more abundant and seemingly more active at 
high pH, resulting in more acetate and release of less complex substrates, which facilitates 
cross-feeding to butyrate. In contrast to what was expected, most butyrate was formed in 
fiber-rich medium and not in the medium with most nutrients (fiber+mucin). Butyrate 
production was lowest for incubations with mucin-rich medium. These observations 
demonstrate that nutritional conditions can selectively facilitate butyrate production although 
it was not reflected in abundance of butyrate producers (Figure 4.9, Figure 4.1).  
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In conclusion, the use of a synthetic bacterial community composed of primary and 
secondary glycan degraders, producers of acetate, propionate, butyrate and lactate, bacteria 
with a narrow as well as with a wide metabolic range, lead us to draw some interesting 
conclusions. A. muciniphila relies on the presence of a mucin-degrading functional niche 
while B. thetaiotaomicron is a more versatile microorganism occupying different glycan 
degrading niches. Yet, joint presence of both primary degraders did not lead to a competitive 
exclusion in the presence of mucin; A. muciniphila was not even overgrown by 
B. thetaiotaomicron when additional dietary glycans were available. Surprisingly, in scenarios 
of low Bacteroides abundance and at low pH L. plantarum can sometimes outcompete 
Bacteroides, indicating that probiotic supplementation of Lactobacillus could become 
successful when circumstances are appropriate. Finally, shifts in pH and consequence for 
primary degrader abundance was selective for butyrate producers (A. caccae as opposed to 
F. prausnitzii) while the butyrate producing functionality was maintained. This indicates that 
functional redundancy facilitating functional stability is an important feature of gut microbial 
ecosystems even at a miniaturized scale. 
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6. Supplementary information 
 
Supplementary Figure 4. 1: DGGE profile of the pure cultures. 
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Supplementary Figure 4. 3: Abundance of the members of the synthetic community (log(copies/µL)) in the 
mucin-rich medium at the beginning (T0) and end (T58) of the experiment as measured by qPCR analyses. 
(Akker= A.muciniphila, Bact= B.thetaiotaomicron, Lacto= L.plantarum, Faecali= F.prausnitzii, Anaer= 
A.caccae, Butyr= B.pullicaecorum). 
 
 
Supplementary Figure 4. 4: Abundance of the members of the synthetic community (log(copies/µL)) in the 
fiber-rich medium at the beginning (T0) and end (T58) of the experiment as measured by qPCR analyses. 
(Akker= A.muciniphila, Bact= B.thetaiotaomicron, Lacto= L.plantarum, Faecali= F.prausnitzii, Anaer= 
A.caccae, Butyr= B.pullicaecorum) 




Supplementary Figure 4. 5: Abundance of the members of the synthetic community (log(copies/µL)) in the 
fibre- and mucin-rich medium at the beginning (T0) and end (T58) of the experiment as measured by 
qPCR analyses. (Akker= A.muciniphila, Bact= B.thetaiotaomicron, Lacto= L.plantarum, Faecali= 
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A. muciniphila is an abundantly present commensal mucin degrading gut bacterium 
( 1 – 4% ), widely distributed among healthy individuals. It has been positioned as a health 
biomarker and is currently explored as a biotherapeutic agent and next generation probiotic. 
Preliminary and ongoing research is mostly based on in vivo mouse models and human 
intervention trials. While these allow the assessment of physiologically relevant end markers, 
the analysis of fecal samples presents limitations with respect to the in-depth mechanistic 
characterization of Akkermansia effects at the level of the microbiome. We aimed to evaluate 
the effect of A. muciniphila treatment on the endogenous community from four different 
donors in a validated, controlled in vitro model of the gut microbial ecosystem (SHIME®). 
Taking into account the nutritional specificity and sensitivity of A. muciniphila to mucin 
deprivation and supplementation (Chapter 2, Chapter 3, Chapter 4), and the prebiotic-like 
action of mucins in the colon environment, the interplay between mucin, A. muciniphila and 
the endogenous community was investigated. Effects of A. muciniphila on the microbial 
community composition were limited and functional changes were primarily attributed to 
mucin addition. Indeed, mucin addition resulted in significantly higher acetate, propionate 
and butyrate production for all four donors, independent from A. muciniphila addition. This 
study revealed that the supplementation of A. muciniphila together with mucin limited the 
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1. Introduction 
Akkermansia muciniphila was isolated as a mucin degrading bacterium in 2004 
(Derrien et al., 2004). Since its discovery A. muciniphila has been reported by many studies 
as its abundance is inversely correlated with disorders such as IBD, obesity, autism, 
appendicitis and diabetes (Png et al., 2010; Santacruz et al., 2010; Swidsinski et al., 2011; 
Wang et al., 2011; Zhang et al., 2009). A study with obese mice showed that A. muciniphila 
can exert therapeutic effects since its supplementation reversed high-fat diet induced insulin 
resistance, dyslipidemia, metabolic endotoxemia and fat mass gain (Everard et al., 2013). 
Plovier et al. (2017) showed that pasteurization of A. muciniphila before treatment enhanced 
its beneficial impact and that the beneficial effects were, at least partly, due to a specific 
outer membrane protein (Amuc_1100). An ongoing clinical study by the university of Leuven 
is investigating the effects associated with the administration of A. muciniphila on the 
metabolic disorders related to overweight and obesity in humans. 
A. muciniphila has been referred to as a possible next-generation probiotic (Belzer and 
de Vos, 2012; Cani and de Vos, 2017; Zhou, 2017), a broad term that conforms to the 
normal definition of a probiotic and comprises micro-organisms with potential health benefits, 
which do not necessarily have a Qualified Presumption of Safety (QPS) or Generally 
Regarded as Safe (GRAS) status. Some of these next generation probiotics are likely to be 
used in a pharmaceutical context, which makes them fit well within the emerging concept of 
live biotherapeutic products: “a biological product that: (1) contains live organisms, such as 
bacteria; (2) is applicable to the prevention, treatment, or cure of a disease or condition of 
human beings; and (3) is not a vaccine” (O'Toole et al., 2017). Since there is no consensus 
on the correct terminology yet, we consider A. muciniphila to be a live biotherapeutic product, 
thereby avoiding confusion with established probiotic products. The mode of action of 
A. muciniphila can be by directly interacting with the host, for example through the 
Amuc_1100 protein, of by indirect interplay with the endogenous microbial community.  
This established community, together with the high turn-over in the gastrointestinal 
tract, however, presents a challenge for the stable introduction and maintenance of 
biotherapeutics. In that respect, the availability of nutrients, selectively sustaining the growth 
of a biotherapeutic agent, could be an important factor in determining the success rate of 
future therapies. In case of A. muciniphila, mucins have been identified as a major 
determinant of its colonization capacity (Berry et al., 2013; Ottman et al., 2017a). In the 
Simulator of the Human Intestinal Microbial Ecosystem (SHIME®), a dynamic model of the 
colonic microbial ecosystem; mucin deprivation and supplementation was shown to 
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specifically affect A. muciniphila abundances, more than any other species present (Chapter 
2, Chapter 3).  
This reflects the superior ability of A. muciniphila to use up to 85% of the complex mucin 
structure, which is composed of O-glycosylated and to a lesser extent N-glycosylated protein 
backbones, with chains of 2 to 12 monosaccharides, mostly galactose, fucose, N-
acetylgalactosamine, N-acetylglucosamine, mannose and sialic acid (Derrien, 2007; Lai et 
al., 2009). In vivo mice trials have demonstrated that A. muciniphila efficiently degrades 
mucins (Berry et al., 2013; van Passel et al., 2011). To this end, it possesses an entire 
repertoire of enzymes with both extracellular and intracellular activity (Derrien, 2007). A study 
of its genome showed the presence of 61 proteins predicted to be involved in mucin 
degradation (11% of all proteins). Mucin degradation by A. muciniphila leads to the release of 
oligosaccharides and the production of acetate and propionate, both of which can stimulate 
microbial metabolic interactions, as well as, a host response (Derrien et al., 2004; Reunanen 
et al., 2015). Other bacteria in close proximity could profit from the mucolytic activity by using 
the oligosaccharides and acetate for growth and metabolic conversions, such as butyrate 
production (Belzer et al., 2017; Chia et al., 2018). It has been hypothesized that the presence 
and activity of these cross-feeding bacteria co-existing with A. muciniphila at the mucus 
layer, might provide additional colonization resistance against pathogens and could impact 
host response due to their proximity to the epithelial cells (Belzer and de Vos, 2012; Cani 
and de Vos, 2017). 
Only a few other species have the enzymatic capacity for initiating partial or full mucin 
degradation, including Bacteroides thetaiotaomicron, Ruminococcus gnavus, Ruminococcus 
torques and Bifidobacterium bifidum (Hoskins et al., 1985; Marcobal et al., 2013d; Martens et 
al., 2008; Png et al., 2010). Considering the limited number of species that can degrade the 
complex mucin structure and described health effect conferred by its degradation, mucins fit 
the definition of prebiotic substances: ‘substrates that are selectively utilized by host 
microorganisms conferring a health benefit’ (Cani and de Vos, 2017; Gibson et al., 2017; 
Ouwehand et al., 2005). As mucin glycans constitute 80% of the dry weight of the mucus 
layer covering the intestinal epithelium and are present in the luminal content as a 
consequence of the continuous mucus desquamation, the human body can be described as 
producing its own prebiotic (Johansson et al., 2011; Johansson, 2012; Johansson et al., 
2008). Mucin thus plays an important role in the interaction between A. muciniphila, the 
microbial community and the host.  
Considering the ongoing studies and future perspective for A. muciniphila as a 
biotherapeutic agent, we aimed at investigating the effect of A. muciniphila treatment on the 
endogenous community. For this purpose, the in vitro SHIME model was used, with colon 
compartments separately inoculated with the microbiota from four human donors. Taking into 
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account its nutritional specificity, treatment of A. muciniphila was investigated with and 
without addition of mucin. This allowed us to elucidate the importance of mucin presence to 
modulate the efficiency of the supplementation with A. muciniphila. At the end of these 
treatments, an antibiotic pulse was administered after which the microbial community was 
allowed to recover. The goal was to establish whether the interplay between A. muciniphila, 
mucin and the microbial community would lend resilience towards an antibiotic-induced 
disturbance or mediate a faster ecosystem recovery. 
2. Materials and methods 
2.1 Bacterial strains 
Akkermansia muciniphila (DSMZ 22959, Type strain) was cultured in reinforced 
clostridial medium (RCM) medium with mucin for 24h, prior to the daily treatment of the colon 
vessels (day 10-20). After 24h growth the pure culture was washed with anaerobic PBS (0.8 
g L-1 NaCl and 0.2 g L-1 KCl) in an anaerobic (10 % CO2 and 90 % N2) workstation (GP 
Campus, Jacomex, Dagneux, France). Using flowcytometry (as described in Chapter 4), the 
A. muciniphila concentration was quantified and was standardized to 2,5*108 ± 5*107  
cells mL - 1 before supplementation to the SHIME colon compartments (Van Nevel et al., 
2013). 
 
2.2 Long-term dynamic in vitro gut model for the luminal colon microbiota 
(SHIME) 
The dynamic in vitro SHIME® model (ProDigest-Ghent University, Ghent, Belgium) 
was used to study the impact of supplementation of live A. muciniphila, with or without the 
presence of a host glycan degradation niche, in different microbial communities. The model 
and its nutritional medium is described in Chapter 2. Fecal samples were collected from 
healthy donors between the age of 25-35 and prepared within 1h according to standard 
procedures (Molly et al., 1993) (Chapter 2) and used for inoculation. 
The set-up of this experiment is shown in Figure 5.1. Fecal suspension of 4 donors 
was used to inoculate the colon vessels (4 colon vessels/donor), with a retention time (RT) of 
40h and a pH between 6.6-6.9 (distal colon pH). During the mucin deprivation period (day 0-
10), a mucin-free nutritional medium was fed to the colon vessels. From day 10-20 onwards 
(treatment period), 4 different treatments were applied to the 4 colon vessels/donor: 
“+Akk+Muc” where A. muciniphila was daily administered to the colon vessels after sampling 
and mucin (4 g L-1) was added to the feed; “+Akk-Muc” where only A. muciniphila was 
added; “-Akk+Muc” where only mucin (4 g L-1) was added; and “-Akk-Muc” which is 
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identical to the medium provided during the mucin deprivation period. After this ten-day 
treatment period, an antibiotic mix, containing ciprofloxacin, amoxicillin and tetracycline at 
respectively 40, 40 and 10 mg L-1 final colonic concentration, was supplemented directly into 
every colon vessel to induce an acute stress (Marzorati et al., 2017). 
 
Figure 5. 1: Experimental set-up of the SHIME experiment. Akk: A. muciniphila. Muc: mucin. RT: retention 
time. 
Samples were taken daily for SCFA analysis, as described previously (Andersen et al., 
2014) and every two days for DNA extraction (Geirnaert, 2015), followed by 16S rRNA gene 
amplicon sequencing (Illumina MiSeq) (De Paepe et al., 2017) and A. muciniphila qPCR 
quantification (Collado et al., 2007). 
 
2.3 Microbial community analysis 
DNA extraction was performed by a combination of chemical and mechanical lysis 
through a bead beating step as reported by Geirnaert et al. (2015). As starting material, the 
pellet obtained after centrifuging 1 mL of luminal sample at 5,000 x g for 10 min was used. 
The DNA quality was verified on a 1.5 % (w/v) agarose gel.  
Total bacterial and Akkermansia-specific 16S rRNA gene copy number was quantified 
with qPCR on 100- and 10- fold diluted DNA extracts, respectively, using a StepOnePlus 
Real-Time PCR system (Applied Biosystems, Carlsbad, CA), as described in Chapter 3. 
The bacterial community on various timepoints during the experiment was assessed 
using amplicon sequencing of the 16S rRNA gene (De Paepe et al., 2017). DNA samples 
were sent out to LGC Genomics (Teddington, Middlesex, UK) for library preparation and 
sequencing on an Illumina Miseq platform, as described by De Paepe et al. (2017). The V3-
V4 region of the 16S rRNA gene was amplified by PCR using primers (341F 
CCTACGGGNGGCWGCAG, 785R GACTACHVGGGTATCTAAKCC) derived from 
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Klindworth et al. (2013), with a slight modification to the reverse primer by introducing 
another degenerated position (K) to make it more universal. The sequencing data has been 
submitted to the NCBI (National Center for Biotechnology Information) database under 
accession code (SRP126579). The mothur software package (v.1.39.5) and guidelines were 
used to process the amplicon data generated by LGC Genomics, as described in detail by 
De Paepe et al. (2017)(Kozich et al., 2013). 
2.4 Statistical analysis 
All statistical analysis were performed in R, version 3.4.3. 
2.4.1 Functional data 
Non-parametric, rank based longitudinal data analysis of the SCFA production 
(measured acetate, propionate, butyrate and branched SCFA concentrations) over time was 
conducted using the R package nparLD (nparLD_2.1). Wald and ANOVA type statistics were 
used to assess the significance of the combined mucin and A. muciniphila treatment in 
function of time (f1-ld-f1 design). A significant time effect was observed, which was expected 
as the treatment was applied after an initial stabilisation period of ten days and the system 
was disturbed after 20 days by an antibiotic pulse. The longitudinal data analysis was 
therefore repeated on the subsetted data (stabilisation, treatment prior to antibiotic pulse and 
treatment post antibiotic pulse). The relative treatment effects obtained by nparLD were 
verified by a partial redundancy analysis, followed by a PCA (package vegan_2.4-4). 
Acetate, propionate, butyrate and branched SCFA levels were modelled in function of 
the treatment (with A. muciniphila and mucin), conditional on the period (stabilisation, 
treatment prior to antibiotic pulse and treatment post antibiotic pulse) and inter-individual 
differences (factor donor). Similarly, donor and period were considered as main effects, 
conditional on the other factors. Permutation tests were applied to assess the statistical 
significance of the global model and the individual canonical axes (Legendre et al., 2011). 
The RDA results were plotted in a type II scaling correlation triplot, displaying the constrained 
canonical (labelled RDA1/2) and in case of the A. muciniphila or mucin effect the first 
unconstrained residual (labelled PC1) axis. Both axes were annotated with the proportional 
eigenvalues representing their contribution to the total (both constrained and unconstrained) 
variance. The coordinates of the sites were derived from the weighed sums of the scores of 
the response variables. Next to the absolute metabolite concentrations, the relative 
proportion of the metabolites is an important marker. Therefore the above outlined procedure 
was repeated using the metabolite ratios. Additionally, in order to assess if significant 
interactions occurred between the explanatory variables, a global RDA was performed based 
on a regression model including interaction terms in addition to each of the main effects. 
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2.4.2 Microbial community data 
To visualize differences in microbial community composition between donors, 
treatments and antibiotic response, ordination and clustering techniques were applied. For 
these purposes, the shared file was further processed to remove OTU’s with too low 
abundance according to the arbitrary cut-off’s described by McMurdie and Holmes (2014). 
An OTU is defined in this manuscript as a collection of sequences, that are found to be more 
than 97% similar to one another in the V3-V4 region of their 16S rRNA gene after applying 
hierarchical clustering (Chen et al., 2013; Schloss and Westcott, 2011; Schloss et al., 2009; 
Wang et al., 2012). To deal with differences in sampling depth, proportional data transformed 
on the common scale to the lowest number of reads was used (McMurdie and Holmes, 
2014). A table with the most abundant OTUs classified to the species level using both RDP 
Seqmatch tool and NCBI BLAST is given in Supplementary Table 5.1.   
Principle Coordinate Analysis (PCoA; package stats) was conducted based on the 
abundance-based Jaccard dissimilarity matrix (package vegan and visualized with ggplot2 
(Anderson et al., 2006; Cox, 2001; Oksanen, 2016; Ramette, 2007). This procedure was 
repeated on OTU and genus level focusing on both the comparison between the donors and 
between the applied treatments. On the genus level, weighed averages of genera 
abundances were a posteriori added to the ordination plot using the wascores function in 
vegan (Oksanen, 2016). Donor and treatment both influenced the grouping of samples, 
which was further explored using a partial distance based redundancy analysis at species 
level (db RDA) (Vardakou et al., 2007). The scores obtained by a PCoA were modelled in 
function of the treatment, with the effects of the inter-individual variability and treatment 
period being partialled out using the capscale function of the package vegan (package 
vegan_2.4-4) (Oksanen, 2016; Ramette, 2007). Interpretation of the results is preceded by a 
permutation test of the db RDA results to confirm that a relationship exists between the 
response data and the exploratory variables. Using the same principle, the significance of the 
first two constrained axis was evaluated. The constrained fraction of the variance, explained 
by the exploratory variables is adjusted by applying a subtractive procedure (Borcard et al., 
2011; Peres-Neto et al., 2006). The fraction of the variance explained by the exploratory 
variables and its significance are given in Supplementary Table 5.2. 
In a next step, Sparse Partial Least Squares Discriminant Analysis (sPLS-DA) 
(mixOmics_6.3.1) was performed to select the taxonomic features most predictive of the 
treatment ("+Akk+Muc","-Akk+Muc","+Akk-Muc","-Akk-Muc") (Figure 5.2). Hereto, a factorial 
response variable was created, indicating the treatment condition of each sample. The 
filtered proportional OTU level abundances were used as predictors. The number of 
components and OTUs or genera to include in the sPLS-DA model was assessed based on 
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the classification error rates obtained after a five-fold Cross-validation. The final sPLS-DA 
model, with an optimum of 3 components was displayed (Supplementary Figure 5.2) and the 
proportional abundances of the most predictive and most abundant OTUs and genera were 
represented in a heatmap (Figure 5.6). 
Finally, in order to find statistically significant differences in species and genus level 
abundance between the different treatments, the DESeq package was applied on the 
filtered, unnormalized data at the end of the treatment period (Day 20) (α=0.05) as 
suggested by (Love et al., 2014); McMurdie and Holmes (2014) (Figure 3.3). The factors 
Treatment and Donor were used in the design formula and the effect of the treatment was 
determined by a likelihood ratio test on the difference in deviance between a full and reduced 
model formula. An empirical Bayes shrinkage correction was employed for low counts (Love 
et al., 2014). Pairwise significant differences were obtained using Wald tests, specifying all 
pairwise combinations of treatments as the contrast argument. Results from the pairwise 
comparisons were visualized in a volcanoplot, showing the -log10 (adjusted p-value) as a 
function of the shrunken log2 FoldChange. Species with an absolute shrunken 
log2FoldChange exceeding 2, were annotated in the plot (Quackenbush, 2002). The most 
pronounced significant differences at species level were shown in side-by-side boxplots 
comparing the normalized counts (plus a 0.5 pseudocount) during treatments. 
To assess the effect of the antibiotic pulse on the microbial community, the DESeq 
package was again applied. The effect of the antibiotic pulse was determined by a likelihood 
ratio test on the difference in deviance between a full and reduced model formula. An 
empirical Bayes shrinkage correction was employed for low counts (Love et al., 2014). 
Results from the pairwise comparisons, for each treatment comparing before and after 
antibiotic pulse, were visualized in a volcanoplot, showing the -log10 (adjusted p-value) as a 
function of the shrunken log2 FoldChange. Genera with an absolute shrunken 
log2FoldChange exceeding 1, were annotated in the plot (Quackenbush, 2002) 
(Supplementary Figure 5.4). Also alpha-diversity was calculated using the Shannon 
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3. Results 
During the 10 day mucin deprivation period, mucin free medium was fed to the 
SHIME system, creating mucin deprived communities, derived from the fecal samples of four 
different donors. These communities were characterized by a reduction of A. muciniphila 
abundances (Figure 5.5) and similar short chain fatty acid (SCFA) profiles (Figure 5.3) with 
36.32 ±6.85 mM acetate, 9.41±0.81 mM propionate and 4.19±1.42 mM butyrate (n=16). The 
A. muciniphila abundance of around 0.01% in donors 1,2,3 decreased a 1000 fold due to 
mucin deprivation for donors 1 and 2 and was close to the quantification limit in donor 3 
(Figure 5.5). In the case of donor 4, A. muciniphila abundance levels remained close to the 
quantification limit during the entire mucin deprivation period (Figure 5.5). 
From day 10 onwards, A. muciniphila and/or mucin were added to the SHIME. Partial 
redundancy analysis indicates that mucin treatment accounted for 17% of the observed 
variation in SCFA concentrations (p=0.001) (Figure 5.4). Treatments with mucin (-Akk+Muc, 
+Akk+Muc) caused an increase in acetate, propionate and butyrate production in all donors, 
whereas the addition of A. muciniphila did not have a significant effect, contributing to only 
0.5% of variation in SCFA concentrations (p=0.11) (Figures 5.3 and 5.4). Besides mucin 
treatment, inter-individual differences were significant but less pronounced (2%) (Figure 5.4). 
The donor effect was most visible during the combined A. muciniphila and mucin treatment 
(Figure 5.4). In donor 2 the response to the addition of mucin depended on A. muciniphila co-
administration: when treated with both A. muciniphila and mucin, propionate production 
increased but when treated with only mucin, butyrate production increased (Figure 5.3). 
Interestingly, the endogenous A. muciniphila in this donor did not respond to the mucin 
treatment (Figure 5.5), whereas it did in the other donors; mucin addition in donor 1 resulted 
in a delayed increase of endogenous A. muciniphila abundances after four days; in donor 4, 
the delay lasted longer (six days) and levels remained lower compared to the A. muciniphila 
and mucin combination; for donor 3, a fast increase was observed followed by a decrease 
after 4 days. Daily supplementation of A. muciniphila resulted in a fast increase in 
A. muciniphila abundances resulting in a stable high population density throughout the 
treatment period (Figure 5.5). Mucin further stimulated growth of endogenous or 
supplemented A. muciniphila. Unlike previous observations (Chapter 2, Chapter 3) when no 
A. muciniphila and mucin were added (-Akk-Muc), A. muciniphila was not entirely washed out 






Figure 5. 3 : Short chain fatty acid concentration (mM) measured in the colon vessels inoculated with fecal samples of donors 1-4. From day 0-10 mucin-free feed 
was administered. From day 10-20 onwards, different treatments were applied:vessels were treated with either A.muciniphila (+Akk-Muc), mucin (-Akk+Muc) (4g L-
1), a combination of both (+Akk+Muc) or no treatment(-Akk-Muc). At day 20 all vessels were treated with an antibiotic mix (ABX), after which A. muciniphila 
treatments, in contrast to the mucin treatments were discontinued. 




Figure 5. 4: Partial redundance analysis correlation triplot with the response variables (Ac=acetate, 
Pr=propionate, Bu=butyrate, Br=branched SCFA) indicated in red and the different factors represented 
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Figure 5. 5: Log (base 10) scaled relative abundance of A. muciniphila over total bacteria, measured with 
qPCR. Colon vessels were inoculated with fecal samples of donors 1-4. From day 0-10 mucin-free feed 
was added. From day 10-20 different treatments were imposed: vessels were treated with either 
A. muciniphila (+Akk-Muc), mucin (-Akk+Muc) (4g L-1), a combination of both (+Akk+Muc) or no 
treatment(-Akk-Muc). At day 20 all vessels were treated with an antibiotic mix (ABX), after which 
A. muciniphila treatments, in contrast to the mucin treatments were discontinued. 
 
Besides A. muciniphila (OTU9), other members of the microbial community were 
affected by the different treatment combinations. An unsupervised principle coordinates 
ordination displayed no clear donor or treatment dependent clustering, illustrating the 
individuality of the response to mucin and A. muciniphila (Figure 5.6). To quantify and 
distinguish between donor and treatment effects a partial distance based rda analysis was 
performed, showing that mucin (8%) and A. muciniphila (7%) effects were limited and non-
significant (Supplementary Table 5.2). In order to select the taxonomic entities which were 
most discriminative for each of the different treatments a sPLS-DA was performed. The final 
model, retaining only the 75 most predictive OTUs, showed a clustering by treatment (3D plot 
Supplementary Figure 5.2). Clostridium cluster XIVa OTU26 and Veillonella OTUs 44 and 46 
were characteristic of the control treatment without mucin or A. muciniphila (Figure 5.7). The 
addition of A. muciniphila had little effects on the microbial community, whereas mucin 
supplementation resulted in proportional increases of A. muciniphila (OTU9), OTU20, 
OTU21, OTU24, OTU48, OTU43, OTU32 and OTU37. Interestingly, co-administration of 
A. muciniphila restricted the effect of mucin to these OTUs and amplified the A. muciniphila 
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upsurge (Figure 5.7). This was also reflected at the genus level (Figure 5.7) and in the 
DESeq2 analysis, comparing the different conditions after ten days of treatment (Figure 5.8). 
Mucin treatment     (-Akk+Muc vs -Akk-Muc), significantly stimulated A. muciniphila (OTU9), 
OTU32-OTU63 (~ Clostridium cluster XIVa) and OTU48 (~Ruminococcus torques) (Figure 
5.6). OTU46 (~Veilonellaceae), OTU41 (~Enterobacter) and OTU26 (~Clostridium cluster 
XIVa), on the other hand, were characteristic of mucin-deprived communities (Figure 5.8). In 
the presence of added A. muciniphila (+Akk+Muc vs +Akk-Muc) less OTUs were significantly 
affected, comprising OTU9 and OTU32 increasing in abundance and OTU62 
(~Enterobacteriaceae) and OTU78 (~Lachnospiraceae) decreasing in abundance (Figure 
5.8).  
In line with the spls-DA, the effect of A. muciniphila supplementation on the community 
was very limited, with only 0.33% of the community at OTU level significantly affected. 
A. muciniphila adversely affected OTU48 (~R.torques) abundances in the presence of mucin 
(+Akk+Muc) and OTU41 (~Enterobacter) in the treatment without mucin (+Akk-Muc). 
 
 
Figure 5. 6: A PCoA biplot revealed the effect of treatment (colors) on the bacterial communities of the 
different donors (shapes) comparing day 10 and 20 (size). Blue ellipses show clustering of donors 1-3 
with mucin; with or without A. muciniphila. Green ellipses show clustering according to donor without 
mucin, independent from A. muciniphila treatment. Weighted average scores of genera characteristic of 




Figure 5. 7: Heatmap representation of the most predictive genera (left side) and OTUs (right side) for the 
different treatments as determined by sPLS-DA regression analysis. 
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Figure 5. 8: Boxplots of OTUs that were significantly different in abundance between treatments (day 20) 
over all four donors as determined by DESeq2 analysis (α=0.05). Color of the boxplots represents the 




The DeSeq2 procedure resulted in few significant OTUs across all four donors. These 
inter-individual differences are apparent from the PCoA analyses at the genus level before 
(day 10) and after treatment (day 20) (Figure 5.6). Samples from donor 4 clustered 
separately, partly due to the higher relative abundance of Fusobacterium spp. For the other 
donors, different clusters could be distinguished in response to the treatments. Communities 
after treatment with mucin are characterized by Ruminococcus, Roseburia and 
Parabacteroides presence. Conditions without mucin on the other hand clustered according 
to donor, independent from A. muciniphila treatment (green ellipses). So the mucin effect on 
the community composition is influenced by addition of A. muciniphila whereas 
A. muciniphila had no effect without mucin. 
After 10 days of treatment (day 20), an antibiotic pulse, containing ciprofloxacin, 
tetracycline and amoxicillin was applied to the colon vessels, after which A. muciniphila 
treatment ceased but mucin treatment continued. The effect of this antibiotic disturbance was 
followed up to investigate whether preceding treatment with mucin and/or A muciniphila 
would have protective effects. At the functional level as well no protective effects were 
observed as the drop in SCFA production after the antibiotic pulse resulted in more similar 
SCFA profiles across treatments (Figure 5.3). The decrease in propionate and butyrate after 
the antibiotic pulse was significantly larger (p<0.05) in the presence of mucin, off-setting the 
initial positive effects of mucin addition. Acetate almost fully recovered to the levels before 
antibiotic disturbance within ten days. Propionate and butyrate levels remained significantly 
lower throughout the antibiotic wash-out period (p<0.01). Four to six days after the 
disturbance, A. muciniphila abundance was lowest, after which it increased again in 
conditions with mucin and after ten days recovery a clear difference, although not significant, 
between conditions with and without mucin was visible (Figure 5.5). Also at the community 
level, no protective effects were observed from the treatments and the disturbance persisted 
after 10 days. The antibiotic pulse marginally reduced total bacterial count (Supplementary 
Figure 5.3) and affected the same genera, such as Roseburia, Bifidobacterium, Alistipes, 
Butyricicoccus, Enterobacteriaceae, …, independent of the preceding treatment, as was 
determined by DESeq analysis (Supplementary Figure 5.4). Alpha-diversity was significantly 
reduced after antibiotic treatment and did not recover within 10 days (p<0.01) 
(Supplementary Figure 5.5). 
An interesting effect of the treatments and antibiotic disturbance was observed for 
donor 2. Endogenous A. muciniphila did not increase with mucin addition during the 
treatment period, but suddenly responded to mucin after the antibiotic disturbance (Figure 
5.5). Interestingly, this mucin treatment, without response of A. muciniphila, caused an 
increase in butyrate, significantly larger than in any other donor or for any other treatment, 
and induced no response in propionate (Figure 5.3). A detailed inspection of the time course 
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of the relative abundances from species that were significantly affected solely by the mucin 
treatment, revealed an interesting response of Ruminococcus species OTU48 and OTU65, 
together with butyrate producing Roseburia OTU34 to the mucin treatment in donor 2 (Figure 
5.9). These species might be involved in the observed difference in butyrate between those 
two treatments (Figure 5.2). Ruminococcus species OTU48 and OTU65 responded to mucin 
treatment without A. muciniphila supplementation, but not to other treatments, together with 
butyrate producing Roseburia species (OTU34) which increased greatly. After antibiotic 
disturbance, OTU65 and OTU34 did not recover, whereas OTU48 did. OTU34 and OTU48 
displayed a similar response to mucin treatment in donor 3, which was characterized by a 
less pronounced A. muciniphila response (Figure 5.5, Figure 5.9). 
 
 
Figure 5. 9: (upper) Volcano plot showing results from DESeq2 analysis between treatments “+Akk+Muc” 
and “-Akk+Muc” in donor 2. Green and red dots represent OTUs more abundant in “-Akk+Muc”, 
respectively,“+Akk+Muc” and the size indicates the relative abundance of the OTU in the community. 
(lower) Relative abundance of OTUs stimulated by mucin treatment“-Akk+Muc” in donor 2. As a 




Synbiotics are the combination of a probiotic/live biotherapeutic and prebiotic with the 
potential advantage of the prebiotic compound increasing the survival and activity of the 
probiotic (Gibson and Roberfroid, 1995; Schrezenmeir and de Vrese, 2001). Studies 
combining Lactobacillus or Bifidobacterium species with inulin or fructooligosaccharides, 
observed a superior functionality of the synbiotic, as it was more effective at modulating the 
gut microbiota than the prebiotic or probiotic alone (Markowiak and Slizewska, 2017; Paturi 
et al., 2015; Saulnier et al., 2008). We hypothesized that the same might be true for the 
combination of biotherapeutic A. muciniphila and prebiotic-like mucin: A. muciniphila, being a 
specialist mucin degrader, would use the mucin, producing acetate and propionate and 
releasing mucin-derived oligosaccharides and thus have a greater impact on the community 
composition and functionality. For example by stimulating cross-feeding on acetate by 
butyrate producing species (Belzer et al., 2017; Chia et al., 2018) (Chapter 4). Therefore, we 
set out to investigate the ecological effect of supplementation of live A. muciniphila, the 
prebiotic-like action of mucin and the interplay between the two on complex microbial 
communities of four donors in the in vitro SHIME model.  
Mucin addition had the largest impact on the microbial community composition and 
functionality. Mucin enriched communities, without addition of exogenous A. muciniphila, 
were characterized by higher endogenous Akkermansia, Roseburia, Ruminococcus and 
Parabacteroides proportions. Similar community shifts upon mucin addition were observed in 
previous studies (Chapter 2, Chapter 3). Mucin addition resulted in significant increases in 
acetate, propionate and butyrate production (p<0.01) for all donors. This increase was 
independent of A. muciniphila addition, except for donor 2, where the butyrate increase was 
three times higher in the absence of A. muciniphila supplementation. Interestingly 
endogenous A. muciniphila, although present, did not increase upon mucin supplementation 
in this donor. In contrast with the mucin treatment, the addition of A. muciniphila hardly 
affected the community. Abundances of OTU41 (~Enterobacter) and OTU48 (~R.torques) 
decreased and no changes in SCFA production were induced by the Akkermansia treatment. 
When comparing the effect of A  muciniphila with and without mucin on community 
level, only two species were significantly increased by the combined supplementation of 
A. muciniphila and mucin: A. muciniphila for obvious reasons and a Clostridium cluster XIVa 
species (OTU32). It is not clear whether the latter would benefit from putative cross-feeding 
interactions. Ruminococcus torques, a known mucin degrader (Png et al., 2010), on the other 
hand, significantly decreased by co-administered A. muciniphila and mucin compared to the 
condition supplemented with only mucin. This suggests that co-administration of 8 log units 
of A. muciniphila gives an initial numerical advantage over other species, resulting in a more 
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efficient occupation of the mucin-degradation niche, thereby outcompeting endogenous 
community members like R. torques. In contrast, if mucin is administered alone, the 
endogenous microbiota can probably compete more efficiently with the endogenous 
A. muciniphila, eventually resulting in a bigger community change. 
These findings confirm earlier findings with a synthetic microbial community 
investigating competition for mucin degradation between A. muciniphila and B. 
thetaiotaomicron (Chapter 4). When both were added as primary degraders, at the same 
concentration on a mucin rich medium, they became equally abundant, whereas when 
A. muciniphila was added in 1.000 times higher amounts compared to B. thetaiotaomicron, 
A. muciniphila outcompeted B. thetaiotaomicron. It would be interesting to repeat this study 
with other mucin-degrading bacteria, such as Ruminococcus species. 
To conclude, our initial hypothesis, stating that joint supplementation of A. muciniphila 
and mucin more effectively induces cross-feeding to for instance butyrate compared to mucin 
alone, does not seem to hold. The highest increase in butyrate was induced by mucin at low 
A. muciniphila abundance (Donor 2). OTU32, belonging to the butyrate-producing genus 
Roseburia, was specifically increased by mucin treatment in donor 2 and to a lesser extent in 
donor 3. However, no Roseburia species have been identified to degrade mucin. Butyrate 
production would thus be the result of cross-feeding, with for example OTU48 and OTU65, 
both belonging to Ruminococcus and increased by the mucin treatment. Species like 
R. gnavus and R. torques are known mucin degraders and might thus deliver acetate and 
mucin-derived oligosaccharides to Roseburia and other butyrate producing species (Hoskins, 
1993; Hoskins et al., 1985; Marcobal et al., 2013d; Png et al., 2010). It is a possibility that 
this cross-feeding consortium prevented endogenous A. muciniphila from benefitting from the 
mucin. In support of this hypothesis, we observed that A. muciniphila abundance increased 
upon mucin treatment after disturbance of the community with antibiotics, together with 
OTU48 (~R. torques), while OTU32 (~Roseburia) and OTU65 (~Ruminococcus) did not 
recover. 
Yet the combined addition of A. muciniphila and mucin may still provide a protective 
advantage in case of an acute stress. We chose antibiotic administration as a relevant stress 
factor for the gut microbiota and the mix of amoxicillin, tetracycline and ciprofloxacin was 
previously found to display a broad antimicrobial spectrum (Marzorati et al., 2017). Antibiotic 
disruption of the microbial community ten days after the mucin and/or Akkermansia treatment 
caused a profound decrease in SCFA production, in line with results from in vivo and in vitro 
studies (Gustafsson et al., 1998; Marzorati et al., 2017; Van den Abbeele et al., 2012); yet 
the profiles of SCFA were not altered. In addition, community composition was heavily 
affected and it did not recover within the ten day recovery period. This antibiotic stress 
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abolished the functional and compositional changes induced by the different treatments. 
Thus, no protective effects from mucin and/or Akkermansia treatment were observed. 
In contrast with previous studies, A. muciniphila was not washed out of the system 
when no mucin was added to the feed during 30 days (Chapter 2, Chapter 3). Its abundance 
decreased due to the mucin deprivation in the first 10-14 days, but stabilized afterwards. 
Plovier et al. (2017) previously obtained dense A. muciniphila cultures on a mucin-free 
medium, containing peptone, glucose; N-acetylglucosamine and threonine. All compounds of 
this mucin-free medium were also present in our mucin-free SHIME feed, possibly explaining 
why A. muciniphila did not completely disappear. 
To conclude, this in vitro study with four donors revealed that the joint supplementation 
of A. muciniphila with mucin limited the prebiotic-like effect that was observed for mucin in 
inducing compositional changes. While cross-feeding on mucin has been shown for butyrate-
producing bacteria and A. muciniphila in co-culture experiments (Belzer et al., 2017) 
(Chapter 4), A. muciniphila does not seem to enhance cross-feeding in a complex microbial 
background. Addition of both mucin and A. muciniphila might lead to A. muciniphila, 
dominating the mucin degradation niche, while sole mucin addition leads to involvement of 
several species, including A. muciniphila, Ruminococcus, Clostridium cluster XIVa, and 
Lachnospiraceae. When aiming at the modulation of (mucus-associated) microbiota, 
stimulation of endogenous A. muciniphila might thus be more successful compared to its 
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6. Supplementary information 
 
Supplementary Figure 5. 1: Proportions of acetate, propionate, butyrate and branched SCFA for the 
different donors and treatments at day 20. 
 
Supplementary Table 5. 1: RDP Seqmatch and NCBI BLAST results for the most abundant and relevant 
species in the microbial communities, as determined by amplicon sequencing. The similarity score (Sab) 
as calculated by RDP, and the NCBI BLAST output for the best hit and the next best hit(s) are shown. 









OTU1 Escherichia/Shigella fergusonii 1 100 0 100 
 Escherichia/Shigella flexneri 1 100 0 100 
 Shigella sonnei 1 100 0 100 
OTU2 Clostridium bolteae 1 100 0 100 
 Clostridium clostridioforme 0,977 100 0 100 
 Clostridium citroniae 0,964 100 0 99 
OTU3 Bacteroides ovatus 0,961 100 0 99 
 Bacteroides xylanisolvens 0,891 100 0 98 
OTU4 Fusobacterium varium 0,995 100 0 100 
 Fusobacterium ulcerans 0,928 100 0 99 
OTU5 Bacteroides uniformis 1 100 0 100 
 Bacteroides rodentium 0,906 100 0 97 
OTU6 Bacteroides dorei  1 100 0 100 
 Bacteroides vulgatus 0,954 100 0 99 
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OTU7 Bilophila wadsworthia 0,973 
   
 Desulfovibrio simplex 0,701 100 9E-173 92 
OTU8 Kluyvera cryocrescens 0,983 100 0 99 
 Enterobacter aerogenes 0,947 100 0 99 
OTU9 Akkermansia muciniphila 1 100 0 100 
 Verrucomicrobium spinosum 0,567 99 3E-107 84 
OTU10 Phascolarctobacterium succinatutens 0,985 100 0 99 
 Phascolarctobacterium faecium 0,723 100 0 94 
OTU11 Bacteroides thetaiotaomicron 1 100 0 100 
 Bacteroides faecichinchillae 0,947 100 0 99 
OTU12 Fusobacterium nucleatum 0,982 100 0 99 
 Fusobacterium simiae 0,946 100 0 99 
OTU13 Cloacibacillus porcorum 0,929 100 0 99 
 Cloacibacillus evryensis 0,837 100 0 96 
OTU14 Alistipes onderdonkii 1 100 0 100 
 Alistipes shahii 0,882 100 0 97 
OTU15 Bacteroides xylanisolvens 1 100 0 100 
 Bacteroides acidifaciens 0,959 100 0 99 
OTU16 Clostridium aldenense 0,964 100 0 99 
 Clostridium saccharolyticum 0,869 100 0 98 
OTU17 Veillonella tobetsuensis 0,978 100 0 99 
 Veillonella rogosae 0,971 100 0 99 
OTU18 Veillonella atypica 0,956 100 0 99 
 Veillonella dispar 0,932 100 0 98 
OTU19 Blautia coccoides 1 100 0 100 
 Blautia schinkii  0,985 100 0 98 
OTU20 Pseudomonas aeruginosa 1 100 0 100 
 Pseudomonas otitidis  959 100 0 99 
OTU21 Parasutterella excrementihominis 1 100 0 100 
 Parasutterella secunda 0,603 100 4E-166 91 
OTU22 Parabacteroides distasonis 0,956 100 0 99 
 Parabacteroides gordonii  0,664 100 4E-171 92 
OTU23 Citrobacter freundii 1 100 0 100 
 Raoultella terrigena 0,964 100 0 99 
OTU24 Bifidobacterium adolescentis  1 100 0 100 
 Bifidobacterium faecale 1 100 0 100 
OTU25 Bacteroides cellulosilyticus  0,951 100 0 99 
 Bacteroides intestinalis 0,92 100 0 99 
OTU26 Clostridium hathewayi  1 100 0 100 
 Clostridium xylanolyticum 0,879 100 0 97 
OTU27 Dialister invisus 1 100 0 100 
 Dialister propionicifaciens 0,839 100 0 95 
OTU28 Insolitispirillum peregrinum 0,525 99 2E-127 87 
 Novispirillum itersonii 0,525 99 9E-128 87 
OTU29 Enterobacter asburiae 1 100 0 100 
 Enterobacter xiangfangensis 1 100 0 100 
OTU30 Bacteroides acidifaciens 0,889 100 0 96 
 Bacteroides thetaiotaomicron 0,843 100 0 95 
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OTU32 Clostridium hylemonae 0,896 100 0 98 
 Ruminococcus gnavus 0,83 100 0 96 
OTU34 Roseburia faecis 0,949 100 0 99 
 Eubacterium rectale 0,949 100 0 100 
OTU37 Clostridium xylanolyticum 0,849 100 0 97 
 Clostridium saccharolyticum 0,849 100 0 97 
OTU41 Enterobacter kobei 0,983 100 0 99 
 Enterobacter cloacae 0,966 100 0 99 
OTU42 Clostridium scindens 1 100 0 100 
 Clostridium hylemonae 0,843 100 0 96 
OTU43 Terrisporobacter glycolicus 0,956 100 0 99 
 Terrisporobacter mayombei 0,951 100 0 99 
OTU44 Selenomonas infelix 0,983 100 0 99 
 Selenomonas noxia 0,896 100 0 97 
OTU45 Blautia faecis 1 100 0 100 
 Blautia glucerasea 0,926 100 0 99 
OTU46 Selenomonas infelix 0,923 100 0 98 
 Selenomonas noxia 0,897 100 0 97 
OTU48 Ruminococcus torques  0,98 100 0 99 
 Ruminococcus faecis 0,89 100 0 98 
OTU53 Stenotrophomonas maltophilia 0,978 100 0 98 
 Stenotrophomonas pavanii  0,894 100 0 98 
OTU60 Murimonas intestini  1 100 0 100 
 Ruminococcus lactaris  0,877 100 0 97 
OTU65 Ruminococcus torques 0,87 100 0 96 
 Ruminococcus lactaris 0,826 100 0 97 
OTU78 Clostridium colinum 0,83 100 0 96 
 Eubacterium ventriosum 0,638 100 2E-149 90 
OTU100 Lactonifactor longoviformis 0,811 100 0 96 
 Roseburia intestinalis  0,749 100 4E-176 94 
OTU119 Anaerofilum pentosovorans 0,861 100 0 97 
 Anaerofilum agile  0,843 100 0 97 
OTU130 Clostridium lactatifermentans 0,741 100 3E-167 93 
 Clostridium propionicum 0,723 100 6E-179 95 
 
Supplementary Table 5. 2: Partial distance based redundancy analysis. The contribution of the different 
factors, and significance level, to the variation in species level community composition. 
 % variance explained p-value 
Donor 14% 0.041 
Treatment 20% 0.346 
Mucin 8% 0.197 





Supplementary Figure 5. 2: Optimal sPLS-DA model, as determined by fivefold cross-validation, retaining 
the species most predictive of the different treatments (+Akk+Muc; +Akk-Muc; -Akk+Muc; -Akk-Muc). 
 
 
Supplementary Figure 5. 3:qPCR analysis of 16S rRNA gene showing the response of the total acterial 
counts to the antibiotic pulse for the different donors and treatments. 
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Supplementary Figure 5. 4: Volcano plot showing results from the DESeq2 analysis showing the 
significantly (p<0.01) affected genera by antibiotic disturbance for each treatment (AM=+Akk+Muc;     
aM=-Akk+Muc; Am=+Akk-Muc; am=-Akk-Muc). Green and red dots show OTUs more abundant before and 
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Supplementary Figure 5. 5: Alpha-diversity, measured by Shannon coefficient, over time (Days) for the 





Supplementary Figure 5.6: Volcano plot showing results from the DESeq2 analysis comparing treatments 
“ –Akk+Muc” and “-Akk-Muc”. Green and red dots show OTUs more abundant in “-Akk+Muc”, 
respectively, “- Akk- Muc” and the size indicates the relative abundance of the OTU in the community. 
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Supplementary Figure 5. 7: Volcano plot showing results from DESeq2 analysis between treatments 
“ + Akk+Muc” and “+Akk-Muc”. Green dot show OTUs more abundant in “+Akk+Muc”, red dots for 
“+ Akk- Muc” and the size indicates relative abundance of the OTU in the community. 
 
Supplementary Figure 5. 8: Volcano plot showing results from DESeq2 analysis between treatments 
“ + Akk-Muc” and “-Akk-Muc”. Green dot show OTUs more abundant in “+Akk-Muc”, red dots for “- Akk-




Supplementary Figure 5. 9: Volcano plot showing results from DESeq2 analysis between treatments 
“ + Akk+Muc” and “-Akk+Muc”. Green dot show OTUs more abundant in “+Akk+Muc”, red dots for “-
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The colonic mucus layer, a viscous gel matrix made up of mucin glycoproteins, 
separates the gut lumen from the epithelial cells and provides the interface for host-microbe 
interactions. The presence and the activity of mucin degrading consortia in the mucus layer, 
close to the host cells, induces host response and may play a relevant role on gut health. 
The aim of this study was to evaluate  the differential effects in vitro of the gut microbiota 
modulation by mucin and/or A. muciniphila on the epithelial barrier function and immune 
response. Fecal microbial communities from three healthy donors were stabilized in the 
simulator of the human intestinal microbial ecosystem (SHIME) and the microbial 
communities were shaped through supplementation of A. muciniphila as live biotherapeutic 
or by introduction of mucin, representing a host glycan degradation niche. The effect of 
filtered-sterilized SHIME supernatants on intestinal barrier and cytokine (IL-6 and TNF-α) 
production was evaluated in a co-culture model of Caco-2 cells with differentiated 
macrophage-like THP-1 cells using a bi-compartmental system. Mucin and Akkermansia-
modulated communities induced the most beneficial response by increasing the trans-
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1. Introduction 
The human colon hosts a complex and diverse microbial community that is able to 
impact host health through intricate host-microbe interactions, which have to be carefully 
regulated to maintain homeostasis (Backhed et al., 2012). The mucus layer is a viscous gel 
matrix made up of mucin glycoproteins that separates the gut lumen from the epithelial cells 
and thus provides the interface between the host and the gut microbiota. Besides acting as a 
barrier, the mucus layer, and specifically the mucin glycans, also serves as a growth 
substrate for colonic bacteria, an aspect that has gained more attention recently (De Weirdt 
and Van de Wiele, 2015). It has recently been established that mucin degradation, which 
was previously thought of as detrimental for gut health,  is part of a normal turn-over process 
(Norin et al., 1985). Due to the complexity of the mucin structure and the variation in 
glycosylation, a wide variety of specific enzymes are required for its degradation, and as a 
consequence few bacteria possess the enzymatic capacity to grow on mucins (Marcobal et 
al., 2013a; Marcobal et al., 2013d; Martens et al., 2008; Png et al., 2010; Tailford et al., 
2015a). Degradation of mucins leads to the release of less complex carbohydrates and the 
production of metabolites like acetate, lactate, and propionate, which can be used by other 
bacteria to produce butyrate or other end products (Belzer and de Vos, 2012). The presence 
and the activity of mucin degrading consortia in the mucus layer, close to the host cells, is a 
key element in the host-microbiome crosstalk affecting gut health in a positive or detrimental 
way.  
Akkermansia muciniphila is regarded as a mucin degrading specialist as it can use up 
to 85% of the total mucin structure and has a an entire repertoire of intra-and extracellular 
enzymes involved in this process with both extracellular and intracellular activity (Derrien, 
2007). A study of its genome revealed 61 proteins predicted to be involved in mucin 
degradation (11% of all proteins) and its high mucin-degrading capacity was shown in an in 
vivo mice study (Berry et al., 2013; van Passel et al., 2011). Metabolic activity of 
A. muciniphila on mucins can stimulate microbial metabolic interactions and induce a host 
response (Belzer et al., 2017; Chia et al., 2018; Derrien et al., 2004; Reunanen et al., 2015). 
Recently, A. muciniphila has been proposed as a key bacterial modulator in the cross-talk 
between host and gut microbiota, in which a specific outer membrane protein (Amuc_1100) 
played an important role. A. muciniphila and Amuc_1100 induced both anti-and pro-
inflammatory cytokine response in human derived peripheral blood mononuclear cells and 
both increased epithelial cell-layer integrity of Caco-2 monolayer (Ottman et al., 2017d), 
indicating a complex immunomodulatory role, affecting the dialogue with the host. The 
improvement of epithelial barrier function by A. muciniphila has been shown in several in vivo 
mice studies (Everard et al., 2013; Li et al., 2016; Shin et al., 2014), including a study with 
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obese mice showing that genes encoding tight junction proteins were affected by treatment 
with A. muciniphila and Amuc_1100, possibly through TLR2 activation (Plovier et al., 2017).  
The epithelial barrier is constituted by intestinal epithelial cells that are firmly attached 
to each other by tight junctions and regulate translocation to underlying immune effector cells 
(Groschwitz and Hogan, 2009). Decreased epithelial barrier functioning can increase gut 
permeability which leads to low grade inflammation and is observed for a variety of human 
diseases such as IBD, diabetes and obesity (Bischoff et al., 2014). The commensal bacteria 
can regulate epithelial barrier function, by releasing metabolites such as acetate and butyrate 
or by inducing the release of cytokines which can reduce (TNAα, IFNγ) and enhance (IL-10) 
barrier function (Arrieta et al., 2006; Fukuda et al., 2011; Hamer et al., 2008). Modulation of 
the microbiota, by pre-or probiotics, may thus provide therapeutic options for maintaining 
epithelial barrier functioning and gut homeostasis. 
The aim of this study was to assess the in vitro effect of gut microbiota  modulation by 
supplementation of live A. muciniphila and/or introduction of a mucin niche on the epithelial 
barrier function and immune response. A combination of the simulator of the human intestinal 
microbial ecosystem (SHIME) with a co-culture of enterocyte-like (Caco-2) and macrophage-
like (THP-1) showed that microbial communities modulated by mucin and A. muciniphila had 
a significant impact on gut barrier function and immune response. 
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2. Materials and methods 
2.1 Cell cultures 
2.1.1 Caco-2 cells 
Caco-2 is the most widely used immortalized cell line for developing human GI tract in 
in vitro models. This cell line spontaneously differentiates into polarized cells with distinct 
mucosal (apical) and serosal (basolateral) cell membrane domains, brush border enzymes 
and polarized expression of transporters (Artursson et al., 2012). The Caco-2 cells were 
obtained from the European Collection of Authenticated Cell Cultures (Caco-2 ECACC 
86010202, Public Health England, UK). Cell maintenance was carried out in 25 cm2 flasks to 
which 4 mL of Dulbecco’s Modified Eagle Medium (DMEM) with high glucose (4.5 g L-1) and 
GlutaMAX™ (Gibco, Langley, OK, USA) was added. The DMEM was supplemented with: 
10% (v/v) heat-inactivated fetal bovine serum (FBS) (FBS, Greiner Bio-One, Wemmel, 
Belgium), 1% non-essential amino acids and 2% penicillin/streptomycin (Life Technologies, 
Merelbeke, Belgium) to obtain complete cell growth medium (DMEMc). Medium was 
refreshed every two days and cells were subcultured when they reached 70-80% confluence. 
Briefly, Caco-2 cells were detached with a pre-wash with 10 mL of PBS without calcium and 
magnesium (PBS, Gibco, Langley, OK, USA), trypsinized for 5-8 min with 1 mL of trypsin 
solution (2.5 g L-1) and EDTA (0.2 g L-1) (Gibco, Langley, OK, USA) and neutralized by the 
addition of supplemented medium, followed by reseeding at a density of 5 x 104 cells cm-². 
The cells were incubated at 37°C in an atmosphere with 95% relative humidity and a CO2 
flow of 10%. All the cell cultures were used between passages 43 and 47. 
2.1.2 THP-1 cells 
The THP-1 cells were obtained from the European Collection of Authenticated Cell 
Cultures (THP-1 ECACC 88081201). Cell maintenance was carried out in 75 cm2 flasks 
containing 20 mL of Roswell Park Memorial Institute (RPMI) 1640 medium, supplemented 
with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (FBS, Greiner Bio-One, Wemmel, 
Belgium), 1% sodium pyruvate, and 2% penicillin/streptomycin (Life Technologies, 
Merelbeke, Belgium). Medium was refreshed every two days and cells were subcultured after 
reaching 1 x 106 cells mL-1. Briefly, THP-1 cells were centrifuged (1000 rpm; 5 min), 
suspended in 5 mL of media and diluted 1/5 in a new cell culture flask. The cells were 
incubated at 37°C in an atmosphere with 95% relative humidity and a CO2 flow of 10%. All 
the cell cultures were used between the passage 71 and 73.  




2.1.3 Co-culture in Transwell plates 
Caco-2 cell differentiation and the posterior tests were carried out in double chamber 
wells (Corning® HTS Transwell®-24 well, pore size 0.4 µm; Costar, NY) equipped with 
separate apical and basolateral compartments and a porous support on which the Caco-2 
cells form a monolayer. The Caco-2 cells were seeded at a density of 7.5 x 104 cells cm-² on 
top of the semipermeable filter and maintained with DMEMc without antibiotic/antifungal 
solution, until differentiation (15 days). Refreshments of the apical and basal media were 
done every 2 days.  
At day 16 post-seeding, THP-1 cells were added to the basal compartment of the 
Transwells in a density of 1x105 cells cm-2 in RPMI 1640 media without antibiotic/antifungal 
solution, and maintained in co-culture for 24 hours. Subsequently, the THP-1 were 
differentiated to macrophages by adding phorbol 12-myristate 12-acetate (PMA) (25 nM) 
(Sigma, Belgium) for two days. Thereafter, the cells were refreshed and maintained 24 hours 
in absence of PMA. Then, SHIME supernatants were added to the apical compartment (1.5 
mL), simultaneously to LPS (10 ng mL-1). As control conditions, also cell culture medium was 
added to the co-culture, with and without LPS. All conditions were tested in triplicate and the 
exposure lasted 24 hours. 
 
2.2 SHIME supernatant 
The dynamic in vitro SHIME® model (ProDigest-Ghent University, Ghent, Belgium) 
was used to study the impact of a probiotic treatment of A. muciniphila, with or without the 
presence of a host glycan degradation niche, in four microbial communities from healthy 
donors. The set-up is described in detail in Chapter 4. Briefly, fecal suspension of four 
donors was used to inoculate the colon vessels (4 colon vessels/donor). During the 
stabilization period (day 0-10), a mucin-free nutritional medium was delivered to the colon 
vessels. From day 10-20 onwards (treatment period), 4 different treatments were applied: 
“+Akk+Muc” where A. muciniphila was daily administered to the colon vessels and mucin 
was added to the feed; “+Akk-Muc” where only A. muciniphila was added to the colon 
vessels; “-Akk+Muc” where only mucin was added to the feed; and “-Akk-Muc”, which was 
not different from the stabilization period where neither A. muciniphila nor mucin were added. 
At the end of the treatment period, samples were taken from the established communities 
from donors 1,2 and 4 (further mentioned as donors A, B, C) to use for co-culture 
experiments with Caco-2 and THP-1 cells. These three donors were selected for following 
reasons: the experiment with inoculum from donor 2 showed an interesting reaction of 
Akkermansia muciniphila and butyrate/propionate to the mucin supplementation (Chapter 5); 
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donor 4 was most dissimilar from the other donors with respect to his microbiome 
composition (Supplementary figure 6.3); and the experiment with inoculum from donor 1 had 
the most expected response in Akkermansia abundance: delayed response to mucin 
treatment, but after 10 days of treatment reaching equal levels as after mucin+Akkermansia 
treatment (Chapter 5).  
Samples were centrifuged for 10 min. at 1500g, the supernatant was collected and 
filter-sterilized over a 0.22 µm PVDF syringe filter (Merck Millipore, Darmstadt, Germany) and 
immediately stored at -80°C in 1 mL aliquots. 
 
2.3 Analysis 
2.3.1 Measurements of epithelial barrier function: transepithelial electrical 
resistance (TEER) and apparent permeability coefficient (Papp) of paracellular 
marker 
The monolayer integrity was assessed by measuring the transepithelial electrical 
resistance (TEER) and the apparent permeability coefficient (Papp) of the paracellular 
transport marker lucifer yellow (LY, Sigma-Aldrich, Belgium). A Millicel-ERS (Millipore 
Corporation, Belgium) was used for the TEER measurements. Measurements of the TEER 
were performed every 3-4 days after Caco-2 seeding. In addition, TEER was measured at 
day 15 post- seeding, at the moment of co-culturing with THP-1 cells, after THP-1 
differentiation, before supernatant addition, and at the end of the assay. TEER values were 
expressed as increase/decrease of TEER values at the end of the assay (24h) relative to the 




Papp of LY, which is mainly transported via the paracellular route, was used to assess 
the integrity of the epithelial cell monolayer. Papp of LY was measured by adding the marker 
(100 µM) to the apical compartment of the wells. After 15, 30, 60 and 120 min, 100 µL of 
medium was removed from the basolateral compartment and replaced with an equal volume 
of fresh medium (DMEM high glucose supplemented with 20% FBS). LY fluorescence was 
measured at an excitation/emission wavelength of 485/520 nm in black 96 plates (Greiner), 
using a microplate fluorescence reader (Spectramax Gemini XS Microplate Reader, 
Molecular devices, Orleans, CA). A calibration curve (0, 5, 10, 25, 50 and 100 µM) for LY 
quantification was included in duplicate in each reading. The Papp was calculated as 
previously described (Calatayud et al., 2010).  
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2.3.2 Western blot analysis 
Cells were lysed in radio-immunoprecipitation assay (RIPA) buffer supplemented with 
phosphatase and a protease inhibitor cocktail (Sigma-Aldrich). The concentrations of protein 
lysates were determined (Bio-Rad Laboratories), and 30 µg of each sample was separated 
on a 4-20% Criterion Stain Free gradient gel (Bio-Rad Laboratories). Next, the gel was 
activated by UV exposure for 1 min using the Chemidoc MP Imaging system (Bio-Rad 
Laboratories), and proteins were transferred to a nitrocellulose membrane (Bio-Rad 
Laboratories). Membranes were blocked with 5% skim milk in Tris buffered saline with 0.1% 
Tween-20 (TBST) (Sigma-Aldrich) and incubated overnight at 4°C with primary antibodies 
(1/1000 dilution) in 5% BSA/TBST [anti-ZO-1 (Cell Signaling), anti-E-cadherin (Cell 
Signaling) or anti-occludin (Abcam)]. Next, blots were incubated for 1 hour at room 
temperature with horseradish peroxidase-conjugated secondary antibodies (1/10 000 
dilution, Cell Signaling). Bands were visualized using chemiluminescence (Bio-Rad 
Laboratories) and imaged on a Chemidoc MP Imager. 
2.3.3 Cytokine quantification 
Protein levels of IL6 and TNFα in the supernatant were determined using Luminex 
technology according to the manufacturer’s guidelines (Bio-Rad Laboratories). 
2.4 Statistical analysis 
Statistically significant differences were determined by Pairwise Wilcoxon Rank Sum 
Tests with Holm correction (α=0.05). 
Donor and treatment were explored as explanatory variables in a partial redundancy 
analysis, with as response variables the epithelial barrier function parameters (TEER and 
Papp of LY), inflammatory markers (IL-6 and TNFα) and SCFA concentration in the 
supernatant (to which the co-culture model was exposed) (package vegan_2.4-4). The 
statistical significance of the global model and the individual canonical axes was assessed 
using Permutation tests (Legendre et al., 2011). The RDA results were plotted in a type II 
scaling correlation triplot, displaying the constrained canonical (labelled RDA1/2) axes, 
annotated with the proportional eigenvalues representing their contribution to the total 
variance. The coordinates of the sites were derived from the weighed sums of the scores of 
the response variables and explanatory variables are represented by centroids denoting the 
donor or treatment factor levels. 
In order to relate the microbiome composition to the functional response, sparse partial 
least squares regression was performed (mixOmics_6.3.1) (Le Cao et al., 2016). A smart 
feature selection procedure was applied to identify genera associated with the cell response. 
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The initial model was built in regression mode with the TEER, LY, TNFα and IL-6 values as 
response (Y) variables as a function of the proportional microbial community composition at 
genus level (X). 2 Dimensions and 50 X variables were selected after tuning based on a 
Leave One Out (LOO) validation (Le Cao et al., 2016; Le Cao et al., 2008). Results were 






Characteristics of the SHIME supernatants amended or not with A. muciniphila and/or 
mucin are shown in Supplementary Figure 6.1-6.3. These supernatants were used to study 
whether the different amendments would affect the epithelial cells and elicit a response from 
immune cells (Figure 6.1). The epithelial barrier function was evaluated by measuring 
TEER and Papp of LY, and the inflammatory response was measured by quantifying IL-6 
and TNF-α in apical and basal compartments. LPS was administered as a stressor to the 
differentiated Caco-2 cells to enhance the effect of the applied treatments. LPS 
administration, without SHIME supernatant, did not affect TEER values, but significantly 
increased the Papp of LY (~380%, p < 0.05) and induced the production of IL-6 and TNFα 
production in both apical and basal compartments (Supplementary Figure 6.4).  
 
Figure 6. 1: Experimental set-up of the co-culture experiment with Caco-2 and THP-1 cells that were 
exposed to SHIME supernatant (in triplicate), previously modulated by different treatments. 
 
The SHIME supernatants were derived from microbial communities with different donor 
origin, and this inter-individual variability impacted the cellular response. The ∆TEER in cells 
exposed to SHIME supernatants without any amendment (“-Akk-Muc” : controls) was similar 
and close to 0 in donors B and C. Cells exposed to control supernatant from donor A were 
characterized by decreased TEER values after 24h (Figure 6.2). Papp of LY also showed 
interindividual variability, with Papp values around 10-5 cm s-1 in donor C and lower LY Papp 
values in donor A and B (donor C > donor B > donor A (~4 x 10-6 cm s-1). Despite the donor-
related differences, epithelial barrier parameters also responded to the treatments. 
Supernatant from microbial community amended with mucin (from donor A and C) caused a 
significantly (p < 0.05) higher increase in TEER value compared to the supernatants without 
mucin. For donor A, TEER increase was higher with the addition of A. muciniphila, and for 
donor C it was higher without A .muciniphila. Supernatant from amended microbial 
communities of donor B caused no significant change in TEER value. Interestingly, the 
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response of the Papp of LY, also a parameter for epithelial barrier function, showed a 
consistent trend for the three donors. Contrary to the TEER values, which responded more to 
mucin-amended samples than to A. muciniphila treatment, the Papp of LY was significantly 
(p < 0.05) reduced by A. muciniphila-amended supernatants, independent from mucin 
presence (Figure 6.2). Papp values of LY from cells exposed to cell culture media (control) 
were 1.2 x 10-7  cm s-1 (Supplementary Figure 6.4).  
 
 
Figure 6. 2: Epithelial barrier function in the co-culture model with Caco-2 and THP-1 cells exposed (24h) 
to SHIME supernatant samples (3 donors A-C), amended with A. muciniphila (+Akk-Muc), mucin (-
Akk+Muc), both (+Akk+Muc) or untreated (-Akk-Muc) (n=3). Statistically significant differences between 
treatments (α=0.05) are denoted by the letters a, b and c. Identical letters indicate no significant 
differences (p>0.05). The trans-epithelial electrical resistance (TEER) is expressed as the proportional 
change in TEER values after 24h exposure (%); Apparent permeability coefficient (Papp) of LY is 
expressed in cm/sec. 
 
Next, the tight junction proteins (ZO-1, E-cadherin, and occludin) of the Caco-2 cells 
exposed to supernatants from donors A and C were qualitatively assessed by western blot 
(Figure 6.3). Donors A and C were selected because they induced the largest response in 
TEER and Papp of LY. The response of the tight junction proteins was variable between the 
donors.  
Samples exposed to supernatant from donor A did not show differences in protein 
expression between treatments, or between treatments and control cells exposed to cell 
culture media. By contracts, an apparent reduced protein expression of ZO-1, E-cadherin 
and increased occludin expression was observed for the cells exposed to SHIME 
supernatant from donor C without amendment (-Akk-Muc) compared to the control. The 
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presence of mucin, A. muciniphila or both induced an apparent increase in E-cadherin 
expression, while occludin was apparently reduced in -Akk+Muc condition, when compared 
to the non-amended samples (-Akk-Muc). 
 
 
Figure 6. 3: Expression of tight junction (TJ) proteins : Zonula occludens-1 (ZO-1), E-Cadherin and 
Occludin in the Caco-2 cells assessed by Western blotting. Co-culture model with Caco-2 and THP-1 cells 
was exposed (24h) to SHIME supernatant samples, amended with A. muciniphila (+Akk-Muc), mucin (-
Akk+Muc), both (+Akk+Muc) or not treated (-Akk-Muc). Control condition is referred to the Caco-2 cells 
exposed to cell culture media (DMEMc). 
 
The inflammatory response of the Caco-2 and THP-1 cells was evaluated by 
measuring IL-6 and TNFα production in both the apical and the basal part of the co-culture 
model (Figure 6.4). The inter-individual variability induced no specific trends, but one outlier 
was observed in the apical part: supernatant from the microbial community of donor A 
without amendment increased IL-6 threefold and TNFα fourfold, while other supernatant 
evoked a more moderate response. For donor C, IL-6 production was significantly decreased 
(~65%, p < 0.05) when cells were exposed to mucin-amended supernatants compared to 
conditions without mucin. For donor B, this trend was only observed in cells exposed to 
supernatant of the mucin treatment without A. muciniphila. TNFα production was significantly 
higher when exposed to supernatant of mucin with A. muciniphila treatment from donor B, 
but otherwise there were no difference in response to treatments. Concentration of IL-6 in the 
basal part was significantly higher when treated with supernatant without mucin, independent 
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of A. muciniphila treatment, from donors B and C, but for donor A there seemed to be an 
additional effect of A. muciniphila treatment. TNFα was only significantly reduced (~80%. p < 
0.05) in cells exposed to mucin-amendment supernatants from donor C (Figure 6.4). 
 
Figure 6. 4: Inflammatory response in the co-culture model with Caco-2 and THP-1 cells exposed (24h) to 
SHIME supernatant samples (3 donors A-C), amended with A. muciniphila (+Akk-Muc), mucin (-Akk+Muc), 
both (+Akk+Muc) or not treated (-Akk-Muc). Statistically significant differences between treatments 
(α=0.05) are denoted by the letters a, b and c. Identical letters indicate no statistical differences (p>0.05). 
Cytokines IL-6 and TNFα in both apical and basal part: relative to concentration produced in control (cells 




Figure 6. 5: Redundancy analysis (RDA) with donor and treatment explored as explanatory variables and 
the epithelial barrier function parameters (TEER and Papp of LY), inflammatory response (IL-6 and TNFα) 
and SCFA concentration (to which the co-culture model was exposed) as response variables. 
 
Besides a donor-dependent effect, redundancy analysis revealed a clear treatment 
effect on the epithelial barrier function and the inflammatory response, as observed from the 
treatment based grouping of samples (Figure 6.5). Treatment had a higher impact than inter-
individual variability on the cellular response. The different grouping is mainly based on the 
presence or absence of a mucin degradation niche. Mucin increased microbial SCFA 
production and induced higher TEER values. In the absence of mucin, TNFα and IL-6 
production was stimulated to a higher extent. A. muciniphila treatment had less impact on the 
cellular response, but was associated with lower paracellular transport of LY. Sparse partial 
least squares regression analysis, visualized as a correlation heatmap (Figure 6.6), 
correlates the cellular response with the relative abundance of the most predictive genera in 
the SHIME samples, from which the supernatants were derived. Higher pro-inflammatory 
cytokine production (TNFa and IL6) was correlated with an increased abundance of some 
genera known to include opportunistic pathogens, such as Escherichia/Shigella and 
Klebsiella but also with Bifidobacterium and Anaerostipes. Genera correlated with better 
epithelial barrier functioning include Lactonifactor (~Papp), Bacteroides and Anaerofilum 
Impact of SHIME supernatant on epithelial barrier and immune response  
169 
(~TEER) and members of the Ruminococcaceae (~TEER), Alphaproteobacteria and 
Clostridiales (~Papp). Some genera were correlated with both TEER and Papp like 





Figure 6. 6: Heatmap visualizing the correlation between the response variables (TNFα, IL6, Papp-1 and 
TEER) and the 50 most predictive genera as determined by sparse partial least squares regression 
analysis (the inverse of the Papp values was used to calculate the correlations with Papp of LY. A higher 






Supernatant from SHIME microbial communities treated with A. muciniphila and /or 
mucin induced a response of the co-culture model of epithelial cells and macrophages that 
was dependent on treatment and maintained some of the inter-donor variability. Both mucin 
and A. muciniphila treatment strengthened the epithelial barrier but displayed differential 
effects on TEER and Papp of LY, two common measures for epithelial barrier functioning. 
Supernatant from microbiota treated with mucin increased TEER, except from donor B, but 
did not impact paracellular permeability, which was decreased by supernatant from 
A. muciniphila treatment, independent from mucin presence. The samples from mucin 
treatment were characterized by a higher concentration of acetate, propionate, and butyrate 
compared to the samples of treatment without mucin (Supplementary Figure 6.1). The effect 
of short chain fatty acids, especially butyrate, on epithelial barrier function is well studied in 
both in vitro and in vivo studies (Mariadason et al., 1997; Ploger et al., 2012), showing that 
butyrate, propionate and acetate increased barrier integrity, in a dose dependent manner. At 
concentrations similar to those of our mucin treatment samples (1.5-2 mM), butyrate 
increased TEER, decreased paracellular permeability of LY, promoted expression of tight 
junction proteins and increased the relocation of ZO-1 and occludin which resulted in an 
increased barrier integrity of Caco-2 monolayer (Mariadason et al., 1997; Peng et al., 2007; 
Peng et al., 2009). This explains the observed increase in TEER after exposure of Caco-2 
cells to the supernatants of microbiota treated with mucin from donors A and C, but fails to 
explain why these changes were not observed with samples from donor B, having a similar 
SCFA profile. This deviating response is likely due to other bacterial metabolites, such as N-
acyl amides, which also affect the host cells (Ray, 2017). 
The supernatant from mucin treatment induced no response in paracellular 
permeability of LY but the permeability was decreased by supernatant of microbiota treated 
with A. muciniphila. The tight junctions are composed by, at least, two functional pathways: 
1) high-capacity and charge selective pore pathways allowing passage of non-charged, small 
ions; 2) low-capacity leak pathway allowing the flux of larger ions and molecules, 
independently of their charge (Keita and Soderholm, 2012; Shen et al., 2011; Ulluwishewa et 
al., 2011). It is possible that mucin, A. muciniphila or combination of both alters the 
paracellular flux of the co-culture model in a different way. The field of host-microbe 
interaction is still developing and there is not yet clear answer for this finding. Most of the 
permeability and drug transport assays have been performed using well defined media 
composition, but in this study the supernatant of complex microbial communities were used. 
The incorporation of  complex and more realistic matrices when studying host-microbe 
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interactions can improve our understanding of pathophysiological processes occurring in the 
gut and can change our understanding of routine tests of intestinal permeability. 
A. muciniphila has been described to improve epithelial barrier in many studies, both in 
vitro as well as in vivo. Mice studies showed that increased abundance of A. muciniphila, by 
prebiotic (polyphenols or oligofructose) or probiotic treatment, improved gut barrier function 
by increasing the expression of tight junction proteins ZO-1 and occludin, by increasing 
mucus thickness, and impacting GLP-2 secretion from L-cells (Everard et al., 2013; Everard 
et al., 2011; Li et al., 2016; Roopchand et al., 2015). In vitro cell culture studies described 
that exposing differentiated Caco-2 monolayers to A. muciniphila or its supernatant improved 
the enterocyte monolayer integrity, as measured by TEER (Ottman et al., 2017d; Reunanen 
et al., 2015). These protective effects of A. muciniphila have been attributed to a highly 
abundant outer membrane protein, Amuc_1100, which may have been liberated and could 
be present in our supernatant (Ottman et al., 2017d; Plovier et al., 2017). The changes in 
paracellular permeability in this research were observed for supernatant of microbiota to 
which A. muciniphila was added (+Akk+Muc, +Akk-Muc ). However endogenous 
A. muciniphila increased to similar levels upon treatment with mucin (-Akk+Muc), questioning 
the role of A. muciniphila (Supplementary Figure 6.2 and 6.3). This might be an indication of 
a different host response to endogenous and externally added A. muciniphila. However, this 
was not indicated in mice studies where endogenous A. muciniphila was first increased 
through prebiotic treatment and in a second study externally added (Everard et al., 2013; 
Everard et al., 2011).  
The selection of the cell lines used in this research was based on previous literature. 
Caco-2 cells spontaneously differentiate into an enterocyte-like phenotype and display a 
good functional correlation to human intestinal tissue (Rubas et al., 1996; Rubas et al., 
1993). It is the standard model for studying epithelial barrier function since these cells 
develop functional tight junction complexes in a higher degree compared to other monolayer 
of cell lines (e.g. HT29-MTX) (Geirnaert et al., 2017; Lea, 2015). The differentiation of Caco-
2 cells induce a small intestine-like phenotype, but the colon origin is still retained in the cells, 
as demonstrated by high TEER values (up to 1500 Ω cm-2) (Artursson et al., 2012; Artursson 
et al., 1993). Recent research has showed that the T84 cell line could be a better model to 
resemble the colonocyte phenotype (Devriese et al., 2017), however it Is less characterized 
than the Caco-2 cells. 
The co-culture of Caco-2 with PMA-differentiated THP-1 cells (macrophage-like) offers 
the possibility to study the exposure effect on health status and pro-or anti-inflammatory 
responses of the epithelium (Kampfer et al., 2017; Kanzato et al., 2001). Supernatant from 
microbiota treated with mucin was more successful at reducing the inflammatory response 
(TNF-α and IL-6) caused by LPS applied to the apical part. This might be due to their higher 
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SCFA concentrations, as mentioned above, since butyrate has been shown to reduce 
production of pro-inflammatory mediators, such as TNF-α and IL-6, by macrophages (Fukae 
et al., 2005; Saemann et al., 2000; Vinolo et al., 2011). It may also be an indirect effect as 
these samples increased the TEER and thus strengthened the epithelial barriers such that 
the THP-1 cells were less exposed to the LPS or other pro-inflammatory antigens in the 
supernatant. Supernatant from untreated microbiota (-Akk-Muc) from donor A induced a 
specific decrease in TEER and an increase in paracellular permeability, indicating an 
impaired epithelial barrier which may have led to the three- and fourfold increase in the pro-
inflammatory cytokines IL-6, respectively, TNF-α compared to the control). This increase was 
undone by A. muciniphila supplementation, which is surprising given the finding that 
A. muciniphila supernatant exposure resulted in higher IL-10 and TNF-α production 
compared to supernatant from F. prausnitzii and L. plantarum in a study measuring cytokine 
production in human derived peripheral blood mononuclear cells (PBMCs) (Ottman et al., 
2017d). The latter study, however, was limited to pure cultures, while supernatants in our 
experiment originated from a complex microbial SHIME community, which is more 
representative of the complex colonic environment  
Despite the limitation of immortalized cell lines for in vitro modelling, the use of well 
characterized and stable cell lines also offers advantages as repeatability, reproducibility, 
and low cost. Our results suggest that further tests using more representative models of the 
human colonic epithelium, such as cell lines originated from normal tissues or organoids are 
desirable.  
To conclude, the goal of this experiment was to evaluate whether modulation of 
complex microbial communities by the biotherapeutic treatment with A. muciniphila, prebiotic-
like mucin or the combination of  A. muciniphila with mucin, would differentially impact gut 
barrier function and immune response. Thereby, our set-up differs from most  in vitro studies 
applying probiotic candidates (culture supernatant of) the pure culture probiotic candidate to 
epithelial cells (Ohland and Macnaughton, 2010). By using the complex microbial 
supernatant to treat the co-culture model more realistic treatments effects including microbe-
microbe interactions are considered. This experiment showed that treatments applied to a 
SHIME system, inoculated with microbiota from different donors, resulted in microbial 
communities whose supernatant could differentially impact the intestinal epithelial barrier and 
the underlying immune cells, hence preserving inter-individual differences. The supernatant 
of the treatment with both mucin and A. muciniphila induced the most beneficial response, 
with the mucin responsible for increased trans-epithelial resistance (TEER) and reduced 
TNF-α and IL-6 production, and A. muciniphila responsible for decreased epithelial 
permeability. 
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6. Supplementary information 
 
Supplementary Figure 6. 1: Short chain fatty acids concentration (mM) applied to the co-culture cell-
model in the amended supernatants.  
 
Supplementary Figure 6. 2: Relative abundance of A. muciniphila in the microbial communities from the 
different donors after treatment. 
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Supplementary Figure 6. 3: Relative abundance of the 13 most abundant genera in the microbial 
communities from the different donors after treatment. 
 
 
Supplementary Figure 6. 4: Effect of cell culture medium without (grey) and with (black) LPS on the co-
















1. Positioning of the research and main results 
The notion that our gut microbiota correlates with and even impacts our health has 
inspired many researchers to investigate, unravel, and understand the complex microbial 
community and its interaction with the human host. Research into identification of biomarkers 
for gut health and ways to modulate the microbiota composition and activity to improve 
health, has put A. muciniphila in the spotlight. Its abundance is decreased in patients 
suffering from IBD, obesity, diabetes and autism, but it occurs in high abundance and with 
high prevalence in healthy people. Studies with high-fat diet fed mice showed that treatment 
with A. muciniphila reversed metabolic endotoxemia and had preventive effects on obesity 
and diabetes development. As a mucin degrader, A. muciniphila colonizes an interesting but 
not-fully described niche, being host-glycan degradation. Given the diversity and complexity 
of host glycan structures, strategies for degradation to free sugars rely on the action of a 
panel of enzymes, produced by only 1% of the microbial community. The release of 
oligosaccharides and fermentation products during mucin degradation can be used by other 
bacteria, thereby expanding the host glycan degradation niche. The ability of these 
microorganisms to profit both directly and indirectly from endogenous glycans can facilitate 
their close location to the host epithelium. The presence and the activity of mucin degrading 
consortia in the mucus layer, close to the host cells, is a key element in the host-microbiome 
crosstalk affecting gut health in a positive or detrimental way. Plenty of research concerning 
A. muciniphila has been done, but little is known about its behavior in the complex microbial 
ecosystem in the colon, about the potential role of mucins to influence A. muciniphila 
behavior and the impact of its probiotic administration on the microbial ecosystem and the 
host (Figure 7.1).  
To gain more insight into the role of A. muciniphila in host glycan degradation and 
the importance of this niche for the microbial ecosystem and for gut health, several in 
vitro models were used (Figure 7.1): the SHIME system in chapters 2,3 and 5 to study 
A. muciniphila and host glycans in different complex microbial communities, a fed-batch 
system with a synthetic microbial community in chapter 4 to examine bacterial interactions in 
different nutritional environments and a co-culture cell model with epithelial cells and 
macrophages in chapter 6 to study the effect of A. muciniphila and host glycan treated 
communities on epithelial barrier function and pro-or anti-inflammatory responses. 
The SHIME experiment in Chapter 2, inoculated with a fecal sample from a donor with 
high A. muciniphila abundance, revealed that A. muciniphila preferentially colonized the 




distal colon and that this preference was due to pH, which is more neutral compared to the 
proximal colon. Mucin deprivation decreased A. muciniphila abundances and subsequent 
mucin supplementation caused a specific increase of A. muciniphila, far exceeding the 
response of other bacteria present, together with an increase in propionate. Since this 
research served as a start to characterize A. muciniphila, a donor was selected with high 
amounts of A. muciniphila previously shown to successfully colonize the SHIME (Van den 
Abbeele et al., 2013; Van den Abbeele et al., 2011a; Van den Abbeele et al., 2010). To study 
the biological reproducibility of these findings, the effect of pH and the presence or absence 
of a host-glycan degradation niche was investigated in colon compartments separately 
inoculated with the microbiota from eight donors in Chapter 3. pH specificity and nutrient 
sensitivity of A. muciniphila was confirmed in these different microbial communities with 
variable A. muciniphila concentrations. We found that mucin supplementation resulted in 
more similar microbial communities for the eight donors, indicating that host glycans 
constitute an important ecological niche shaping the microbiota composition. With higher 
levels of Akkermansia, Bacteroides, and Ruminococcus, the cluster of mucin-enriched 
bacterial communities was significantly different from the mucin-deprived communities, yet 
no differences at the functional level were observed. The effect of colonic pH had a less 
profound impact on the microbiome with donor origin explaining most of the variability. 
Chapter 4 studied the competitiveness of A. muciniphila in different nutritional and 
environmental conditions and how this affected cross-feeding to butyrate in a synthetic 
microbial community. A. muciniphila was equally abundant as B. thetaiotaomicron at high pH 
when mucin was present, even when B. thetaiotaomicron had additional fibers to grow on. 
However, when B. thetaiotaomicron was inoculated at lower abundances the host glycan 
degradation niche was dominated by A. muciniphila. Butyrate concentration was affected by 
pH and by medium and highest in fiber-rich medium at high pH. Butyrate producing species 
responded differentially to pH or cross-feeding partner, with F. prausnitzii preferring high pH 
and A. caccae responding to L. plantarum. Cross-feeding on mucin between butyrate 
producing species and A. muciniphila was shown in this synthetic community experiment. 
However in complex microbial communities, in Chapter 5, A. muciniphila supplementation 
did not seem to enhance cross-feeding on mucin to butyrate, in contrast to other mucin 
degrading bacteria. Addition of both mucin and A. muciniphila may lead to A. muciniphila 
dominating the mucin degradation niche, while sole mucin addition led to involvement of 
several species, including A. muciniphila, Ruminococcus, Clostridium cluster XIVa, and 
Lachnospiraceae. This study revealed that mucin was more effective in inducing 
compositional changes and equally effective on the functional level compared to the 
combination of A. muciniphila and mucin. Supernatant samples were taken from these 
microbial communities shaped by the treatment with A. muciniphila, mucin or both, to study 
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their effect on the intestinal epithelium and the underlying immune cells in Chapter 6. The 
response of the co-culture model of epithelial-like cells (Caco-2) and macrophage-like cells 
(THP-1) was dependent on treatment and maintained some of the inter-donor variability. The 
supernatant of the treatment with both mucin and A. muciniphila induced the most beneficial 
response, with the mucin responsible for increased trans-epithelial resistance (TEER) and 
reduced TNF-α and IL-6 production, and A. muciniphila responsible for decreased epithelial 
permeability and increased expression of tight junction protein occludin. 
Overall, this research, using the complex microbial communities from several donors, 
showed the nutrient specificity of A. muciniphila and its sensitivity to changes in the colon 
environment, and provided valuable information about the prebiotic action of host derived 
glycans. However, inter-individual differences remain an important factor of variability in 








Figure 7. 1: Overview of the experiments in this PhD research. CH II &III: Study of the response of microbial communities, and in specific A. muciniphila, to 
environmental changes in the colon; CH IV: synthetic community experiment, with a selection of microorganisms, to study the cross-feeding and competition 
interaction on mucins and fibers; CH V: Modulation of microbial communities by addition of exogenous A. muciniphila and/or mucin; CH VI: impact of the 




2. Possible future applications 
2.1 Akkermansia muciniphila as a biomarker for gut health 
Considering the impact of the microbial gut communities on host health and association 
between dysbiosis and many diseases (Chapter 1), the gut microbiota provides a huge 
potential of new biomarkers. Biomarkers are measurable biological indicators that can be 
used to assess health status, for (early) detection or diagnosis of diseases or to evaluate the 
efficacy of treatments. A panel of biomarkers, including SCFAs produced by and cytokines 
induced by the microbial community, has proven useful to discriminate clinically diagnosed 
IBS patients from healthy controls (Mujagic et al., 2016). Not just compounds produced or 
induced by the microbial community can serve as biomarkers, in some instances the 
microbial community composition itself could be used to detect gut related diseases before 
conventional diagnostics can (Marchesi et al., 2016; Tedjo et al., 2016). The microbial 
community in the gut of Parkinson’s patients differs from that of healthy people even at a 
very early stage of the disease, and so using this biomarker can lead to early treatment of 
the disease (Heintz-Buschart et al., 2018). By better understanding the role of the microbiota 
in the development of a disease, it might be possible in the future to use the absence or 
presence of certain specific key species as a biomarker.  
The abundance of A. muciniphila in the gut has been reported by many studies to be 
inversely correlated to health, with lower numbers of A. muciniphila in patients suffering from 
IBD, obesity, diabetes and autism (Chapter 1). In IBD the decrease in A. muciniphila 
corresponds with an increase of Ruminococcus species (R. gnavus and R. torques), and this 
shift in mucolytic species has been proposed to be a suitable biomarker for mucosal integrity 
in IBD (Berry and Reinisch, 2013). Abundance of A. muciniphila was also indicated as a 
subclinical biomarker for increased risk of obesity and type 2 diabetes (Yassour et al., 2016). 
A. muciniphila was shown to be associated with a healthier metabolic status and might thus 
be useful as a biomarker for metabolic syndrome (Dao et al., 2016; Everard et al., 2013; 
Everard et al., 2011). Our results show A. muciniphila to be sensitive to certain changes in 
the colon environment, which is a requisite for a potential bacterial biomarker. It is highly 
dependent on mucin as a nutrient source, and so changes in the mucus layer in IBD or other 
patients, would impact A. muciniphila abundance (Berry et al., 2013). A. muciniphila also 
showed sensitivity toward decreasing pH, which is dependent on microbial activity and host 
regulation. Given the sensitivity of A. muciniphila to changes in important environmental 
factors, regulated by both microbial activity and the host itself, and given its correlation with 
several diseased states, A. muciniphila might indeed be a very interesting biomarker 
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candidate. Also Clostridium clusters IV and XIVa, containing butyrate producing species, 
have gained a lot of attention in the last years due to their contribution to gut health 
(Velasquez-Manoff, 2015). The abundance of B. pullicaecorum, F. prausnitzii, and E. rectale 
is markedly decreased in IBD patients compared to healthy individuals (Riviere et al., 2016) 
and an association has been suggested between F. prausnitzii and disease activity in CD 
patients (Tedjo et al., 2016). 
Though still at the research stage, constructing specific gut biomarker panels 
comprising several key species, like A. muciniphila and F. prausnitzii, host and bacterial 
metabolites might be a future approach to assess health status, diagnose certain diseases or 
evaluate the efficacy of a therapy. To eventually reach the point where we could use these 
intestinal biomarkers, several hurdles need to be overcome, like the validation of candidate 
biomarkers an the standardization of their measurement. A critical hurdle is the extensive 
inter-individual differences. In the studies mentioned above, groups of patients were 
compared to groups of healthy individuals, which partly cancelled out the inter-individual 
differences. However, when interpreting observations of one person, the question remains 
how to define baseline or healthy levels for our indicators, since it is still unclear how a 
healthy gut microbiome should be defined 
 
2.2 Akkermansia muciniphila as a (live) biotherapeutic product 
Currently a clinical trial is ongoing to evaluate the effects associated with the 
administration of live or heat-killed A. muciniphila on the metabolic disorders related to 
overweight and obesity in humans. Administration of Akkermansia muciniphila was already 
found to reduce body weight gain, fat mass gain, glycaemia and inflammatory markers in 
diet-induced obese mice and its effect could partly be explained by the action of an abundant 
outer membrane protein Amuc_1100 (Everard et al., 2013; Plovier et al., 2017). The 
unexpected finding that pasteurized A. muciniphila exerted stronger effects than the live 
bacterium and the identification of Amuc_1100, demonstrated that A. muciniphila doesn’t 
have to be alive and metabolically active for its effects. Chapter 6 showed indeed a decrease 
in intestinal permeability induced by supernatant of microbial communities treated with 
A. muciniphila, independent of its metabolic activity. This is highly significant from a possible 
application point of view since it circumvents the problems associated with the large scale 
production and application of a strict anaerobic bacterium. Beside pasteurized A. muciniphila, 
also treatment with isolated bacterial proteins, like Amuc_1100, is a future possibility. The 
data from the study by Plovier et al. (2017) indicate that other pasteurization-resistant outer 
membrane proteins might be involved in the beneficial interaction between A. muciniphila 
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and the host. Further research into identifying and isolating these proteins is needed and 
might lead to the application of a mix of bacterial proteins in the treatment of obesity and 
related metabolic disorders. 
The discovery of the potential role and use of A. muciniphila in obesity occurred after a 
dietary intervention study with obese mice that increased the levels of A. muciniphila and 
improved host health (Everard et al., 2011). Various other animal studies reported that 
treatment with a specific nutritional component, like polyphenols, conjugated linoleic acid and 
betacyanins, improved host health (e.g. by inducing weight loss) and increased 
A. muciniphila abundances (Anhe et al., 2015; Chaplin et al., 2015; Gomez-Gallego et al., 
2014; Roopchand et al., 2015; Song et al., 2016; Tachon et al., 2013). However this positive 
correlation between A. muciniphila and healthier phenotypes is mainly described after high 
fat diets and in obese animals. Despite the studies observing a negative correlation between 
A. muciniphila abundance and several diseases, the opposite has only been reported for 
obesity and related metabolic disorders. An intervention study showed that obese and 
overweight individuals with high abundance of A. muciniphila displayed greater improvement 
in insulin sensitivity markers and other clinical parameters after calorie restriction (Dao et al., 
2016). 
Future research should explore the possible application of A. muciniphila in other 
diseases, like IBD. The defects in the mucus layer, characteristic in IBD, allow bacteria to 
reach the epithelium and induce an immune response, which could result in the development 
of intestinal inflammation. Microbial dysbiosis is important in IBD pathogenesis and given the 
reduced protection of the mucus layer and the enhanced interaction with the epithelium, 
modulation of the microbiota to restore gut homeostasis can be of interest (Frank et al., 
2011; Larsson et al., 2011; Swidsinski et al., 2002). Due to lacking efficacy of current 
probiotic formulations, research focus is shifting towards novel species that can be used as 
next generation probiotics or live biotherapeutic product (Geirnaert, 2015). As mentioned 
above, A. muciniphila abundance is inversely correlated with IBD while other mucolytic 
bacteria, Ruminococcus spp., are more abundant (Png et al., 2010). Interestingly, treatment 
with A. muciniphila, live or pasteurized, was found to stimulate mucin production and 
A. muciniphila increased goblet cell abundance (Plovier et al., 2017; Shin et al., 2014). An in 
vitro study with colonic cell lines (HT-29 and Caco2) showed that A. muciniphila adhered to 
the epithelium, strengthened the intestinal barrier and demonstrated low inflammatory 
potential (Reunanen et al., 2015). In human derived peripheral blood mononuclear cells, 
A. muciniphila was found to induce both anti-and pro-inflammatory cytokine response, 
indicating a more complex role in immunomodulation. Live A. muciniphila induced production 
of anti-inflammatory IL-10 to the same extent as F. prausnitzii and L. plantarum, while 
A. muciniphila supernatant induced higher IL-10 production (Ottman et al., 2017d). 
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F. prausnitzii has been correlated with remission in IBD and its ability to induce high levels of 
IL-10 is one of the mechanisms behind its anti-inflammatory effect (Sokol et al., 2008a; Sokol 
et al., 2008b). In conclusion, both in vitro and in vivo studies demonstrate that A. muciniphila 
can improve intestinal barrier functioning, both epithelial barrier and the mucus layer, and 
can communicate with the host, with potential anti-inflammatory responses. This makes 
A. muciniphila an interesting target for further research into biotherapeutic products for IBD. 
However, the effects of biotherapeutic application of A. muciniphila have not yet been 
studied in immunocompromised conditions and additional research is certainly needed. 
Indications of a beneficial effect of A. muciniphila in IBD can be derived from a study by Kang 
et al. (2013) where extracellular vesicles from A. muciniphila were found to protect against 
DSS-induced colitis. 
Careful attention has to be paid to the risks involved in administering high doses of live 
bacteria to immunocompromised patients, since this could lead to infection, bacterial 
translocation and sepsis. The work by Duparc et al. (2017) leads us to wonder whether the 
pasteurization of other bacteria could enhance their beneficial effects on inflammation and 
epithelial barrier integrity as it did for A. muciniphila. The use of pasteurized bacteria could 
already significantly reduce the risk of using biotherapeutic products in susceptible patients. 
Butyrate producing species, specifically F. prausnitzii and B. pullicaecorum, have been 
proposed as potential live biotherapeutic products for use in IBD and future research should 
investigate whether pasteurization influences their beneficial effects. Given the high 
interindividual variability in response to probiotic treatments, the use of a multi-species mix 
that possesses different beneficial properties would be more effective and result in a wider 
spectrum of action. Besides the effect of pasteurization, the combination of butyrate 
producing species with A. muciniphila as a multi-species mix is worth further studying.  
 
3. A protective role for Akkermansia muciniphila in the host 
glycan degradation niche? 
Given its specialized mucin degradation activity A. muciniphila has been proposed to 
be a keystone species supporting other bacteria through cross-feeding interactions and 
shaping the microbial community at the mucosal interface (Belzer and de Vos, 2012; Chia et 
al., 2018). However, very little is known about the importance of A. muciniphila in the mucin 
degradation niche and whether it is interchangeable with other mucolytic bacteria. Due to its 
specific response to mucin, as shown throughout this research, and its high prevalence in 
humans (Collado et al., 2007), the study of a mucin degradation niche without A. muciniphila 
is very difficult when working with fecal samples. In Chapter 5, one donor provided us with a 
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microbial community where mucin supplementation did not lead to the increase of 
endogenous A. muciniphila abundance as was observed for the others donors and thus 
allowed us to study mucin degradation without dominance of A. muciniphila. A higher 
abundance of Ruminococcus and Roseburia species was observed, which might be 
responsible for the higher concentration of butyrate. 
A way to avoid the mentioned drawbacks of a fecal inoculum is by using a synthetic 
community. By trimming down ecosystem complexity it becomes more feasible to discern 
one-on-one microbial interactions which is often difficult in the complex background of human 
gut microbiota. The ability to select and compare different community compositions can give 
an indication about the role specific bacteria play in the community. In Chapter 4 we 
observed that changing the primary degrader, be it A. muciniphila or B. thetaiotaomicron, did 
not impact butyrate producing functionality. More research is needed to discern whether the 
identity of the mucolytic species affects the functionality and composition of the bacterial 
community of the mucin degradation niche. This further research should focus on: (i) 
Expanding the synthetic community by including mucolytic Ruminococcus species, more 
butyrate producing bacteria and other cross-feeders; (ii) assessing functionality broader than 
SCFA production and including other parameters such as stability and resilience of the 
community and colonization resistance; (iii) investigating the effect on the host by combining 
these in vitro studies with cell cultures or by introducing the synthetic communities into 
germfree mice, as was done by Desai et al. (2016). The use of in vivo models introduces an 
important factor, being the cross-talk between the bacteria and the host, into this research. 
A. muciniphila might differentiate itself from other mucolytic bacteria in this aspect, since it 
has shown to have the ability to stimulate mucus production, modulate host response and is 
commonly associated with a healthy gut. In a study by Png et al. (2010) an interesting 
hypothesis was posited of a negative feedback loop in which A. muciniphila determines the 
abundance of the mucosa-associated bacteria in health: mucolytic activity of A. muciniphila 
increases substrate availability, thereby sustaining the mucosa-associated community. When 
this community becomes too abundant it will inhibit growth of A. muciniphila, thus limiting the 
substrate availability and controlling the abundance of mucosa-associated bacteria. 
However, this assumes that no other mucolytic bacteria would be present in the community 
that could take over mucin degradation, even if A. muciniphila was inhibited as hypothesized. 
The mice study by Desai et al. (2016) showed that the presence of A. muciniphila in a 
synthetic community could not protect against excessive mucolytic action during dietary fiber 
deprivation, which shaped the synthetic community into a mucus-eroding microbiota and 
promoted epithelial access. Repeating this experiment with different synthetic communities 
could reveal whether Akkermansia or other bacteria or bacterial consortia could exert 
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protective effects, shielding the host from excessive mucolytic action and keeping the mucus 
layer healthy. 
 
4. Prebiotic-like properties of host glycans 
The mucus layer plays an important role in the intricate interactions between the 
bacteria that colonize our colon and the host. Besides being an essential part of the intestinal 
barrier, the mucus layer provides an important source of nutrients in the form of mucins, 
whose complex structure requires the interaction of specific bacteria for its degradation and 
can involve many others through cross-feeding interactions. This nutritional aspect of the 
mucus layer is especially important during periods of fasting or dietary fiber deprivation 
(Desai et al., 2016; Kohl et al., 2014; Sonoyama et al., 2009). Due to the proximity to the 
epithelium, the metabolites of the bacteria involved in this mucin degradation niche might be 
more readily taken up by the epithelial cells, thereby enhancing their influence on the host. 
Considering the limited number of species that can degrade the complex mucin structure and 
the described and proposed health effects conferred by its degradation, mucins fit in the 
definition of prebiotic substances, ‘substrates that are selectively utilized by host 
microorganisms conferring a health benefit’, and the human body can be described as 
producing its own prebiotic-like substance (Belzer and de Vos, 2012; Derrien et al., 2004; 
Gibson et al., 2017; Ouwehand et al., 2005; Reunanen et al., 2015). 
Mucin degrading capacities have been described for several species (Chapter 1), but 
few studies have focused on trophic interactions during growth on mucin or the importance of 
this host-glycan degradation niche for the microbial ecosystem. The in vitro models used 
throughout this research allowed the study of introducing host glycans and observing the 
prebiotic-like effect on microbial communities coming from different donors. Overall, mucin 
supplementation made different microbial communities more similar to each other, increased 
A. muciniphila and Ruminococcus abundance and increased SCFA production (Chapter 2, 
Chapter 3, Chapter 5). The presence of a host-glycan degradation niche induced 
strengthening of the epithelial barrier and modulated cytokine production (Chapter 6). Our 
results indicate that host-glycans deserve further attention for their prebiotic-like properties in 
modulating gut microbiota and possibly host health. 
Certain fibers are capable of altering the secretion dynamic of colonic mucus and could 
increase mucus turnover (Brownlee et al., 2007). Besides better protective properties of the 
mucus layer by enhanced exclusion of trapped bacteria, this would increase mucin released 
by desquamation. We posit here that this increase in mucin could be an endogenous 
prebiotic-like treatment, stimulating mucin degradation without harming the mucus layer. In a 
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rat study, prebiotic treatment with inulin was posited to increase levels of ceacal mucin, 
which were degraded along the colon and increased fecal A. muciniphila abundance (Van 
den Abbeele et al., 2011a). Future research should identify more mucogenic compounds and 
assess whether the induced increase in mucin production and degradation is indeed not 
harmful to the mucus layer and consequently host health. Due to its animal origin, prebiotic 
treatment with mucin glycans is impossible and highly impractical. However, biotechnological 
production of (fucosylated) human milk oligosaccharides is already a possibility (Petschacher 
and Nidetzky, 2016; Soetaert, 2016) and given the structural similarity biotechnological 
production of mucin glycans might not be too far in the future? Of course, more research is 
necessary to assess the effect of prebiotic treatment with synthetic mucin glycans. The 
expected increase in mucolytic bacteria might be a risk for mucus layer structure and gut 
homeostasis. 
 
5. Advantages and disadvantages of the in vitro models for the 
study of the host glycan degradation 
During this research we used in vitro models to study the interactions between mucin 
glycans, A. muciniphila, and the microbial community and their ability to elicit a host 
response. In vitro models of the colon microbial community are designed to simulate the 
physiological conditions of the colon and are ideal for mechanistic studies because of the 
ability to control and vary several parameters and to take samples at regular timepoints and 
from different, in vivo difficult to reach, regions (Marzorati et al., 2011; Marzorati et al., 2014). 
The in vitro models used here include a semi-continuous system (fed-batch; Chapter 4) and 
a continuous model (SHIME; Chapter 2, 3 and 5). The SHIME model allows for preservation 
of inter-individual differences in microbial composition and functionality and makes it possible 
to differentiate between responders and non-responders to a certain treatment (Van den 
Abbeele et al., 2010; Van den Abbeele et al., 2012), as was observed in Chapters 3 and 5. 
The ability to control the supply of mucin glycan (varying the concentration but not the 
structure) necessitated the use of in vitro models. Besides, the nutritional role of mucins 
cannot be separated from the protective role of the mucus layer in vivo, and attachment to 
the mucus layer or the anti-microbial peptides in the mucus layer would have confounding 
effects. The in vitro model (SHIME) used in the research thus provided essential advantages 
to study the impact of mucin degradation on the community. However, there still remain 
many aspects of the mucin degradation niche that should be addressed in future research, 
such as variability in mucin structure and supply influenced by inter-individual variability, host 
health and the cross-talk with the microbial community. 
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Compared to dietary glycans, the composition and structure of mucin glycans are often 
described as less variable, making them a more consistent source of nutrients. However, 
mucin glycans have been described to be susceptible to certain bacterial factors. Probiotic 
Lactobacillus species are able to increase the secretion of mucin by stimulating the 
production of MUC2, B. thetaiotaomicron has been shown to increase the differentiation of 
goblet cells, thereby influencing mucin production (Caballero-Franco et al., 2007; Mattar et 
al., 2002; Wrzosek et al., 2013) and A. muciniphila, live or pasteurized, was found to 
stimulate mucin production increase goblet cell abundance (Plovier et al., 2017; Shin et al., 
2014). More indirectly, bacterial fermentation products such as butyrate and propionate can 
increase the mucin production by goblet cells in the colon (Barcelo et al., 2000). Besides 
these bacterial factors, also host genetics influence mucin structure through the α1–2 
fucosyltransferase (FUT2) gene. This FUT2 gene encodes for the addition of a L-fucose 
residue to the terminal galactose residue of mucin glycans and is not functional in 
approximately 20% of the people. Due to the terminal position of fucose, this sugar plays an 
important role at the interface of bacterial interactions with the mucus. The absence of fucose 
significantly impacts gut microbial composition and recent studies have found non-secretors 
to have increased susceptibility to chronic inflammatory conditions linked to the gut 
microbiota, such as Crohn’s disease (Rausch et al., 2011; Wacklin et al., 2014). 
Mucus thickness and structure is highly involved in many gut related diseases, 
amongst others ulcerative colitis (UC) and Crohn disease (CD). Under normal conditions, 
bacterial mucin degradation is in balance with new production by the goblet cells. Changes in 
the structure of the mucin glycans, for example due to altered glycosylation, might shift the 
balance toward faster degradation (Larsson et al., 2011). These changes in glycosylation, 
resulting in shorter glycan structures, have been observed in patients with active UC, but 
seemed to be caused by inflammation and not UC per se (Johansson, 2014; Johansson et 
al., 2014). Reduced sulfation, which makes the mucin glycans more susceptible to 
degradation (as described in Chapter 1), has been observed for UC patients and leads to 
increased susceptibility to induced colitis in mice (Corfield, 2015; Dawson et al., 2009). UC 
involves increased immune reactions towards the microbiota due to increased bacterial 
exposure, which might be the result to reduced thickness and increased permeability of the 
mucus layer (Johansson et al., 2014). Without the intact (inner) mucus layer providing 
separation between bacteria and epithelium, bacteria can reach the epithelium and stimulate 
an immune system response that can lead to the development of intestinal inflammation. 
Unlike UC, a thicker mucus layer has been observed in CD patients. However, CD involves 
defects in the secretion of antimicrobial molecules, which allows bacteria to penetrate the 
crypts inducing intestinal inflammation (Geirnaert, 2015). 
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A study by Schroeder et al. (2018) identified diet to be an important factor indirectly 
influencing the intestinal mucus layer. Mice fed a western style diet had an altered gut 
microbiota composition, increased permeability and reduced growth rate of the inner mucus 
layer. After microbial transplantation with microbiota from chow fed mice, the barrier defects 
were reversed. Prebiotic treatment with inulin prevented the increase in mucus permeability 
and administration of Bifidobacterium longum could increase mucus growth rate. Another 
mice study, mentioned before (Desai et al., 2016) with a synthetic human microbiota 
observed that during dietary fiber deprivation, the microbial community uses the host derived 
mucin glycans as nutrients. This led to erosion of the mucus barrier leaving the epithelium 
vulnerable for colitis by the mucosal pathogen, Citrobacter rodentium. 
Overall, the effects of these environmental and host factors result in differences in the 
trophic interactions between the mucus layer and the gut microbiota, and impact the role of 
the mucin degradation niche in the gut ecosystem. At the moment, neither in vivo nor in vitro 
models provide suitable possibilities to take these factors into account, due to the intricate 
interplay between bacteria, mucins and host. To overcome these problems, more in vivo 
studies are needed to study the variances in mucin glycans and mucus layer structure more 
in detail. With more knowledge gathered from the in vivo studies, it might be possible to use 
this for in vitro simulation. As mentioned above, biotechnological production of mucin glycans 
might be possible in the future and with more detailed knowledge about the variability in 
mucin glycan structure, we would be able to produce different types of mucin glycans. 
However, at the moment this biotechnological production of mucins is still something of the 
future and the bottleneck for more detailed in vivo studies is the difficulty to access and study 
the mucus layer. This is exemplified by the recent study by (Kamphuis et al., 2017) where the 
commonly accepted organization of the mucus layer is put into question. Given the 
involvement of the mucus layer in gut health and the undefined role of the mucin degradation 
in the ecosystem, which has been extensively described in this research study, it is of 




Studies linking changes in the gut microbiota composition to human health status have 
reported an inverse correlation between Akkermansia muciniphila and disorders such as 
IBD, obesity and diabetes. A.muciniphila has been positioned as a health biomarker and is 
currently explored as a therapeutic agent for obesity. The key characteristic of A. muciniphila 
is its mucin degrading capacity, by which it may contribute to cross-feeding networks 
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enhancing its effect on the microbiota and the host. The focus of this PhD research was to 
unravel the behavior of A. muciniphila in the complex microbial ecosystem of the colon and 
the potential role of mucins to influence A. muciniphila and its impact on the microbial 
community and the host. By using in vitro technologies, including the SHIME® model and a 
co-culture cell model, we have shown that: 
 
- A. muciniphila is sensitive to slightly acidic pH and therefore preferentially colonizes 
the distal colon, where the pH is closer to neutral; 
o Biotherapeutic application of A. muciniphila may need to consider protection 
from pH until arrival at more neutral pH. 
- A. muciniphila shows high nutrient specificity: mucin deprivation leads to decreased 
abundance of A. muciniphila and mucin supplementation induces a specific and 
strong increase in A. muciniphila abundance; 
o Stimulation of endogenous A. muciniphila might be achieved by stimulation of 
mucin production or by prebiotic-like supplementation of biotechnologically 
produced mucin. The latter could be used as well for synbiotic formulations 
with A. muciniphila. 
- Cross-feeding on mucin to butyrate is not enhanced with increased A. muciniphila 
abundance as primary degraders do not impact butyrate producing functionality but 
might induce phylogenetic shifts; 
o Strategies with primary degraders to modulate the microbiota’s functionality 
may depend on an individual’s microbiome composition and response. This 
indicates that effects on the microbiome cannot be generalized across human 
individuals and it is a plea for a more personalized approach. 
- Host glycans constitute an important ecological niche shaping the microbiota 
composition more effectively, exceeding donor variability, compared to the 
environmental modulator pH; 
o Administration of biotechnologically produced compounds with mucin-like 
molecular structures may in that sense be a possible prebiotic treatment. 
- Mucin and A. muciniphila display differentially protective effects towards in vitro 
epithelial barrier and immune modulation. 
o Incorporating complex and more realistic matrices when studying host-
microbe interactions is needed to improve our understanding of routine tests 




This research gained more insight into the positioning of A. muciniphila in host glycan 
degradation and the importance of this niche for the microbial ecosystem and its possible 
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Scientific research in the last decades has revolutionized our insight in how 
microorganisms colonizing the human body correlate with and even impact our health and 
how intricate the microbe-microbe and the host-microbe interactions are. Subtle imbalances 
in our microbial populations can cause disease and studies have shown correlations 
between gut microbiota composition and obesity, inflammatory bowel diseases, diabetes, 
cancer, acute appendicitis, colon cancer, … Research into identification of biomarkers for gut 
health and ways to modulate the microbiota composition and activity to improve health, has 
put A. muciniphila in the spotlight. Its abundance is decreased in patients suffering from IBD, 
obesity, diabetes and autism, but it occurs in high abundance and with high prevalence in 
healthy people. As a mucin degrader, A. muciniphila colonizes an interesting but not-fully 
described niche, being host-glycan degradation. These mucin glycans make up the 
protective mucus layer that separates the epithelial cells from the gut lumen. Besides acting 
as a barrier, the mucus layer, and specifically the mucin glycans, also serve as a substrate 
for growth for colonic bacteria, an aspect that has gained more attention recently. Previously, 
it was thought that mucin degradation was detrimental for gut health but it is now clear that it 
is part of a normal turnover process. Given the diversity and complexity of host glycan 
structures, strategies for degradation to free sugars rely on the action of a panel of enzymes, 
produced by only 1% of the microbial community. The release of oligosaccharides and 
fermentation products during mucin degradation can be used by other bacteria, thereby 
expanding the host glycan degradation niche. The ability of these microorganisms to profit; 
both directly and indirectly, from endogenous glycans can facilitate their close location to the 
host epithelium, where they may exert a disproportionate effect on human health. Plenty of 
research concerning A. muciniphila has been done, but more information is required 
concerning its behaviour in the complex microbial ecosystem in the colon, the potential role 
of mucins to influence A. muciniphila behaviour and the impact of its probiotic administration 
on the microbial ecosystem and the host, which was the focus of this PhD research. In vitro 
technology used in this research, such as the simulator or the human intestinal ecosystem 
(SHIME®) and the transwell co-culture cell model, allowed for mechanistic research that 
aimed at unravelling the ecology of mucin degraders and helped to overcome some 
confounding elements of in vivo studies, such as variations in mucin production by the host. 
The first part of this PhD research focused on the role of A. muciniphila in host glycan 
degradation and the importance of this niche for the microbial ecosystem. Chapter 2 studied 




A. muciniphila preferentially colonized the distal colon and that this preference was due to 
pH, which is more neutral compared to the proximal colon. Mucin deprivation decreased 
A. muciniphila abundances and subsequent mucin supplementation caused a specific 
increase of A. muciniphila, far exceeding the response of other bacteria present. To study the 
biological reproducibility of these findings, the effect of pH and the presence or absence of a 
host-glycan degradation niche was investigated in colon compartments separately inoculated 
with the microbiota from eight donors in Chapter 3. pH specificity and nutrient sensitivity of 
A. muciniphila was confirmed in these different microbial communities. Mucin 
supplementation resulted in more similar microbial communities for the eight donors, 
indicating host glycans to constitute an important ecological niche shaping the microbiota 
composition. The effect of colonic pH had a less profound impact on the microbiome with 
donor origin explaining most of the variability. 
To asses microbial cross-feeding and competition interactions of A. muciniphila more in 
detail, Chapter 4 investigated different primary degraders for host or dietary glycan 
degradation and their effect on butyrate production. These interactions are difficult to study in 
a complex bacterial community and so a synthetic microbial community was used, with 
A. muciniphila and B. thetaiotaomicron as the primary glycan degraders. Joint presence of 
both primary degraders did not lead to a competitive exclusion in the presence of mucin; 
A. muciniphila was not even overgrown by B. thetaiotaomicron when additional dietary 
glycans were available. Shifts in pH and primary degrader abundance was selective for 
butyrate producers while the butyrate producing functionality was maintained. 
The second part of this PhD research focused on the modulation of the microbial 
community by administration of A. muciniphila and the presence/absence of a host-glycan 
degradation niche, and its impact gut barrier function and immune response. Addition of both 
mucin and A. muciniphila to microbial gut communities from different donors (Chapter 5) 
might lead to A. muciniphila dominating the mucin degradation niche, while sole mucin 
addition led to involvement of several species, including A. muciniphila, Ruminococcus, 
Clostridium cluster XIVa, and Lachnospiraceae. Supernatant samples were taken from the 
microbial communities shaped by these treatments, to study their effect on the intestinal 
epithelium and the underlying immune cells in Chapter 6. The supernatant of the treatment 
with both mucin and A. muciniphila induced the most beneficial response, with the mucin 
responsible for increased trans-epithelial resistance (TEER) and reduced TNF-α and IL-6 
production, and A. muciniphila responsible for decreased epithelial permeability 
Overall, this research, using the complex microbial communities from several donors, 
showed the nutrient specificity of A. muciniphila and its sensitivity to changes in the colon 
environment, and provided valuable information about the prebiotic-like action of host derived 
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De laatste decennia heeft wetenschappelijk onderzoek ons inzicht in de bacteriën die 
ons lichaam koloniseren gerevolutioneerd: hoe deze een impact hebben op onze gezondheid 
en hoe complex de interacties tussen de bacteriën onderling en tussen de bacteriën en de 
gastheer zijn. Subtiele verschillen in onze microbiële gemeenschap kunnen ziektes 
veroorzaken en studies tonen een correlatie tussen de darmmicrobiota en obesitas, 
inflammatoire darmziekten (IBD), diabetes, kanker, … Onderzoek naar het identificeren van 
biomarkers voor intestinale gezondheid en naar manieren om de samenstelling en 
functionaliteit van de microbiota te beïnvloeden, heeft de darmbacterie Akkermansia 
muciniphila in de kijker gezet. Deze bacterie is minder abundant aanwezig in patiënten die 
lijden aan IBD, obesitas, diabetes en autisme, maar komt abundant voor in gezonde 
mensen. A. muciniphila wordt gekarakteriseerd door zijn capaciteit om mucines af te breken. 
Deze mucines zijn een belangrijk onderdeel van de mucuslaag, een beschermende slijmlaag 
die de darmcellen beschermt tegen darmbacteriën.  De mucuslaag en de mucines die hem 
opbouwen, hebben niet enkel een barrièrefunctie maar dienen ook als voedingsbron voor 
darmbacteriën, een aspect dat meer en meer aandacht krijgt. Waar er voorheen gedacht 
werd dat mucine-afbraak schadelijk zou zijn, is het ondertussen duidelijk dat de degradatie 
bijdraagt tot een gezonde mucuslaag en mucineproductie door de gastheer stimuleert. 
Omwille van de complexiteit van de mucinestructuur, is er voor de afbraak een resem aan 
enzymen nodig, die slechts door 1% van de microbiota geproduceerd worden. Hoewel 
mucine-afbraak door slechts enkele bacteriën kan worden uitgevoerd, kunnen andere 
bacteriën hier ook indirect van profiteren: ze kunnen gebruik maken van de minder complexe 
suikers en omzettingsproducten die vrijgesteld worden tijdens de afbraak. Vanwege de 
nabijheid van de mucuslaag tot de darmcellen, hebben de bacteriën die betrokken zijn bij de 
mucine-afbraak, zowel direct als indirect, een groter effect op de menselijke gezondheid. 
Hoewel er reeds veel onderzoek gevoerd is naar A. muciniphila, is er nog informatie nodig 
over hoe deze bacterie zich gedraagt in de microbiële gemeenschap in het colon, hoe 
mucine dit gedrag kan beïnvloeden en hoe het toedienen van A. muciniphila de microbiële 
gemeenschap en de gastheer zal beïnvloeden. Het gebruik van in vitro technologie in dit 
onderzoek, zoals de simulator van het humaan intestinaal ecosysteem (SHIME) en het co-
cultuur celmodel, ondersteunde mechanistisch onderzoek dat doelde op het ontrafelen van 
de ecologie van mucine-degraderende bacteriën en liet toe dat bepaalde nadelige 





In het eerste deel van dit doctoraatsonderzoek lag de focus op de rol van 
A. muciniphila in de mucinedegradatie en de betekenis van deze niche voor het microbieel 
ecosysteem. Hoofdstuk 2 bestudeerde het kolonisatiegedrag van A. muciniphila in het colon 
in variërende omstandigheden en toonde aan dat A. muciniphila de distale colonregio 
prefereert omwille van de zuurtegraad (pH), die hier neutraler is dan in de proximale regio. 
Mucinedeprivatie verminderde de aanwezigheid van A. muciniphila en de daaropvolgende 
toevoeging van mucine veroorzaakte een specifieke toename van A. muciniphila bacteriën 
die de respons van de andere bacteriën ver oversteeg. Om de biologische herhaalbaarheid 
van deze bevindingen te testen, werd in Hoofdstuk 3 onderzocht of gelijkaardige effecten 
van pH en mucine op de microbiële gemeenschappen van acht donoren werden 
waargenomen. De pH- en mucinespecificiteit van A. muciniphila werd bevestigd in deze acht 
verschillende microbiële gemeenschappen en het toedienen van mucine maakte deze 
gemeenschappen meer gelijkend op elkaar, erop wijzend dat mucines een belangrijke 
ecologische niche zijn die de microbiële gemeenschap vormgeeft. Het effect van pH was 
minder diepgaand en meer onderhevig aan interindividuele verschillen. 
Om de nutritionele interacties van A. muciniphila meer in detail te kunnen bestuderen, 
werd in Hoofdstuk 4 gebruik gemaakt van een minder complexe, synthetisch 
samengestelde microbiële gemeenschap in medium met mucine en/of vezels als 
voedingsbron. Met A. muciniphila en Bacteroides thetaiotaomicron als primaire 
degradeerders, werd de competitie tussen beiden onderzocht. Daarnaast werd er ook 
gekeken naar de syntrofische interacties met butyraatproducerende bacteriën. Groei van 
beide primaire degradeerders zonder competitieve uitsluiting was mogelijk op medium met 
mucine, zelfs wanneer B. thetaiotaomicron daarbovenop gebruik kon maken van vezels. 
Veranderingen in pH en primaire degradeerder selecteerden specifieke butyraatproducenten, 
maar de productie van butyraat werd gehandhaafd. 
In het tweede deel van dit doctoraatsonderzoek lag de focus op het wijzigen van de 
microbiële gemeenschap door toediening van A. muciniphila en de aan- of afwezigheid van 
mucine en de impact hiervan op de epitheliale barrière en het immuunsysteem. Toediening 
van zowel mucine als A. muciniphila aan microbiële gemeenschappen van verschillende 
donoren, kan leiden tot de dominantie van A. muciniphila in de mucinedegradatie niche. 
Toediening van enkel mucine daarentegen, leidde tot betrokkenheid van verschillende 
bacteriën waaronder A. muciniphila, Ruminococcus, Clostridium cluster XIVa, and 
Lachnospiraceae. Stalen werden genomen van de microbiële gemeenschappen na deze 
behandelingen om hun effect op de epitheliale cellen en de onderliggende immuuncellen te 
bestuderen in Hoofdstuk 6. Het supernatans van de behandeling met zowel mucine als 
A. muciniphila induceerde de meest voordelige respons, met mucine verantwoordelijk voor 
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een stijging in trans-epitheliale resistentie (TEER) en verminderde TNF-α en IL-6 productie, 
en A. muciniphila verantwoordelijk voor verminderde epitheliale permeabiliteit. 
Tijdens dit doctoraatsonderzoek, gebruik makende van de complexe microbiële 
gemeenschappen van meerdere donoren, werd de nutriëntspecificiteit van A. muciniphila 
voor mucine aangetoond, de gevoeligheid van deze bacterie voor veranderingen in de 
colonomgeving, en werd er waardevolle informatie verschaft over de prebiotisch-achtige 
werking van mucine. Niettemin is er nood aan verder onderzoek om de impact van 
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de Wiele T. (2017), A host glycan degradation niche in a dynamic gut model increases 
Akkermansia muciniphila abundance and changes microbiome composition in a donor 
independent fashion. Presented at: 11th International Scientific Conference On Probiotics, 
Prebiotics, Gut Microbiota And Health (Budapest, Hungary, June 20th  2017) 
Poster presentations 
1. Van Herreweghen F. and Van den Abbeele P., De Mulder T., De Weirdt R., Geirnaert A., 
Hernandez-Sanabria E., Vilchez-Vargas R., Jauregui R., Pieper D.H., Belzer C., De Vos 
W.M. and Van de Wiele T. Unraveling the behavior of Akkermansia muciniphila in a 
complex microbial gut community. Presented at: 16th Gut Day Symposium (Amsterdam, 
The Netherlands, November 27th, 2014). 
2. Van Herreweghen F. and Van den Abbeele P., De Mulder T., De Weirdt R., Geirnaert A., 
Hernandez-Sanabria E., Vilchez-Vargas R., Jauregui R., Pieper D.H., Belzer C., De Vos 
W.M. and Van de Wiele T. Akkermansia muciniphila colonization of an in vitro distal colon 
is mucin dependent. Presented at: 18th Gut Day Symposium (Venlo, The Netherlands, 
November 27th, 2016). 
 
Teaching 
1. Responsible for practical exercises for the course ‘Host-microbe interactions’ (Prof. Tom 
Van de Wiele) (2014-2015) 
2. Tutor of 3 bachelor and 1 master students during their thesis (2014-2017) 
3. Teaching STEM project for Atheneum Zottegem (2017) 
 
Awards 
1. Best oral presentation, 22nd National Symposium For Applied Biological Sciences, 


















A PhD trajectory is typically one with a few bumps in the road, and mine wasn’t any 
different. The work in the lab can lead to great highs when everything is working fine, results 
keep on coming in and are confirming hypotheses; or when you find something completely 
unexpected. But it can also lead to deep sinkholes when you have no idea what is going 
wrong or how you can fix it, when the bacteria just don’t want to listen and behave or when 
staring at a blank page and forcing your mind to make a perfect sentence. Well, during my 
bumpy road I got to share my highs with -and got pulled out of some sinkholes by- quite a 
few extraordinary people and in this chapter I will attempt to thank them adequately. 
Eerst en vooral zou ik de leden van mijn jury willen bedanken voor hun kritische 
feedback en discussies tijdens mijn verdedigingen. Jullie grondig nazicht van mijn 
manuscript, komende vanuit diverse wetenschappelijke achtergronden, heeft mijn thesis 
verder geoptimaliseerd, waardoor het nog beter onderbouwd werd.  
Goede begeleiding gedurende het doctoraatstraject is zeer belangrijk en daarvoor zou 
ik mijn promotor Tom willen bedanken. Dankzij de lessen van ‘Microbe-gastheer interfase 
processen’ wou ik graag mijn thesis bij CMET doen en daar is mijn Akkermansia-verhaal 
begonnen. Na mijn thesis wou ik het onderwerp en het interessante werk nog niet opgeven, 
dus hebben we samen met Pieter het IWT overtuigd om nog vier jaar onderzoek te 
sponsoren. Ik heb enorm veel bijgeleerd tijdens deze jaren, genoten van de interessante 
discussies over interpretatie van resultaten en opzetten van experimenten maar ook van de 
niet-werk gerelateerde gesprekken. Je hebt me de ruimte gegeven om te proberen, hier en 
daar te falen en opnieuw te beginnen en daar heb ik zeer veel uit geleerd. Dus Tom, bedankt 
voor de interessante lessen en de kans om mijn thesis en mijn doctoraat onder jouw 
begeleiding te kunnen doen; voor al je input bij het schrijven van papers en uiteindelijk mijn 
doctoraat; voor je verbeterwerk; voor de interessante gesprekken, kortom voor de goede 
begeleiding.  
Dit onderzoek is mede tot stand gekomen met de hulp van enkele studenten tijdens 
hun thesis: Chloë, Jana, Liesbet, Joyce en Frauke. Hierbij wil Chloë bedanken voor het 
mooie werk met het synthetisch inoculum experiment en Jana en Liesbet om te blijven 
geloven in ons celwerk, hoewel we veel tegenslagen hebben gehad, kijk ik met plezier terug 
op onze samenwerking. 
Daarnaast zijn er ook heel wat andere mensen die ik wil bedanken voor de fijne 
samenwerking tijdens mijn doctoraat. Professor Debby Laukens, bedankt voor de hulp en 
uitleg bij de analyses van het celexperiment en Griet Driesschaert, dank u voor de 
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praktische hulp in het labo bij het uitvoeren van die analyses. Auréelie Crabbé, heel erg 
bedankt om me te komen helpen met de 3D RWV reactoren, hoewel we het raadsel helaas 
niet hebben kunnen oplossen.  
I did not only enjoy doing my PhD because of the interesting research, but also 
because of the people who make CMET such a wonderful place to work. A group of amazing 
and talented people (Charlotte, Ioanna, Curro, Antonin, FM, Stephen, Francis, Jan, 
Racha, Benjamin, Ruben, Jo, Marlies, Gio, Amanda, Hugo, Massimo, Eleftheria, Lisa, 
Charlène, Mélanie, …), with whom I enjoyed having lively discussions, many many coffee 
breaks, some salsa dancing, fruitful teamwork, housewarming parties, team-building 
moments and/or a beer at the end of the week which sometimes leads to even more lively 
discussions,  
Het ATP is essentieel/onmisbaar voor CMET en voor de doctoraatstudenten. Mike, 
Greet, Siska, Annick en Renée, dank u voor de hulp in het labo, bij dringende bestellingen 
en voor het bezorgen van het nodige materiaal. Christine, Regine en Sarah, bedankt voor 
jullie vriendelijke hulp met de vele praktische regelingen en administratie en voor de 
gezellige koffiekletsjes, Tim, heel erg bedankt voor de hulp en tips bij het moleculair 
labowerk (vooral de qPCR’s), de leuke gesprekken tijdens de drinks of in de Koepuur, en 
sorry voor de vele (vele) keren dat ik aan je bureau stond en niet meer wist waarvoor ik weer 
juist kwam. Jana, enorm bedankt voor de vele keren dat je geholpen hebt met de SHIME, 
met opgroeien van bacteriën, met staalnames en met analyses. Het was altijd een plezier om 
samen met jou in het labo te staan. 
I would also like to thank all the people from the HAM cluster, for the nice clusters, the 
discussions, the interesting input and ideas. Marta, you helped me enormously with the cell 
experiments, with the lab work as well as with the interpretation of the results and the 
experimental set-up. I really enjoyed working with you. I would also like to thank my former 
and present office mates, Kim, Kristof, Jo, Xu, Elham, Rui, Ramiro and Yianyun. Kristof, 
sorry voor het inpalmen van je bureau de laatste maanden, het is weer helemaal van jou nu.  
Er zijn enkele mensen die ik in het bijzonder wil bedanken: Annelies, het was heel erg 
leuk om met jou samen te werken, zowel tijdens mijn thesis als tijdens mijn doctoraat, 
bedankt voor het delen van al je kennis en voor de hulp en begeleiding. Ik genoot ook van 
onze occasionele avondjes in De Walrus of op Zebra Beach met enkele glazen wijn, dat 
moeten we snel nog eens opnieuw doen. Rosemarie, het was steeds interessant om jouw 
input te hebben en ik heb veel geleerd uit onze samenwerking, zowel op wetenschappelijk 
als communicatief vlak. Daarnaast hebben ook onze persoonlijke gesprekken mij veel deugd 
gedaan. Eline (en Elien), Jana (en Bart) en Kim, onze gezellige etentjes en avonden zijn 
altijd een succes en doen mij veel deugd. Ik hoop dat we die traditie blijven verder zetten. 
Eline, bedankt voor het beantwoorden van mijn talrijke vragen omtrent celwerk en het 
Dankwoord 
234 
finaliseren van het doctoraat, voor je hulp bij mijn discussie en voor de gezellige pauzes. 
Kim, we zijn samen aan ons doctoraat begonnen, en ik ben zeer blij dat we in hetzelfde 
bureau terechtgekomen zijn. Ik kan eigenlijk onmogelijk beschrijven hoeveel ik aan jou heb 
gehad; je had altijd een luisterend oor als ik luidop wou nadenken (waarschijnlijk tot redelijke 
ergernis van de bureaugenootjes), bood een ongelooflijke hulp bij het verwerken van mijn 
data tot het nalezen van mijn papers, was een lichtend voorbeeld qua werkethiek en 
grondigheid, je zorgde ervoor dat ik de lat altijd wat hoger wou leggen voor mezelf. Ik ga het 
enorm missen om niet meer met jou een bureau te delen, mee je fruitsla op te eten en 
dagelijks ons praatje te doen. Gelukkig zijn we ondertussen goed bevriend en zullen we 
elkaar zeker wel blijven zien! Dries, wat was het een zaligheid om zo een goede vriend te 
hebben op het werk, altijd iemand om bij terecht te kunnen met eender wat, met oneindig 
veel koffiepauzes en leuke gesprekken, iemand die me kon motiveren als het tegenstak. Ik 
kijk uit naar nog vele ‘donderdagavonden’, wandelingen, weekends en fietstochten samen 
met Burcu, Tom, Brecht en Dorien. 
Ook naast het labo waren er heel wat mensen die steeds achter mij stonden en mij 
steunden, door soms te luisteren naar de gang van zaken en ervoor te zorgen dat ik het 
allemaal achter mij kon laten. Lotte, Eva, Emma, Sanne, Sanne, Tom, Brecht, Jonas, 
Leah, Waso, Joosje, Margot, Tinne en Lore; jullie hebben mee gevolgd en meegeleefd 
met mijn doctoraat, sommigen van zeer dicht, anderen van wat verder. Jullie schijnbaar niet 
aflatende interesse in en medeleven met de triomfen en teleurstellingen, maakt mij zeer 
dankbaar en gelukkig. Het was zeer geruststellend te weten dat ik na een moeilijke werkdag 
bij een van jullie terechtkon om te bekomen en mijn verhaal te doen. Lotte, lieve Lotte, dank 
u voor zo veel, om mij goed te begrijpen, om met mij te lachen en op te peppen als ik het 
nodig heb, omdat je zo een leuk persoon bent. Eva, ik geniet steeds van onze momenten en 
zoals al veel gezegd (en misschien maken we het wel waar), we moeten dringend eens tête-
à-têten. Leah, Eva en Lotte; jullie hebben me over mijn schrijfangst/aversie geholpen en mij 
“een shot onder mijn gat gegeven” wanneer ik het nodig had. Margot (en Jan en Thur), ik 
heb enorm genoten van onze wandelingen, gezelschapsspel-namiddagjes of gewoon 
koffiekletsen. Ik ben zo blij dat jullie in Gent wonen en dat ik af en toe kan binnenspringen. 
Leah en Waso, op korte tijd zijn jullie heel belangrijke mensen geworden in mijn leven en dat 
maakt me gelukkig. Jullie zijn ongelooflijke mensen, waar ik mee kan blijven praten en 
heerlijk discussiëren (Waso). Op nog vele ‘vergaderingen’ en vakanties en lange leve Como 
17, meer van dat! Sanne (Devaddere), we begrijpen elkaar, laten we dat vooral zo houden 
en nog veel aperitiefjes op het terras en lange, eerlijke gesprekken. Sanne (Nackaerts), heel 
blij dat jij nog bent gaan bijstuderen in Brussel en we je zo via Simon hebben leren kennen. 
Ik geniet van onze tête-à-têtes, ook al worden ze soms geparty-crashed, laten we dat vooral 
blijven doen! Eva, Hannah, Laura, Rebecca en Tinne; we zien elkaar niet meer zo heel 
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veel, we zijn allemaal wat verspreid geraakt maar jullie blijven ‘de verdinnen’. Ik beloof dat ik 
vanaf nu weer meer aanwezig zal zijn op onze (poging tot) tweejaarlijkse reünies. Tinne, we 
hebben beiden een drukke periode achter de rug en ik ben zeer blij dat jij er toch voor zorgde 
wat we elkaar af en toe hoorden en zagen. Ook aan jou beloof ik beterschap, beginnende 
met onze staptocht, ik kijk er enorm naar uit!  
Lore, jij hebt gesupporterd vanuit Mexico en Burkina Faso, via Whatsapp, Skype en 
Facebook. Je bent een enorm belangrijk persoon voor mij en ik ben dan ook zeer gelukkig 
dat je weer in ons Belgenlandje bent, onze deur staat steeds open! 
Naast mijn vrienden, kon ik ook steeds terecht bij mijn (schoon)familie. Meter Mia en 
peter Willem, heel erg bedankt voor jullie continue interesse en steun, ik kon het niet beter 
treffen. Ook bedankt aan Katleen, Nico, Filip, Elske, Hilde, Freddy en de kindjes, jullie zijn 
een heerlijke schone familie om in terecht te komen en ik geniet steeds van elke 
familiebijeenkomst. Ik kan ook steeds terecht bij mijn fantastische zussen, 3 magnifieke 
vrouwen, die mij elk op hun eigen manier ondersteunen: Marie, ik wil je bedanken om zo 
strijdvaardig naast mij te staan en in mij te geloven; Jo, jouw kalme en kritische analyse van 
de stand van zaken biedt vaak een nieuw perspectief en Margo; bij jou kan ik steeds terecht 
met mijn twijfels en dilemma’s, die je steeds begripvol oplost (soms vergeet ik dat jij de 
jongere zus bent). Dankzij die drie zussen heb ik ook drie schoonbroers; Thomas, Sander 
en Rein, ook jullie bedankt voor jullie interesse en steun. Mama en papa, ik weet niet hoe ik 
jullie voldoende kan bedanken voor jullie continue geloof en vertrouwen in mij. Jullie zijn mijn 
trouwste supporters en ik had dit niet gekund zonder jullie. Bedankt voor alles wat jullie me 
tot nu toe al gegeven hebben, ik kan het me niet beter wensen. 
Peter, liefste schat, bedankt om de laatste 6 jaar aan mijn zijde te staan en in mij te 
geloven. In de tijdspanne van mijn doctoraat zijn we gaan samenwonen, getrouwd, heb jij 
twee zaken geopend en hebben we mooie reizen gemaakt. Je gelooft in mij, ondersteunt me 
en je kan me als geen ander tot rust brengen. Jouw werkethiek werkt inspirerend en je hebt 
de laatste schrijffase draaglijker gemaakt door voor mij te koken en te zorgen en doordat 
we ’s avonds samen werkten in de living. Ik kijk uit naar onze komende jaren. 
 
Florence, 17 juni 2018 
 
 
 
 
 
 
